<<

DIRECTORATE, MEDICAL & HEALTH SERVICES, (E.S.I. SCHEME) LAXMINAGAR, AJMER ROAD, JAIPUR-302006 Tel/Fax 0141-2223572,www.health.rajasthan.gov.in/esi E-Mail [email protected],[email protected]

Ref. No. F434/ESI/Store/LabEmp/2017/5540 Dated:01/11/2017

E- Tender Document

For

“E- Tender forAnalysis of Drugs, Cotton, Gauzes, Bandage & Other items”

For The

Office of the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur & attached ESIS Institutions in Rajasthan ( for the period of two years from the date of award. )

( Non-transferable )

Price of Tender Document Rs. 2000/-

Last date & time of submission of Technical & Financial Bids is 11.12.17 at 1:30 pm

Date & time of online opening of Technical Bid is 11.12.17 at 3:00 pm

Visit Us At http://sppp.raj.nic.in, www.dipronline.org, http://eproc.rajasthan.gov.in, www.health.rajasthan.gov.in/esi

Our Address: DIRECTORATE, MEDICAL & HEALTH SERVICES, (E.S.I. SCHEME) LAXMINAGAR, AJMER ROAD, JAIPUR-302006

1/71

DIRECTORATE, MEDICAL & HEALTH SERVICES, (E.S.I. SCHEME) LAXMINAGAR, AJMER ROAD, JAIPUR-302006 Tel/Fax 0141-2223572,www.health.rajasthan.gov.in/esi E-Mail [email protected],[email protected]

Ref.No.F434/ESI/Store/LabEmp/2017/ 5540 Dated:01/11/2017 E-bids in two separate bids (Technical & Financial) for the Empanelment of Analytic Testing Laboratories For The Test and Analysis of drugs, cotton, bandage, gauze & other items.

Brief Details of E-Tender

 Estimated Cost : Rs 50 lacs  EMD (Bid Security)Rs 100000/-  RISL processing fees Rs 1000/-  Cost of the Tender Document Rs 2000/-  Performance Security 5% of contract value  Services Required:- The service of analysis of drugs, cotton, gauze, bandages & other items are required in the office of the Director cum Ex- officio Dy. Secretary, Medical & Health Services, ESI Scheme, Laxmi Nagar, Ajmer Road, Jaipur abbreviated as DMHS ESIS in this Document & attached ESIS Institutions in Rajasthan.  Period of services will be for 2 years from the date of award.

Schedule of Tender

Description of Tender Process Date & Time Pre-bid conference(ESI Directorate Meeting 16.11.2017 at 1.30 p.m. Hall) Date & time for downloading Tender 07.11.2017 at 6.00 p.m. Document Last date & time for submission of online 11.12.2017 at 1.30 p.m. bids Last date of physical submission of EMD, 11.12.2017 at 1.30 p.m. Tender Document fees, Processing fees Date & time for on-line opening of 11.12.2017at 3.00 p.m. Technical Bid Date & time for opening of Financial Bid(For Will be intimated later on technically qualified bidders ) Bid validity period/validity of bid offer for 70 days from the date of opening of the acceptance by DM&HS ESI Technical Bid

2/71

Eligibility Criteria for Empanelment

(1) Drugs Testing Laboratories should have valid approval for carrying out test on drugs under the Drugs and Cosmetics Act, 1940 and rules there under, with three years standing in drugs, cotton, gauzes, bandages & other item. The Laboratory shall be entitled for empanelment for the categories of items for which Laboratory is having approval. Tender is invited from approved Drugs Testing Laboratories situated in India.

(2) The Laboratory should be GLP compliant under the provision of Drugs and Cosmetics Act, 1940 and rules there under and should hold schedule L-1 certificate or should have NABL accreditation with proper scope of accreditation to undertake testing of drugs, cotton, gauzes, bandages & other items.

(3) The Laboratory should have an average annual turnover of not less than Rs. 50 Lacs for past preceding three years (2013-14, 2014-15, 2015-16 OR 2014-15, 2015-16, 2016-17).Relaxation will be given to Government undertaking/PSU on producing the certificate issued by the competent authority. The certificate should be scanned & uploaded online at the time of submission of tender documents in Technical Bid.

(4) The Laboratory should have undertaken test and analysis of drugs, cotton, gauzes, bandages & other items and supplies of similar nature of at least three government institutions/corporation/ reputed manufacturers of drugs, cotton, gauzes, bandages & other items.

(5) The Laboratory should not stand banned / debarred or blacklisted by any State or Central Government Organizations or its central procurement agencies on the due date of bid submission.

(6) The Laboratory and its responsible persons should not have been convicted under the provisions of applicable laws with regard to the activities and conduct of the Laboratory.

(7) The Laboratory should have all necessary instruments/ equipments/ machines for testing of drugs, cotton, gauzes, bandages & other items. as per standards laid down in Drugs & Cosmetics Act/Pharmacopoeia/ Bureau of Indian Standards and other standards as applicable/ desired.

(8) The Bidder should submit test parameters for individual item given in Annexure-IX as per per standards laid down in Drugs & Cosmetics

3/71

Act/Pharmacopoeia/ Bureau of Indian Standards and other standards as applicable/ desired and should have facilities of testing for the same.

General Conditions

(1) The details of the drugs, cotton, gauzes, bandages & other items to be analyzed has been given in Annexure-IX.

(2) The Bidder should fill the names of test and the procedure to be performed for each item given in annexure-IX as per standards laid down in Drugs & Cosmetic Act/ Pharmacopoeia /Bureau of Indian Standards and other standards as applicable/ desired when submitting Technical Bid. However, the rates for the complete analysis of each item should be submitted in BoQ in Financial Bid. Wherever tests are prescribed and their names and methodology for testing are not stated, such Laboratory will not be considered responsive for testing for such item.

(3) The rates quoted should be exclusive of taxes. The rates quoted should not be higher than quoted elsewhere in any other government institution or rate prevalent in market, otherwise necessary action will be taken to recover the difference amount.

(4) The rates quoted and accepted will be binding on the Bidder for the stipulated period and on no account any revision will be entertained till the completion of the bid period.

(5) Analytical Laboratory, which also has its manufacturing activity, if empanelled by Director cum Ex-officio Dy. Secretary, Medical & Health Services E.S.I. Scheme, Rajasthan, Jaipur [DMHS(ESIS)] then samples of its own manufacturing unit shall not be sent to its Empanelled Laboratory for testing.

(6) The Laboratory will not be permitted to outsource any test from other Laboratory.

(7) DMHS(ESIS) shall have the right to cause the Laboratory to be inspected by the members of its Technical Committee before opening of Financial Bid and subsequently as and when considered appropriate and based on the findings, the Bidder may be disqualified or de-empanelled, as the case may be. 4/71

(8)The successful Bidder will have to collect the samples from Office of the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur & attached ESIS Institutions in Rajasthan at his/her own cost & the cost of transport of items will not be paid separately. At present there are 78 ESIS Instiutions under this office in Rajasthan. The number of ESIS Institutions may be increased or decreased at any time. (9)The department reserves the right to amend or withdraw any of the terms and conditions contained in the Tender Document or to reject all tenders without assigning any reason. The decision of the Director cum Ex-officio Dy. Secretary, Medical & Health Services, ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur in this regard shall be final & binding on all.

Special Instruction Before Participating in Tender

(1)Read Tender Document carefully :The Bidder should go through the detail mentioned in Tender Document completely before submitting the bids.

(2)Compliance with code of integrity: Any person participating in empanelment process shall:-

(a) not offer any bribe, reward or gift or any material benefit either directly or indirectly in exchange for an unfair advantage in procurement process or to otherwise influence the procurement process; (b) not misrepresent, omit, mislead or attempt to mislead so as to obtain a financial or other benefit or avoid an obligation;

© not indulge in any collusion, bid rigging or any-competitive behavior to impair the transparency, fairness and progress of the procurement process;

(d) not misuse any information shared between the Procuring Entity and the bidders with an intent to gain unfair advantage in the procurement process;

(e) not indulge in any coercion including impairing or harming or threatening to do the same, directly or indirectly, to any part or to its property to influence the procurement process;

(f) not obstruct any investigation or audit of a procurement process;

(g) disclose Conflict of Interest, if any; and

5/71

(h) disclose any previous transgressions with any entity in India or any other country during the last three years or any debarment by any other Procuring Entity.

(3)No Conflict of Interest: The Bidder participating in a bidding process must not have a Conflict of Interest. A Conflict of Interest is considered to be a situation in which a party has interests that could improperly influence that party’s performance of official duties or responsibilities, contractual obligations, or compliance with applicable laws and regulations. A Bidder may be considered to be in Conflict of Interest with one or more parties in bidding process if including but not limited to :

(a) have controlling partners/shareholders in common; or

(b) receive or have received any direct or indirect subsidy from any of them; or

(c) have the same legal representative for purposes of the bid; or

(d) have a relationship with each other, directly or through common third parties, that puts them in a position to have access to information about or influence on the bid of another Bidder, or influence the decisions of the Procuring Entity regarding the bidding process; or

(e) the Bidder participates in more than one bid in a bidding process, participation by a Bidder in more than one bid will result in the disqualification of all bids in which the Bidder is involved. However, this does not limit the inclusion of the same subcontractor, not otherwise participating as a Bidder, in more than one bid; or

(f) the Bidder or any of its affiliates participated as a consultant in the preparation of the design or technical specification of the goods , works or services that are the subject of the bid; or

(g) Bidder or any of its affiliates has been hired (or is proposed to be hired by the Procuring Entity as engineer-incharge/ consultant for the contract.

6/71

Procedure to Be Followed :

(1) Deposit Bid Security (EMD), Tender Document fees and RISL (Rajcom Info Service Limited)Processing fees. The last date to deposit these fees is 11.12.2017 at 1.30 pm.

(a) The Bid Security (EMD) of Rs 100,000/- shall be taken as DD for an amount of Rs. 100,000/- (Rupees one lac only) from Nationalized Scheduled Bank drawn in favor of Director Cum Ex-Officio Dy. Secretary, Medical & Health Department, ESI Scheme, Rajasthan Jaipur, payable at Jaipur , has to be submitted offline (and scanned copy of DD to be uploaded online at the time of submission of tender documents in Technical Bid) towards EMD fees, failing which tender will be rejected. Bidders are requested to write their name & full address at the back of the bank draft submitted.

Government undertaking/PSU are exempted for bid security on producing the certificate issued by the competent authority. The certificate should be sent offline & copy of the same should be scanned & uploaded online at the time of submission of tender documents in Technical Bid.

The Bid Security will be forfeited if the Bidder withdraws its bid after expiry of last date & time fixed for receiving bids or in the case of successful Bidder, if the Bidder fails within specified time to sign the contract agreement or/& fails to furnish the Security Deposit (Performance Security).

(b) The Tender Document fees of Rs 2000/-(non-refundable) shall be taken as DD for an amount of Rs.2000/- (Rupees two thousand only) from Nationalized Scheduled Bank drawn in favor of Director Cum Ex-Officio Medical & Health Department ESI Scheme, Rajasthan Jaipur, payable at Jaipur , has to be submitted offline (and scanned copy of DD to be uploaded online at the time of submission of tender documents in Technical Bid) towards Tender Document fees, failing which tender will be rejected. Bidders are requested to write their name & full address at the back of the bank draft submitted.

(c) Rajcom Info Service Limited (RISL) Processing fees of Rs 1000/-(non- refundable) shall be taken as DD for an amount of Rs.1000/- (Rupees one thousand only) from Nationalized Scheduled Bank drawn in favor of MD Rajcom Info Service Limited payable at Jaipur , has to be submitted offline (and scanned copy of DD to be uploaded online at the time of submission of tender

7/71

documents in Technical Bid) towards RISL Processing fees, failing which tender will be rejected. Bidders are requested to write their name & full address at the back of the bank draft submitted.

(d) The aforesaid DDs toward EMD, Tender Document fees & RISL Processing fees should be submitted offline to the tender inviting authority i.e. Director Cum Ex-Officio Dy. Secretary, Medical & Health, ESI Scheme, Rajasthan, Jaipur, Laxmi Nagar, Ajmer Road, Jaipur 302006 on or before 11.12.17 at 1.30 pm & the scanned copies to be uploaded online on or before 11.12.17 at 1.30 pm with Technical Bid, failing which tender will be rejected. Bidders are requested to write their name & full address at the back of each of the aforesaid bank drafts before submitting offline. The aforesaid DDs should bear the date after the date of notice inviting tender (NIT).

(e) The aforesaid DDs should be submitted offline in the duly sealed water proof envelope. The envelope should super-scribed as:

“E-Tender for Empanelment of Analytic Testing Laboratories For the Test & Analysis of Drugs, Cotton, Gauzes, Bandages. Don’t open before 11.12.17”

(f ) The address to send the sealed envelope is DIRECTORATE, MEDICAL & HEALTH SERVICES, (E.S.I. SCHEME) LAXMI NAGAR, AJMER ROAD, JAIPUR-302006 and last date to receive the sealed envelope is 11.12.2017 on 1.30 PM. If the envelope is sent by registeredpost/courier it should be recieved on or before 11.12.2017 on 1.30 PM in the office of DIRECTORATE, MEDICAL & HEALTH SERVICES, (E.S.I. SCHEME) LAXMI NAGAR, AJMER ROAD, JAIPUR-302006. Therefore bidders must post this envelope timely & this office shall not be responsible for delay.

(2)Submission of bids : (a) In order to submit the Bids, the aspirating Bidders have to get themselves registered online on the e-procurement portal (http://eproc.rajasthan.gov.in.) with valid Digital Signature Certificate (DSC).The online registration of the Bidder will be free of cost and one time activity only.The registration should be in the name of Bidder, whearas DSC holder may be either Bidder himself / herself or his/her duly authorized person.

(b)Signature of Bidder : individuals signing tender or other document connected with contract specifying :- (i) Whether signing as a “Sole Proprietor” of the firm or his attorney.

8/71

(ii) Whether signing as a “Registered Active Partner” of the firm or his attorney. (iii) Whether signing for the firm “Per procuration” (iv) In the case of companies firm registered under the Indian Partnership Act the capacity in which signing ex secretary, manager, partner etc or their attorney and produce copy of documents, empowering him to do so, it called upon to do so. (v) In case of unregistered firm all the members or all attorneys duly authorized by all of them or the manager of the firm should sign the tender and subsequent documents.

(c) E- Bids in two separate bids ( Technical & Financial Bid ) will be received till 1:30pm on 11.12.2017 by the Director cum Ex-officio Dy. Secretary, Medical& Health, Services ESI Scheme, Rajasthan, Jaipur for the empanelment of Analytical Laboratory for the test and analysis of drugs, cotton, gauge, bandage for the period of two years from the date of award.

(d)The bid along with necessary documents should be uploaded in the eproc.rajasthan.gov.in portal as per guideline mentioned in the portal. Tenders have to be submitted only online at http//eproc.rajasthan.gov. in two bids system i.e. Technical Bid & Financial Bid in the prescribed Performa. All the documents in support of eligibility criteria etc. are also to be scanned & uploaded along with tender documents. Tender sent by any other mode will not be accepted.

(e)The bids shall be valid for a period of 70 days from the date of opening of Technical Bid .

(f) The Bidder must furnish the following in Technical Bid in the same order as given below. Any additional document if necessary should be annexed in the last.

(i)The bidders shall submit / upload scanned copy of DDs towards EMD,Tender Document fees, RISEL Processing fees in Technical Bid. (ii) Documentary evidence for the constitution of the company/concern. (iii) Attested photocopy of analytical approval duly renewed up to date, issued by the State Licensing Authority. (iv) Compliance of Schedule L-1 of Drugs & Cosmetics Rules, 1945 (GPL certificate)/Copy of NABL accreditation with proper scope for testing of drugs, cotton, gauzes, bandages & other items. (v) Non- Conviction Certificate by the State Licensing Authority/ competent authority.

(vi) Attested copy of certificate of registration for GST.

(vii) A copy of PAN issued by Income Tax Department. 9/71

(viii) Copies of the Balance sheet and Profit and Loss Account for three years i.e. 2013-14, 2014-15, 2015-16, or, 2014-15, 2015-16, 2016-17, duly certified by the practicing Chartered Accountant.

(ix) Annual turnover statement for 3 years i.e. 2013-14, 2014-15, 2015-16, or 2014-15, 2015-16, 2016-17, certified by the practicing Chartered Accountant. (Annexure-I)

(x) Documentary evidence of having analyzed of drugs, cotton, gauzes, bandages & other items for the last three years with a statement in the Performa as given in Annexure-II.

(xi) The list of qualified personnel employed in the Laboratory with proof of their qualifications and relevant approvals. (Annexure-III) (xii) The list of sophisticated instruments available in the Laboratory. (Annexure-IV)

(xiii) Micro Biological facilities available in the Laboratory. (Annexure-V)

(xiv) List of Reference sample along with their date of procurement and quantities, wherever required . (Annexure-VI)

(xv) A declaration in the Performa given in Annexure-VII duly signed and Notarized.

(xvi) Details of Laboratory in Annexure – VIII.

(xvii) List of drugs , cotton, gauzes, bandages & other items proposed to be testing is in Annexure-IX Bidders are allowed the option to quote for any one item or more items as mentioned in bid. The Bidder has to mention names of test and the procedure to be performed for each item given in Annexure-IX as per standards laid down in Drugs & Cosmetic Act / Pharmacopoeia / Bureau of Indian Standards and other standard as applicable/ desired.

(g) The Financial Bid will also be known as Price Bid/Document and every Bidder will be required to submit its price in excel format attached to the Price Bid Document (BoQ). BoQ template must not be modified / replaced by the Bidder and the same should be uploaded after filling the relevant columns, else the Bidder is liable to be rejected for this bid. Bidders are allowed to enter the Bidder name and values only The Bidder should quote rate for the complete tests as applicable to the item. The rate for sterility test for sterile products should also be quoted separately at last entry of BoQ.

Opening & Evaluation of Technaical & Financial Bids

(1) The Technical Bid will be opened on 11.12.2017 at 3.00 pm. There after the bidders found eligible as stated above on the basis of the examination on Technical Bid, the Financial Bid will be opened on the date intimated and after scrutiny thereof, including inspection of the laboratory, if required, the acceptable rates for analysis will be decided and communicated.

10/71

(2) Provided that a Financial Bid is substantially responsive, the Procuring Entity will correct arithmetical errors during evaluation of Financial Bids on the following basis:

(i) If there is a discrepancy between the unit price and the total price that is obtained by multiplying the unit price and quantity, the unit price shall prevail and the total price shall be corrected, unless in the opinion of the Procuring Entity there is an obvious misplacement of the decimal point in the unit price, in which case the total price as quoted shall govern and the unit price shall be corrected.

(ii) If there is an error in a total corresponding to the addition or subtraction of subtotals, the subtotals shall prevail and the total shall be corrected; and

(iii) If there is a discrepancy between words and figures, the amount in words shall prevail, unless the amount expressed in words is related to an arithmetic error, in which case the amount in figures shall prevail subject to clause (i) and (ii) above. If the Bidder that submitted the lowest evaluated bid does not accept the correction of errors, its bid shall be disqualified and its Bid Security shall be forfeited or its Bid Securing Declaration shall be executed.

Acceptance of Bid

(1) The Bid Evaluation Committee formed by the Director cum Ex-officio Dy. Secretary, Medical & Health, Services ESI Scheme, Rajasthan, Jaipur will evaluate the bid with reference to various criteria.

(2) The Director cum Ex-officio Dy. Secretary, Medical & Health, Services ESI Scheme, Rajasthan, Jaipur reserves the right to accept or reject any bid for any one or more of the items bidded for, without assigning any reason.

(3)The acceptance of Bid on the basis of BoQ submitted on line by the Bidder will be provisional and successful Bidder must submit duly stamped and signed copy of BoQ &/or duly stamped and signed copy of revised rates if any as a result of Negotiation to the tender inviting authority to proceed for agreement and deposition of Performance Security.

Agreement & Performance Security

(1) The agreement with Empanelled Laboratories will remain valid up to 2 years from the date of award. This may be further extended for a further period of upto one year with mutual consent.

11/71

(2) All bidders who are empanelled will have to execute an agreement on a non- judicial stamp paper of value Rs. 1000/- (Stamp duty to be paid by the Bidder), in favor of the Director cum Ex-officio Dy. Secretary, Medical & Health, Services ESI Scheme, Rajasthan, Jaipur within 15 days from the date of receipt of the intimation to them informing that their bids have been accepted, the form of agreement will be issued by Director cum Ex-officio Dy. Secretary, Medical & Health, Services ESI Scheme, Rajasthan, Jaipur.

(3) The Bidder shall not, at any time, assign, sub-let or make over the contract or the benefit therefore or any part there of to any person or persons whatsoever.

(4) All notices or communication relating to, or arising out of this agreement or any of the terms thereof shall be considered duly served on or given to the Bidder if delivered to him or left at the premises, places of business or abode.

(5) The successful Bidders shall be required to deposit Performance Security @ 5% of contract value in the form of demand draft at the time of execution of the agreement. Performance Security will be refunded three month after expiry of rate contract subject to successful completion of services.

(6) Term & condition of Agreement :

1 (a) On empanelment and entrustment of the job, the Analytical Laboratory should furnish the test reports within;

(i)10 days from the receipt of the sample in case of (non-sterile products)

(ii) 21 days from the receipt of the sample of drugs, cotton, gauzes, bandages & other items requiring test for sterility.

(b) All the tests prescribed under Drugs & Cosmetics Act/BIS etc. (as the case may be) should be carried out for each and every sample. The results obtained in the test should be mentioned in numerical value (wherever possible). However this condition will not apply when only specific testing is called for/desired on any particular sample.

(c) “COMPLIES” or “PASSES” in the result column of the report of is treated as incomplete report, if the result has some numerical value.

(d) Every test report must have remarks either as “Standard Quality or “Not of Standard Quality”. Any ambiguity/cutting in reports will not be accepted (clear mention of “standard quality or not of standard quality” should be stated in bold letters and crossing/cutting of one of these will not be accepted).

(e) Reports should be in A4 size (8.27” X 11.69”) paper of good quality.

(f) Report should be issued on form 39 and should have serial number, name of drug sample, code number, manufacturing date, expiry date , description of tests, protocol of test specified & applied, findings & results obtained and should be signed by person-in-charge of testing. In the case of products not falling in Pharmacopoeia Drugs & Cosmetics Act 1940 and rules 1945, BIS etc, the method of analysis must be appended

12/71

to the report, especially if the sample is declared as “Not of Standard Quality”. In case of Not of Standard Quality Report the final results and reason for failure should be highlighted by pink/red highlighters.

(g) Reports should be attached along with spectra / chromatography data sheets, if applicable and it will be considered incomplete if spectra of chromatograms are not attached,

2. All test reports of each batch of sample should be submitted to the ESIS Institute from where the samples were collected in triplicate. In case of failure of a sample, the result should be communicated immediately to the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur as well as to the ESIS Institute from where the sample was collected through phone / e-mail and the report should be sent along with protocol.

3. If in any circumstance (like break down of instrument, non-availability of reference standard etc,) the Analytical Laboratory is unable to undertake analysis for a sample it should be reported within 24 hours of receipt of such a sample by phone or e-mail and the sample , the such sample should be returned to ESIS Institute from where it was collected after taken necessary telephonic or mail consent, In case of inability of Laboratory to undertake the testing, a penalty of 25% of testing charges applicable for the product / products will be recovered.

4. If standard test procedure of any product is required the same should be demanded within 48 hours from date of receipt of sample. Period lapsed / taken in providing standard testing procedure will be condoned from prescribed time limit for that sample.

5. If any sample is received in a damaged condition by the Laboratory, the sample should not be analyzed and the information should be sent immediately to the ESIS Institute from where it was collected by telephone & e-mail.

6. The Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur or his authorized representative (s) has/have the right to inspect the Laboratories of the Bidders who have submitted bids, before taking any decision regarding empanelment. Similarly, the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur or his authorized representatives may also inspect any empanelled Laboratory, at any point of time during the continuance of the bid and terminate/cancel its empanelment or any orders issued to the Laboratory, not to entrust any further testing job to the Laboratory based on facts brought out during such inspections.

7. The successful Laboratory shall have to make own arrangement for collection of sample, from Office of the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur & attached ESIS Institutions in Rajasthan. If more than one samples are received of the same batch number of any item from same or different ESIS Institutions it should be informed to Manager Central Medical Store , Directorate Medical & Health Services ESI Scheme Laxmi Nagar Ajmer Road Jaipur and prior permission to test the sample of same batch number must be taken in written from this office otherwise testing charges wii not be paid to the Empennelled Laboratory.If pemission is not provided sample should be returned to the ESIS Institute/ Central Medical Store from where the sample of same batch number was received.

8. It will be sole discretion of DMHS(ESIS) to allot the samples to any Empanelled Laboratory in case when there are more than one Laboratory approved for item.

PAYMENT PROVISIONS

1. No advance payment towards any analysis will be made to the empanelled Bidder, 2. No payment will be made for the incomplete analysis or incomplete report. Deliberate o mission of any critical test will be viewed seriously and shall invite action against the Laboratory as deemed fit by DMHS(ESIS). 3. Payments towards the analysis of drugs, cotton, gauzes, bandages & other items will be made as per approved rate plus tax on it will be along with Tax at the prevailing rate as applicable at the time of payment. 4. The bills should submitted in triplet to the ESIS Institute from where the samples were received by the name of the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur

13/71

5. The original bill should be submitted only once otherwise strict action will be taken against such Laboratory. The bill should be sent along with the Testing Report to avoid delay in payment.

6. Fall Clause Certificate (i.e. the rates of testing charged in the bill is not higher than the rates charged in any other contract or rates prevalent in market) should be given on the body of bill.

7.No extra payement will be made towards collection of samples or transport expenditure to and from the Empenelled Laboratory .

8.If any error is found in the procedure of testing laid down by the Bidder in technical bid &/or in the testing report of item, as the case may be then Bidder will be bound to perform the test by correct/standard procedure & in such cases payement will be made at rates for correct/standard procedure of testing or rates agreed in this agreement,whichever is less, and the decision of Director cum Ex-officio Dy. Secretary, Medical & Health, Services ESI Scheme, Rajasthan, Jaipur shall be final and binding to the respective Bidder/Empenelled Laboratory .

10.If in any case standard procedure to be followed is other than the standard procedure submitted in technical bid then no extra payement will be made and the decision of Director cum Ex-officio Dy. Secretary, Medical & Health, Services ESI Scheme, Rajasthan, Jaipur shall be final and binding to the respective Bidder/Empenelled Laboratory .

11.Tender Inviting Authority can send the demand to repeat the testing of the send sample(s) of item(s) for which no extra payement will be made to Bidder/Empenelled Laboratory .The Empenned Laboratory should keep /retain the part of send samples for a period of not less than 3 months from the date of reporting of result of testing of the send samples of items or as per the guideline decided by the competent authority.

PENALTIES

1. If the successful Bidder fails to execute the agreement and payment of Performance Security within the time specified or withdraws the bid after intimation of the acceptance of the bid has been sent to or owing to any other reasons, he is unable to undertake the contract, the empanelment will be cancelled and the Bid Security (EMD) deposited by the Bidder shall stand forfeited in favor of the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur. Such Bidder(s) will also be liable for all damages sustained by the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur due to breach of bid/tender conditions. Such damages shall be assessed by the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur whose decision shall be final.

2. Non performance of any bid or empanelment conditions will disqualify a Laboratory to participate in the bid for the period as decided by DMHS(ESIS).

3. If it is revealed that the Analytical Laboratory is involved in any form of fraud and collusion with the suppliers of Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur, the Analytical Laboratory will be black listed for a period considered suitable. The Bidders shall also be liable for action under criminal law and the matter will be notified to the concerned Director of Drugs Control for suitable action against them under Drugs & Cosmetics Act & Rules.

4. The Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur will be at liberty to terminate without assigning any reasons, the empanelment of any Laboratory either wholly or in part at one month notice. The Bidder will not be entitled for any compensation whatsoever in respect of such termination.

5. In all matters pertaining to the bid, the decision of the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur shall be final and binding.

14/71

6. (i) If the Laboratory requires an extension in time for submission of test report, on account of occurrence of any hindrance he shall apply in writing for extension on occurrence of hindrance but not after the stipulated date of furnishing the test report.

(ii) The Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur may extend the testing period with or without liquidated damages in case they are satisfied that the delay in the submission of test reports is on account of any hindrances, he shall apply in writing for extension on occurrence of hindrance but not after the stipulated date of submission of report, reasons shall be recorded.

(iii) Extension in testing period:- In case of extension in the testing period with liquidated damages the recovery shall be made on the basis of following percentages of testing charges which the Bidder has failed to submit:-

(a) Delay up to one fourth period of the prescribed testing period; 2.5%

(b) Delay exceeding one fourth but not exceeding half of the prescribed testing period; 5%

(c) Delay exceeding half but not exceeding three fourth of the prescribed testing period; 7.5%

(d) Delay exceeding three fourth of the prescribed testing period; 10%

Note :- Fraction of a day in reckoning period of delay in furnish the test report shall be eliminated if it is less than half a day. The maximum amount of liquidated damages shall be 10%

(iv) If, at any time during the continuance of this Agreement, the Laboratory has, in the opinion of the Procuring Entity, delayed in submitting any test report, by the reasons of any riots, mutinies, wars, fire, storm, earthquakes, tempest or other exceptional cause, on a specific request made by the Laboratory, the time for submitting test report as may be extended by the DMHS(ESIS) purely at his discretion for such period as may be considered reasonable. No further representation from the Laboratory will be entertained on this account. Grievance Redressal During Empanelment Process:

The designation and address of the First Appellate Authority is Deputy Secretary, Labour & Employment, Govt. of Rajasthan.

The designation and address of the Second Appellate Authority is Secretary, Labour & Employment, Govt. of Rajasthan.

(1) Filling an appeal

If any Bidder or prospective Bidder is aggrieved that any decision, action or omission of the Procuring Entity is in contravention to the provision of the Act or the Rule of the Guidelines issued there under, he may file an appeal to First Appellate Authority, as specified in the Tender Document within a period of ten days from the date of such decision or action, omission, as the case may be, clearly giving the specific ground or grounds on which he feels aggrieved; provided that after the declaration of a Bidder as successful the appeal may be filed only by a Bidder who has participated in procurement proceedings, Provided further that in case a Procuring Entity evaluates the Technical Bids before the opening of the Financial Bids, an appeal related to the matter of Financial Bids may be filed only by a Bidder whose Technical Bid is found to be acceptable.

(2) The officer to whom an appeal is filed under Para (1) shall deal with the appeal as expeditiously as possible and shall endeavor to dispose it of within thirty days from the date of the appeal

(3) If the officer designated under Para (1) fails to dispose of the appeal filed with in the period specified in Para (2), or if the Bidder or prospective Bidder or the Procuring Entity is aggrieved by the order passed by the First Appellate Authority, the Bidder or prospective Bidder or the Procuring Entity, as the case may be, may file a second appeal to Second Appellate Authority specified in the Tender Document in this behalf within fifteen days

15/71

Annexure-I ANNUAL TURN OVER STATEMENT

The Annual Turnover (for drugs, cotton, bandage, gauze & other items testing services) of M/s.______for the past three years given below and certified that the statement is true and correct.

S.No. Years Turnover in Lacs (Rs) 1 2013-14 2 2014-15 3 2015-16 Total Rs. Lacs

4 2014-15 5 2015-16 6 2016-17 Total Rs. Lacs Average turnover per annual Rs. Lacs

17/71

Annexure-II

PERFORMA FOR PERFORMANCE STATEMENT (for a period of last 3 years)

Name of the Laboratory:______Address:______

S.No. Types of Sample No. of Sample Analysis Analysis during 1 Drugs & Medicines 2013-14 2014-15 2015-16 2 Cotton, Gauzes & 2013-14 Bandages 2014-15 2015-16 3 Others (Specify) 2013-14 2014-15 2015-16

Signature :

Date :

Name of the Lab :

Office Seal :

18/71

Annexure-III

PERSONNEL IN QC DEPARTMENT Name of the Technical Staff approved by State Licensing Authority along with the Designation. Highest Qualification, Experience (Experience relevant to analysis of drugs, cottons, gauzes, bandages & other items)

Signature :

Date :

Name of the Lab :

Office Seal :

19/71

Annexure-IV

LIST OF SOPHISTICATED EQUIPMENT/INSTRUMENT/APPARATUS AVAILABLE IN THE LABORATORY

S.No. Name of the Make & Date of Date of Approved Equipments/Instruments/Apparatus Description Installation Last for testing Validation of drugs from State Licensing Authority Since

Signature :

Date :

Name of the Lab :

Office Seal :

20/71

Annexure-V

FACILITIES IN THE MICROBIOLOGICAL SECTION

I. LIST OF STOCK CULTURES AVAILABLE

II. LIST OF EQUIPMENT/APPARATUS AVAILABLE WITH ADTE OF INSTALLATION, make and approval from Licensing Authority to permit microbiological testing in the Laboratory

Signature :

Date :

Name of the Lab :

Office Seal :

21/71

Annexure-VI

LIST OF REFERENCES SAMPLES ALONG WITH THEIR DATE OF PROCUREMENT AND QUANTITIES, If required for any item.

Signature :

Date :

Name of the Lab :

Office Seal :

22/71

Affidavit (On Non Judicial Stamp of Rs.100/-) Annexure-VII DECLARATION FORM

1. I (Name of the Bidder) S/O______, Age______, Resident of______, am proprietor/Partner/Director having our office at______and the approved drug testing Laboratory (Name)……………………………………………………………………. Situated at (Address) ______do here by declare that I have carefully read all the conditions of bid of Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur for the bids floated for empanelment of approved drugs testing Laboratories for analysis of drugs , cotton, gauzes, bandages & other items for the period of two years from the date of award and shall abide by all the conditions set forth there in.

2. I further declare that I posses valid approval for testing of all the drugs , cotton, gauzes, bandages & other items for which Price Bid have been submitted by me/us in cover B and permission on form 37 have obtained for testing of these items from States Licensing Authority where ever applicable.

3. That the approval to test drugs , cotton, gauzes, bandages & other items have been obtained on Form 37 bearing No.______which is valid/renewed up to ______

4. That the Bidder firm is a proprietorship/Partnership/Pvt. Ltd./Ltd. firm and following are the other partners/directors:-

S.No. Name of Partner/Director Age Present & Permanent Address

5. That ourLaboratory/Firm/Company does not stand blacklisted/debarred or banned on any ground either by Bid Inviting Authority or Govt. or Rajasthan on the date of bid submission.

Our Laboratory/Firm/Company also does not stand blacklisted, debarred or banned on the ground or wrong reporting of test results or on the ground of submission of fake of forged documents or false information/facts, by any State or Central government or by its central drug procurement agencies, on the date of bid submission for supply of drugs/medicines in India.

(Affidavit page 1)

23/71

6. That I/We have carefully read all the conditions of bid in ref. No.______Dated: ______for the empanelment of analytical testing Laboratories for the test and analysis of drugs , cotton, gauzes, bandages & other items for the period of two years from the date of award for Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur and accept all conditions of bid, including a amendments if any.

7. I/We hereby declare under Section 7 of Rajasthan Transparency in Public Procurement Act, 2012. That :

a. I/We posses the necessary professional, technical, financial and managerial resources and competence required by the Tender Document issued by the Procuring Entity;

b. I/We have fulfilled my/our obligation to pay such of the taxes payable to the Union and the State Government or any local authority as specified in the Tender Document;

c. I/We are not insolvent, in receivership, bankrupt or being wound up. Not have

my/our affairs administered by a court or a judicial officer, not have my/our

business activities suspended and not the subject of legal proceedings for any

of the foregoing reasons;

d. I/We do not have, and our directors and officers not have, been convicted of any criminal offence related to my/our professional conduct or the making of false statements or misrepresentations as to my/our qualifications to enter into a procurement contract within a period of three years preceding the . commencement of this procurement process, or not have been otherwise . disqualified pursuant to debarment proceedings;

e. I/We do not have a Conflict of Interest as specified in the Act, Rules and the Tender Document, which materially affects fair competition;

8. Our complete address for communication with Phone No. :- …………………………………………………………………………………………………………………… ……………………………………………………………………………………………………………………

9. E-mail address:-……………………………………………………………………………………………

(Affidavit Page-2)

24/71

10. Bank detail for e-Baking :-

Name of account holder………………………………………………………………………………………….

Full name of Bank with Branch………………………………………………………………………………..

A/c no. with all digits………………………………………………………………………………………………

IFSC code………………………………………………………………………………………………………………..

(Deponent)

Signature : Date : Name of the Lab : Office Seal :

Verification I………………………………………………….S/o……………………………………….(Designation)………………….P rop./Partner/Director of Lab M/s……………………………………….Address………………………………. Affirm oath that the contents/information from para 1 to 10 as mentioned above are true & correct to the best of my knowledge and nothing is hidden. I also declare on oath, that if any information furnished by me as above is found wrong, false, forged or fabricated; the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur will be at liberty to cancel the bid and forfeiting the earnest money deposit and or performance security, for which I shall be solely responsible and the laboratory/firm may be Debarred/Banned/Prosecuted for the same.

(Name of Deponent & Signature) ATTESTED BY NOTARY PUBLIC

(Affidavit Page-3)

25/71

Annexure-VIII

DETAILS OF LABORATORY

1. Name of the Laboratory & Full Address : Phone No. (Landline) : Fax : Email : 2. Other Branches & their Address (if any) :

3. Whether the firm has it own manufacturing unit? : If yes give details or address, license number etc. : 4. Date of Start testing or drugs , cotton, :

gauzes, bandages & other items

5. Approval No. & Date :

6. Approval Issues by :

7. Valid up to :

8. Schedule L-1 certificate its no. and date or issue :

9. (i) NABL Accreditation no. & date : (ii) Scope of Accreditation : (iii) Its validity : 10. Name of the authorized Signatory of Laboratory :

11. Specimen Signature of the authorized : Signatory of Laboratory 12. Names & Specimen Signatures of the : Approved technical Staff who are a authorized to sign the test reports

(1) (Name) (Specimen Signature)

(2) (Name) (Specimen Signature)

26/71

List of drugs, cotton, gauzes, bandages & other items Annexure-IX

S.No. Item NAME OF ITEM Pack Name of test & procedure Remark code as per standards laid down in drugs & cosmetics Act/Pharmacopoeia/ Bureau of Indian Standards and other standards as applicable/ desired. 1 2 Antacid gel Each 10ml. to contain : Mag Hyd 185mg., 170ml Dimethicone 50mg., Sodium Car methyl cellulose 100mg., Dried Al Hyd gel 830mg. 2 5 Omeprazole Cap Each cap. to contain : Omeprazole 20mg IP 10 Caps 3 6 Tab. Bisacodyl Each tab to contain: Bisacodyl 5mg, IP 10 Tab 4 8 Tab. - Each tab. to contain: Metoclopramide HCL 10 Tab 10mg, IP 5 10 Inj. Metoclopramide 5mg, IP-Metoclopramide HCL Eqv.to 2ml amp Metoclopramide 5 mg. 6 13 Syp. - Each tab. to contain: Promethazine 5mg., IP 100ml Bott. 7 14 Promethazine Inj. Each ml. to contain : Promethazine 25mg. 2ml amp 8 16 Antispasmodic Drops/suspenson Each ml. to contain : 1ml bottle Dicyclomine hcl 10mg. Activated dimethicone 40mg 9 18 Dicyclomine & Paracetamol Tab. Each tab to contain: 10 Tabs Dicyclomine 20mg Paracetamol 325 mg 10 19 Dicyclomine Inj. Each 2ml. to contain : Dicyclomine 10mg. 2ml amp 11 20 Tab. Furazolidone Each tab. to contain : Furazolidone100mg, IP 10 tab. 12 21 Susp. Furazolidone Each 5ml. to contain : Furazolidone 25mg, IP 60ml bot 13 24 Metronidazole Each 5ml to contain Metronidazole 200 mg 100ml bottle 14 25 Susp. Metronidazole Each 5ml. to contain : Metronidazole 60ml bot 200mg, IP 15 26 Norfloxacin & Tinidazole Each tab. to contain : 10 Tabs Norfloxacin400+Tinidazole 600 Tab 16 27 Cap. Digestive- Each cap. to contain: Fungal Diastase (1:2000) 10 Cap 20mg, Lactic acid Bacillus 150million Spores 17 29 Etophylline & Theophylline Inj. Each ml. to contain 2 ml. Amp :Etophylline84.7+Theophylline25.3 18 31 Syp. salbutamol Each 5ml. to contain : salbutamol sulphate 100ml bott. eqv.to Salbutamol 2 mg, IP 19 33 Syp. BRONCHODILATOR - Each 5ml. Each tab. to contain: 200ml Bott. contain : Theopyllin ethanoate of 80mg, Eph. Hcl. 12mg. Guaiphenesin 50 mg. 0.55ml. Absolute alcohol contenl 10.44mg 20 36 Syp. Bromhexine Each 5ml. to contain : Bromhexine Hcl. 4mg. 100ml bott. 21 48 Iso-sorbide Dinitrate Each tab. to contain : Iso-sorbide Dinitrate 10 tab 10mg, IP 22 53 Amlodipine Tab Each tab. to contain : Amlodipine 5mg IP 10 Tabs 23 54 Tab. Methyldopa Each Tab. to contain : Methyldopa 250mg, IP 10 tab 27/71

24 57 Inj. Each ml. to contain : Dopamine HCl 40mg, IP 5 ml amp 25 58 Frusemide Inj. Each tab. to contain : Frusemide 10 mg. IP 2ml Amp

26 59 Tab. Triamterine & Benzthiazide Each tab. to contain : 10 tab Triamterine 50mg, Benzthiazide 25mg 27 60 Tab. Frusemide Each tab to contain: frusemide 40mg, IP 10 tab. 28 63 Inj. Isoxsuprine Each ml to contain: Isoxsuprine 5mg, IP 2ml amp 29 69 Ethamsylate Inj. Each ml. containing : Ethamsylate 125mg. 2ml amp 30 71 Inj. Heparin Sodium- Each ml to contain: Heparin Sodium 5000IU 5ml vial 31 73 Acetyl salicylic Acid Tab. (soluble) Each tab to contain: Acetyl 14 tab. salicylic acid 100mg+calcium carbonate 30mg+anhydrous citric acid 10mg. 32 75 Tab. - Each tab to contain: Flunarizine 10mg 10 Tab 33 79 Nimesulide Tab Each tab to contain : Nimesulide 100mg 10 Tabs 34 80 Tab. Asprin Each tab. to contain : Asprin 300mg, IP 10 tab 35 81 Paracetamol Tab Each tab to contain : Paracetamol 500mg, IP 10 Tabs 36 84 Diclofenac Sod Tab, Each tab. to contain: Diclofenac Sod 50mg, 10 Tabs IP 37 85 Diclofenac sodium Inj. Each ml. to contain : Diclofenac sodium 3ml. Amp 25 mg., IP 38 86 Pentazocine Inj. Each tab to contain :Pentazocine (as lactate) 30 1ml. Amp mg. IP 39 87 Ibuprofen & PCM Tab. Each tab to contain : Ibuprofen 400mg, 10 Tabs Paracetmol 325mg. IP 40 90 Inj. Each ml. to contain: Hyaluronidase IP 1500 units. IP 2ml. Vial 41 92 Tab. - Each tab to contain: Diazepam 5mg, IP 10 tab 42 93 Inj. Diazepam Each ml to contain : Diazepam 5mg, IP 2ml amp 43 95 Tab. Trifluperazine- Each tab. to contain: Trifluperazine 5mg, 10 Tab 44 96 Tab. Each tab. to contain: Imipramine 25mg, IP 10 Tab. 45 97 Cap. Each cap. to contain : Fluoxetine 20mg, IP 10 cap 46 98 Tab. Sodium- Each tab. to contain: Phenytoin Sodium 100 Tab. 100mg, IP 47 99 Tab. Each tab. to contain : Carbamazepine 10 tab 200mg, IP 48 103 Tab. Trihexyphenidyl Each tab. to contain : Trihexyphenidyl 10 tab Hydrochloride 2mg, IP 49 104 Nalidixic Acid Tab. - Each tab to contain: Nalidixic Acid 500mg, 10 tab IP 50 105 Nalidixic Acid Susp Each 5ml to contain: Nalidixic Acid 30ml bottle Susp.300mg IP 51 107 Liq. Disodium Hydrogen Citrate Each 5ml. to Contain : Disodium 100ml bottle Hydrogen Citrate 1.25gm/5ml 52 111 Inj. Methyl Maleate Each ml. to contain : Methyl 1ml amp Ergometrine Maleate 0.2mg, IP 53 112 Inj. Oxytocin Each ml. to contain : Synthetic Oxytocin 5 IU IP 1ml amp 54 114 Inj. Valethamate Each ml. to contain : Valethamate 8mg 1ml amp 55 119 Tab. Povidone Vaginal Each tab. to contain Povidone Iodine 10 tab 200mg 56 121 Tab. Pheniramine Maleate- Each tab. Carboprost contain: 10 Tab. Pheniramine Maleate 25mg, IP 28/71

57 122 Syp. Pheniramine Each 5ml. to contain : Pheniramine Maleate 100ml bottle 15mg 58 123 Syp. Pheniramine Each 5ml. to contain : Pheniramine Maleate 2ml amp 22.75mg 59 124 Tab. Each ml. to contain : Cyproheptadine 4mg, 10 tab IP 60 128 Tab. Norethisterone - Each tab to contain: Norethisterone 5mg, 10 tab IP 61 133 Dexamethasone Inj.Each ml. to contain: Dexamethasone 1 vial Sodium Phosphate 4 mg., IP 62 134 Tab. Prednisolone Each tab. to contain : Prednisolone 5mg, IP 10 tab 63 135 Tab. Thyroxine Sodium Each tab. to contain : Thyroxine Sodium 100 tab 100mcg, IP 64 136 Tab. Carbimazole- Each tab. to contain: Carbimazole 5mg, IP 100 Tab. 65 137 Tab. Acarbose Each tab. to contain : Acarbose 50mg, IP 10 tab 66 138 Glibenclamide Each Tab. to contain: Glibenclamide 5mg IP 10 tab 67 139 Metformin tab. Each Tab. to contain: Metformin HCL Tab 500mg 10 Tabs IP 68 140 Glipizide Each Tab. to contain: Glipizide 5mg IP 10 Tabs 69 145 Sodium Benzyl Inj. Each vial to contain : Sodium 1 Vial Benzyl Penicillin 5Lac, (300mg.) IP 70 146 Sodium Benzyl Penicillin Inj. Each vial to contain : Sodium 1 Vial Benzyl Penicillin 10Lac, (600mg.) IP 71 147 Benzathine Penicillin Inj. Each vial to contain : Sodium 1 Vial Benzathine Penicillin 6Lac, (450mg.) IP 72 148 Benzathine Penicillin Inj. Each vial to contain : Sodium 1 Vial Benzathine Penicillin 12Lac, (900mg.) IP 73 149 Benzathine Penicillin Inj. Each vial to contain : Benzathine 1 Vial Penicillin 24Lac, (1.8gms.) IP 74 151 Inj. Streptomycine Each vial to contain : Streptomycine Sulphate 1 vial 0.75gm, IP per vial 75 155 Pot. Phenoxymethyl Penicilline Tab.Each vial to contain : Pot. 10 Tabs Phenoxymethyl Penicilline 125 mg. IP 76 156 Pot. Phenoxymethyl Penicillin Tab. Each vial to contain : Pot. 10 Tabs Phenoxymethyl Penicillin 250 mg. IP 77 161 Dry Syp. Ampicillin, Each 5ml to contain: Ampicillin IP 125mg/5ml 30ml. Bottle 78 164 Amoxycillin & Cloxacillin Cap. Each cap to contain : 10 Caps Amoxycillin250, Cloxacillin250 Cap. 79 165 Cloxacillin Dry Syp. Each 5ml. to contain: Cloxacillin, 125mg. IP 40ml. Bottle 80 167 Inj. Cloxacillin sodium, Each vial to contain: Cloxacillin sodium IP 1 Vial 250mg 81 168 Syp. Cephalexin, Each 5ml to contain: Cephalexin IP 125mg- 30ml bottle 30ml 82 170 Gentamycin Inj Each ml to contain : Gentamycin Sulphate eqv. to 2ml Vial Gentamycin, 40mg 83 171 Erythromycin Tab. Each tab to contain : Erythromycin Stearate 10 Tabs eqv to erythromycin, 250mg IP 84 172 Susp. Erythromycin Oral Each 5ml. to contain : Erythromycin 30ml bottle 125mg Each 5ml to contain

29/71

85 173 Cotrimoxazole Susp. Each 5ml to contain : Trimethoprim 40mg. 60 ml Bott. Sulphamethoxazole 200mg. IP 86 174 Cotrimoxazole Tab. Each tab. to contain : Trimethoprim 80mg. 10 Tabs Sulphamethoxazole 400mg. IP 87 175 Tetracycline Cap.Each cap to contain : Tetracycline 250mg IP 10 Caps 88 176 Norfloxacin Tab. Each tab to contain : Norfloxacin 400mg IP 10 Tabs 89 178 Inj , IP Each 100ml to contain Ciprofloxacin 200mg 100ml Vial 90 179 Doxycycline Cap/Tab. Each Cap/Tab. to contain: Doxycycline 10 Cap/Tab HCL 100mg 91 183 Dry Syp. Amoxycillin & Clavulanic acid Each 5ml. to contain : 30ml bottle Amoxycillin 200mg, Clavulanic acid 28.5 mg, IP 92 191 Pyrazinamide Kid Tabs. Each Tab. to contain: Pyrazinamide 10 tab 300mg. IP 93 192 Dapsone Tabs. Each Tab. to contain: Dapsone 100mg. IP 10 tab 94 194 Tab. Griseofulvin - Each tab to contain: Griseofulvin IP 125mg 10 tab 95 195 Chloroquine Tab. Each tab. to contain : Chloroquine Phosphate 10 Tab 250mg IP 96 196 Syp. Chloroquine Each 5ml. to contain : Chloroquine Phosphate- 60ml bottle 50mg. 97 197 Inj. Chloroquine, Each ml to contain: eqv. Chloroquine phosphate 5 ml. amp eqv. to Chloroquine base 40mg. IP 98 198 Anti malarial Tab. Each Tab. to contain: Pyrimethamine 25mg. 2 tab. Sulphadoxine 500mg., IP 99 199 Tab. Quinine Each tab. to contain : Quinine Sulphate, IP 300mg 10 tab 100 200 Inj. Quinine, Each ml. to contain : Quinine IP 300mg/ml- 2ml 2ml amp 101 201 Tab. Diethyl Carbamazine- Each tab. to contain: Diethyl 10 Tab. Carbamazine Citrate IP 100mg 102 202 Syp. Diethyl Carbamazine Each ml. to contain : Diethyl 100ml Carbamazine Citrate 120mg 103 204 Tab. Mebendazole- Each tab to contain: Mebendazole 100mg, 6 tab. IP 104 206 Piperazine Citrate Syp. Each 5ml to contain: Piperazine Citrate 60ml bottle IP eqv to 0.75gm of piperazine hydrate IP 105 210 ED. Chloramphenicol- Each vial to contain: Chloramphenicol IP 5ml vial 0.5% w/v 106 211 Chlor. Opth. Oint Each caps to contains: Chlormphenicol IP 1% 100 cap inpliable gelatin caps with elongated tip IP 107 212 Eye/Ear Drop- Gentamycin, Each vial to contain : Gentamycin, 5ml vial IP 0.3% w/v 108 213 Eye/Ear Drop- Ciprofloxacin Each vial to contain : Ciprofloxacin 5ml vial 0.3%, IP w/v 109 218 Norfloxacin Eye/Ear drops Containing: Norfloxacin 0.3% w/v 5ml vial 110 219 Nasal Drop. Oxymetazoline, Each vial to contain : 10ml vial Oxymetazoline, IP 0.05% w/v 111 220 Nasal Drop. Xylometazoline, Each vial to contain : 10ml vial Xylometazoline, IP 0.1% 112 221 Cream Miconazole IP- Each tube to contain: Miconazole Nitrate 15gm tube 2% 113 223 Clotrimazole 1% w/v Ointment, IP 15gm Al Tube

30/71

114 224 Benzyl Benzoate Application- Each bottle to contain: Benzyl 1Ltr Bottle Benzoate 25%, IP 115 225 Povidone Iodine 5% w/v Ointment, IP 15gm Al Tube 116 226 Povidone Iodine Solution, IP 7.5% 500ml 500ml bottle 117 227 Framycetin Skin Cream. Each tube to contain : Framycetin 30gm tube Sulphate 1% 118 229 Flucinolone Oint.., IP Containing: Flucinolone Acetonide IP 15gm tube 0.025% w/w 119 230 Betamethasone+Chinoform Ointment Containing: Betamethasone 15gm tube Valerate IP 0.12%, Chinoform 3% in cream base. 120 233 Cream Containing: Precipitated Sulpur 5% w/w, Benzyl Peroxide 20gm tube 10% w/w 121 234 Elastic Adhesive Bandage Roll Elastic Adhesive Bandage Roll 10 rolls pkt size 8cm x 4mt 122 235 Handloom Cotton Gauze- Handloom Cotton Gauze Absorbent One thaan FII (ISI marked) Size 18m x 60cm 123 236 Handloom Cotton Bandage Cloth -Handloom Cotton Bandage One thaan Cloth FII (ISI marked) Size 20m x 100cm 124 237 Cotton Wool Absorbent, Cotton Wool Absorbent 500 gm. 500gm pkt. 125 240 White Soft Paraffin, Each to contain : White Soft Paraffin, IP 500gm 500gm 126 250 Topical Lignocaine, Containing: Lignocaine 4% w/v 30ml vial 127 251 Inj. Lignocaine Each vial to contain : Lignocaine HCl IP 2% w/v 30ml vial 128 257 Inj. Vecuronium, Each amp to contain : Vecuronium, IP 4mg 1Amp./vial 129 258 Inj. Atracurium - Each ml to contain: Atracurium besylate IP 2.5ml 10mg. 130 260 Alfa calcidol Cap.Each cap. to contain: Alfa calcidol 0.25mcg. 10 cap. 131 262 Polyvitamin Tab. Each tab. to contain : NFI- III Prophylactic 10 Tab 132 265 Inj. Vitamin- Each 2ml to contain : Thiamine 10mg. Riboflavin 2ml amp 4mg. 40mg. Cyanocobalamine 8mcg. 4mg. D-Panthenol 6mg. Benzyl Alcohol 0.9% 133 267 Ferrous Sulphate tab. Each 10 Tab tab. to contain: Ferrous Sulphate 200mg. 134 268 Cap. Ferrous Sulphate 150mg (in S.R. form), Folic acid 0.5mg 10 Cap 135 272 Liq. Potassium Chloride- Each 15ml to contain: Potassium 200ml Chloride USP 1.5gm. bottle 136 273 Dextrose Inj. Containing: Dextrose anhydrous 25% w/v 25ml. Amp. 137 277 Sterile water for Injection, Each amp to contain: Sterile water IP- 5ml Amp 5ml 138 279 Containing : Inj. (for IV infusion) Sodium Chloride IP 0.9% w/v 500ml 139 280 Sodium Chloride & Dextrose Inj., IP (for I.V. Infusion) Containing: 500ml Dextrose anhydrous 5%w/v, Sodium chloride 0.9%w/v 140 282 Chick Embryo Cell Rabies Vaccine: Each dose to Contain: 2.5 IU 1dose Pack inactivated rabies antigen 141 285 Cap. Cyclosporine Each cap. to contain: Cyclosporine 50mg 50 cap 142 286 5-Fluorouracil Inj., Each vial to contain: Fluorouracil IP 250mg. 1 Vial 143 287 Cap. Hydroxy Each cap. to contain : Hydroxy Urea 500mg 10 cap 144 288 Inj. Cytosine Arabinoside- Each vial to contain: Cytosine 1 Vial Arabinoside 100mg

31/71

145 289 Tab. Tamoxifen- Each tab to contain: Tamoxifen IP 10mg 10 tab 146 290 Inj. Etoposide, Each vial to contain : Etoposide, IP 100mg 1 vial 147 291 Cyclophosphamide Tab. Each tab to contain: Cyclophosphamide 10 tab IP 50mg 148 292 Inj. Bleomycin Each vial to contain: Bleomycin IP 15mg 1 vial 149 293 Inj. Vincristine .- Each vial to contain: Vincristine 1mg I.P. 1 Vial

150 301 Cough Linctus Each 5ml. to contain : Codeine phosphate 100ml bottle 10mg, chlor - pheniramine maleate 4mg. 151 302 Levofloxacin Tab.Each tab to contain : Levofloxacin 500mg 10 Tabs 152 303 Inj. Cefpirome Each vial to contain : Cefpirome 1gm 1 vial 153 305 Calcium & Vit. D3 Tabs., BP / USP Each Tab. to contain: 15 tab Calcium Carbonate IP 1250mg eqv to elemental calcium 500mg from an organic source, vitamin D3 –IP 250 IU 154 307 Tab. Cephalexin Dispersible Each tab. to contain : Cephalexin 10 tab 125mg IP 155 317 Essential Phospholipid Cap. Each cap. to contain : Lecithine 10 Cap 350mg Eqv.to 175mg of Essential Phospholipid 156 318 Tab. Naproxen Each tab. to contain : Naproxen IP 250mg 10 tab 157 321 Ribavirin Syp. Each 5ml. to contain: Ribavirin 50mg. 30ml bottle 158 322 Tab. Haemostatic- Each tab to contain: Micronized purified 10 tab. fraction of Rutaceae 500mg. 159 326 Inj. Nitroglycerine- Each ml to contain: Nitroglycerine 5mg 5ml amp 160 327 Dobutamine Injection Each vial/amp to contain: Dobutamine Hcl 1 vial/ amp eqv. To Dobutamine IP 250mg 161 332 Inj. Vancomycin, Each tab to contain: Vancomycin, HCL Eqv. to 1 Vial Vancomycin, IP 500mg 162 334 Tab. Lamivudine, Each tab. to contain : Lamivudine, IP 150mg 10 tab 163 343 Thyroxine tab. Each tab to contain: Thyroxine Sodium IP 50 100 Tabs. mcg Bot. 164 345 Antacid Tab. Each tab to contain -Dried Aluminium Hydroxide 10 Tab Gel 250mg+ Mg. Hydroxide 250mg + Methyl Polysiloxane 50mg 165 358 Haemorrhoidal Cream Containing : Beclomethasone dipropionate 20gm tube 0.025%,phenylepherine hydrochloride 0.1%, Lignocaine hydrochloride 2.5%. 166 359 Ipratropium Inhaler Each metered dose to contain : Ipratropium 200 doses bromide 20mcg 167 362 INHALER Budesonide Each Metered Dose to contain : 200 doses Budesonide 100mcg. 168 363 Tab. Theophyllin CR- Each CR tab to contain: Theophyllin 10 Tab Anhydrous 400mg 169 365 Tab. Losartan Hydrochlorthiazide Each tab. to contain : Losartan 10 tab Potassium 50mg, Hydrochlorthiazide 12.5mg, IP 170 367 Cap. Fenofibrate- Each cap. to contain: Fenofibrate IP 7 cap (Micronised) 200mg 171 371 Analgesic Gel- Each gm to contain : Nimesulide 10mg, Methyl 30 mg tube Salicylate 100mg, Menthol 50mg, Capaicin 0.25mg.in cream base 172 377 Tab. Methyl Ergometrine, Each tab. to contain Methyl 10 tab Ergometrine, IP 0.125mg

32/71

173 379 Syp. Norfloxacin Each 30ml. to contain Norfloxacin 400mg 30ml bottle 174 381 Mesalazine tab. Each Tab. to contain : Mesalazine (5- 10 tab aminosalicylicacid) 400 mg. 175 382 Ethionamide tab. Each Tab. to contain: Ethionamide IP 250mg 10 tab 176 383 Cap./tab. Cycloserine, Each Cap./Tab. to contain : Cycloserine, 10 tab/cap IP 250mg 177 385 Tab. Nevirapine Each to tab. to contain: Nevirapine 200mg 10 tab. 178 386 Indinavir Cap. Each cap to contain : Indinavir 400 mg 30 cap 179 387 TAB. - Each tab. to contain : Ondansetron 10 tab 4mg., IP 180 388 Inj. Ondansetron Each ml to contain: Ondansetron IP 2mg 4ml 181 390 Cap. Rifampicin, Each cap. to contain : Rifampicin, IP 600mg 3 cap 182 391 Pyrazinamide Tab. Each tab to contain: Pyrazinamide IP 1000mg 10 tab 183 392 Saline Nasal Drops Containing : Sodium Chloride 0.65%, 15ml Benzalkonium Chloride 0.001%, Phenyl Mercuric acetate 0.002% 184 394 Lotion. Clotrimazole Each ml. to contain : Clotrimazole 10mg 15ml bottle 185 395 Clotri, Beclomethasone Dipropionate Containing: Clotrimazole IP 10gm tube 10mg, Beclomethasone Dipropionate IP 0.25mg 186 396 Ointment Containing: Silver Sulphadiazine 1 % Chlorhexidine 15gm tube Gluconate 0.2% Aloevera 15 % Allatoin 0.1 % Vitamin E 0.2% 187 398 Xylocaine Inj. Containing: Xylocaine 1% 30ml vial 188 399 Vitamin E Drop Each ml. to contain: Tocopheryl Acetate IP 15ml 50mg. 189 402 Inj. Doxorubicin- Each vial to contain: Doxorubicin IP 10mg 5ml vial 190 403 Tab. Methotrexate Each tab. to contain : Methotrexate IP 2.5mg 10 tab 191 405 Desferrioxamine Inj. Each vial to contain: IP Desferrioxamine 1 vial 500mg 192 406 Tab. Azathioprine Each tab. to contain : Azathioprine IP 50mg 10 tab 193 407 Vitamin Tabs. Each Tab. to contain: Thiamine Mononitrate IP 10 tab 10mg, Pyridoxine Hcl. IP 3mg, Cyanocobalamine IP 15mcg, Riboflavine IP 5mg, Nicotinamide IP 50mg, calcium pantothenate IP 5mg 194 411 Calamine Lotion Containing: Calamine 15%, Oxide 5% 100ml 195 415 Laxative Liq- Each 5ml. to contain : Liquid Parafin 1.25ml, Milk of 110ml bot. Magnesia 3.75ml, Sod.Picosulphate 3.33mg 196 417 Drop Enzyme- Each ml to contain: Alpha-Amylase (Bacterial 15ml. Phial 1:800) 20mg, Papain 10mg, Dill Oil 2mg, Anise Oil 2mg, Caraway Oil 2mg (Drop CDS)-15ml 197 418 Enzyme Syrup Each 15ml to contain: lodised peptone 29 mg., 300ml Mag. Chl 20 mg., Mag. Sulph 4mg., Zn. Sulph. 6 mg., Sod. Metavandate 0.66 mg., Pyridoxine HCL 0.75mg., cyanocobalamin 0.5mcg., Nicotinamide 10mg. Alcohol 0.95 ml. 198 421 Inh. IPRATROPIUM+SALBUTAMOL INHALER - Each Metered 200 doses dose to contain : Ipratropium I.P. 20 mcg. Salbutamol I.P. 100mcg 199 422 Tab. Amiodarone- Each tab. to contain: Amiodarone HCl IP 10 Tab 100mg 200 425 Tab. Indapamide Prolonged Release- Each Prolonged Release 10 tab. tab. to contain: Indapamide 1.5mg

33/71

201 426 Inj. Neostigmine Each ml. to contain : Neostigmine IP 0.5mg/ml 1ml Amp 202 427 Tab. Sulphasalazine- Each tab. to contain: Sulphasalazine 10 Tab 500mg 203 429 Tab. Clopidogrel- Each tab. to contain: Clopidogrel IP 75mg 10 tab. 204 439 Artifical Tears Drop. Each vial to contain : ED- Polyvinyl Alcohol 10ml vial 1.4%, Povidone 0.6%, Benzalkonium Chloride 0.01%- 10ml

205 440 Anti Fungal ear drops Containing: Chloramphenicol IP 5%, 5ml vial Lignocaine HCL IP 2%, Beclomethasone Dipropionate 0.025%, clotrimazole IP 1%, Propylene glycol IP q.s. 206 447 Rocuronium Inj. Each ml to contain: Rocuronium 10mg 5ml vial 207 448 Cream Permethrin 5%- Each tube to contain: Permethrin 5%. 30gm 208 450 Cap. VITAMIN Each cap. to contain : Thiamine 10mg, Riboflavin 10 cap 8mg, Pyridoxine 3mg, Vit. B12 5mcg, Niacinamide 50mg, Calcium Pantothenate 15mg, Folic acid 1mg, Ascorbic Acid 125mg 209 451 Syp. Calcuim Each 5ml to contain: (Vit. D3 200IU, Vit. B12 200ml bottle 2.5mcg, Calcium 82mg ) 210 454 Starch Inj. Each 100ml to contain: Hydroxyethyl Starch 6gms., 500ml bottle Sodium chloride 0.9gm. 211 455 Haemo Dialysis Fluid Containing: Haemo Dialysis Fluid 5Ltr. 212 458 Inj. Fludarabine Each vial to contain : Fludarabine 50mg 1 vial 213 460 Tab. Each tab. to contain : Flutamide 250mg 10 tab 214 462 USP- Each 100ml to contain: Isoflurane 100ml 215 464 Inj. Erythropoietin- Each pack to contain: Recombinant Human 1 pack Erythropoietin 10000Units 216 467 Methylprednisolone Sod. Succinate Inj. Each vial to contain: 1ml vial Methylprednisolone Sod. Succinate 40 mg., 217 471 Tab. Tianeptine Each tab. to contain Tianeptine Sod. 12.5mg 10 tab 218 476 Inj. Each ml to contain: Haloperidol IP 5mg. 1 amp 219 478 Syp. Lactulose Each 15ml to contain: Lactulose 10gm 100ml bot. 220 479 Tab. Prednisolone Each tab. to Contain: Prednisolone IP 10mg 10 tab 221 480 Oint. Mupirocin- Each tube to contain: Mupirocin IP 2% 5gm tube 222 481 Resp. Soln. Ipratropium Each ml to contain: Ipratropium Bromide 15ml bottle 250mcg 223 482 ED Cipro+Dexa - Each vial to contain : Ciprofloxacin 0.3%, 5ml vial Dexamethasone 0.1%, Benzalkonium Chloride 0.01% 224 484 Povidone Iodine Dressing - containing : Povidone Iodine 10% box of 20 Sterile Dressing dressings 225 485 Tibolone tab.Each Tab. to contain: Tibolone 2.5mg 28 tab 226 490 Tab. Mycophenolate Mofetil Each tab. to contain: Mycophenolate 10 tab Mofetil 500mg 227 492 Endoscopic Cleaning Soln. Containing: Proteolytic Enzymes, 1ltr. Bottle Presoak Plus Cleaner 228 496 vit. B Complex Syp. Each 5 ml. to contain: Vit. A 2500 IU, 200ml Cholecalciferol 200 IU, Thiamine 2mg., Riboflavine 1mg., Pyridoxine 1mg., Nicotinaminde 15mg., Ascorbic acid 50 mg., D- Panthenol 2.5mg., Cyanocobalamin 1mcg., Citrus Bioflavonoid Compound 5mg.

34/71

229 500 Haematinic Syp. Each 15ml to contain: Ferric Ammonium citrate 200ml IP 160mg, Vit. B12 -7.5mcg, Folic acid IP 0.5mg, Alcohol (95%) 0.87ml 230 501 Syp. Vit. B Complex + Vit. C SYP- Each 5ml. to contain : 20ml bottle Thiamine 2mg. Riboflavin 2.54mg Pyridoxine 2mg Niacinamide 20mg D- Panthenol 6mg, Ascorbic acid 75mg. 231 502 Magnesium Sulfate Inj. Each ml to contain: Magnesium Sulfate 1ml IP 50%

232 503 PAS Granules Each gm to contain: Sodium Aminosalicylate 100gm jar 800mg. 233 504 Cap./tab. Imatinib- Each Cap./tab. to contain: Imatinib Mesylate 10/12cap/tab IP 100mg 234 505 Dry Syp. Cefuroxime- Each 5ml to contain: Cefuroxime 125mg 30ml bottle 235 507 Prothionamide tab. Each tab to contain : Prothionamide 250mg. 10 tab 236 510 Oint. Metronidazole + Povidone Iodine Each tube to contain: 15gm tube Metronidazole 1% + Povidone Iodine 5% 237 512 Tab. Itopride- Each tab. to contain: Itopride HCl 50mg 10 Tab 238 516 Syp. Etophylline & Theophylline - Each 5ml to contain: 100ml bott. Etophylline 46.5mg, Theophylline 14mg 239 517 Dicyclomine + Diclofenac sodium Each 2ml. to contain : 2ml Amp Dicyclomine 20mg., Diclofenac sodium 50mg. 240 518 Syp. COUGH SEDATIVE - Each 5ml to contain: 100ml bott. Chlorpheniramine Meleate 2.5mg, Guaiphenesin 100mg, Noscapine 15mg, Sod. Citrate 60mg 241 519 Fluocinolone Oint. Containing: Fluocinolone Acetonide 0.1% + 15gm tube Methyl Paraben 0.15% + Propyl Paraben 0.05% 242 521 Tab. Tranexamic Acid Each tab. to contain: Tranexamic Acid IP 10 Tab 500mg 243 522 Inj. Tranexamic acid- Each 5ml to contain: Tranexamic Acid 1 amp. 500mg BP 244 526 Goserelin Inj.Each PFS to contain: Goserelin 3.6mg. 1 PFS 245 533 Ear Drops Containing : 4-Carboxymethylamino-4, Aminodiphenyl 5ml vial sulphone 0.84%, dihydroxymethyl carbamide 0.42% Dibucaine 1.1% 246 534 Pre & Probiotic Cap.- Each to cap. to contain: Streptococcus 10 cap faecalis 30 million, Clostridium butyricum 2 million Bacillus mesentericus 1 million, lactic acid bacillus spoiogenes 50 million 247 536 Inj. Pantoprazole- Each ml to contain: Pantoprazole 40mg vial 248 540 Tab. Sulbutiamine Each tab. to contain: Sulbutiamine 200mg 10 tab 249 542 Vaccine Vero Cell Culture Rabies- Each dose to contain: Purified 1 dose pack Vero cell culture Human Rabies Vaccine 250 543 Inj. Sodium Hyaluronate (INTRA ARTICULAR) - Each PFS to 1 PFS contain: Sodium Hyaluronate 25mg Sodium Chloride, sodium phosphate Dihasic Monobasic qs 251 545 Inj. Erythropoietin Each vial to contain: Erythropoietin 20000 1 vial Units 252 550 Flutcasone + Salmetrol Rotacaps- Each Rotacap to contain: 30 Cap Flutcasone 250mcg. + Salmetrol 50 mcg. , IP

35/71

253 551 Ear Drop. - Clotrimazole 1% + Lignocaine HCl 2%- 10ml 10ml vial 254 553 Tab. Flavoxate- Each tab. to contain: Flavoxate Hydrochloride IP 10 Tab. 200mg 255 559 Coal Tar + Salicylic Acid- Each bottle to contain: Coal Tar 60ml bottle Topical sol. 4.25% + Salicylic Acid I.P. Sol 2% 256 560 Each Tab. to contain: Dried Aluminium Hydroxide gel 240mg, 10 Tab. Mag. Hydroxide 100mg,Mag.Carbonate 60mg, Activated Dimethicone 25mg. 257 562 ED Tropicamide- Each vial to contian: Tropicamide 0.8% + 5ml vial Phenyl Ephrine HCl 5% 258 564 Prednisolone Eye drops containing : Prednisolone Acetate IP 1% 5ml 259 565 Betamethasone Eye drops Containing: Betamethasone Sodium 5ml Phosphate 0.1% 260 569 Inj. Methylprednisolone Acetate- Each vial to contain: 1 vial Methylprednisolone Acetate 40mg 261 573 Tab. Piribedil- Each tab. to contain: Piribedil 50mg 10 Tab. 262 577 Each tab. to contain: Ursodesoxycholic acid 150mg., IP 10 Tab.

263 579 Povidone Iodine Mouth Wash Each bottle to contain: Povidone 50ml bottle Iodine 1% 264 580 Coagulant solution Each ml. to contain: Aqueous solution of 10ml bottle Haemocoagulase Isolated from Bothrops atrox or Bothrops Jararaca 0.2CU, Chlorhexadine Gluconate soln. 0.1% (as preservative), Water for injection q.s. 265 581 Inj. Lignocain HCl 21.3mg+Sod. Chloride 6mg water for inj.to 50ml bottle make 1ml. 266 582 Ambroxol+Salbutamol+Theophylline Each Tab. to contain : 10 tab Ambroxol 30mg., salbutamol 2mg., theophylline (anhydrous) 100mg. 267 588 Lignocaine with Inj. Each ml. to contain: Inj. 30ml Lignocaine IP 21.3mg., Adrenaline IP 0.005mg. 268 589 Mecobalamin + Lactic Acid Bacillus, Each Tab. to contain: 10 tab Mecobalamin IP 500mcg., Lactic Acid Bacillus Spores 40 million, Alpha Lipoic Acid 100mg., Folic Acid IP 1.5mg., Vit. B1 IP 10mg., Vit. B6 IP 3mg. 269 590 Ritodrine Tab.Each tab. to contain: Ritodrine 10mg. 10 tab 270 592 Beclomethasone Inhaler- Each metered dose to contain: 200 doses Beclomethasone Inhaler Dipropionate 200mcg. 271 595 Calcium (Absorable) Cap. - Each cap. to contain: Elemental 15 cap calcium 150mg (in the form of Calcium Hydroxide and Calcium Oxide and pretreated with heated algae) 272 597 Inj. Amiodarone- Each ml to contain: Amiodarone IP 50mg 3ml 3ml 273 599 Tab. Doxylamine Succinate + Pyridoxin- Each tab. to contain: 10 Tab Doxylamine Succinate 10 mg. + Pyridoxin 10 mg. 274 600 Inj. Infliximab- Each vial to contain: Infliximab 100mg 1 Vial 275 601 Inj. Vitamin K -Each ml to contain: Phytomenadione BP 10mg 1ml 276 602 Inj. Ofloxacin- Each 100ml to contain: Ofloxacin IP 200mg/ 100 Ml bottl. 277 713 Cream.- Each tube to contain: Desonide 0.05% 10gm tube 278 1002 Antacid Gel- Each 5ml to contain: Oxetacain 10mg, Al. Hydroxide 200ml Bott. 291mg, Mg.Hydroxide 98mg

36/71

279 1007 Ranitidine Inj., Each ml to contain : Ranitidine HCl eqv. to 2ml Amp Ranitidine 25mg 280 1010 Laxative Liquid- Each 15ml to contain: Milk of Magnesia 170ml 11.25ml, Liquid Paraffin 3.75ml 281 1013 Domperidon Tab., Each tab. to contain : Domperidon 10 mg 10 Tabs 282 1014 Domperidone Susp. Each ml. to contain : Domperidone 1mg. 30ml bottle 283 1019 Tab. Drotaverine Hydrochloride- Each tab. to contain: Drotaverine 10 tab Hydrochloride IP 80mg 284 1020 Tab. Metronidazole + Diloxanide- Each tab. to contain: 10 Tab Metronidazole 200mg + Diloxanide 250mg 285 1028 Enzyme Syp.- Each 10ml to contain: Fungal Diastase (1:2000) 200ml bottle 40mg, (Aspergillus Oryzae Enzyme)Cinnamon Oil 0.25mg, Caraway Oil 0.5mg, Cardamom Oil 0.5mg, In Glycerol sorbitol base in 10ml 286 1029 Enzyme Cap.- Each tab. to contain: Pepsin (1:3000) 12.5mg, 10 cap Fungal Diastase (1:2000) 18.75mg 287 1032 Tab. Etophylline & Theophylline Each tab. to contain: Etophylline 10 tab 77mg & Theophylline 23mg 288 1033 Tab. Etophylline & Theophylline, Each tab. to contain: Etophylline 10 tab 231mg & Theophylline 69mg 289 1035 Syp. Terbutaline Sulphate- Each 5ml to contain: Terbutaline 100ml Bott. Sulphate IP 1.5mg. 290 1038 Theophylline CR Cap Each CR Cap to Contain: Theophylline 10 cap anhydrous 200 mg 291 1039 Inh. Salbutamol Each Metered dose to contain : Salbutamol 200 doses 100mcg IP 292 1041 Inh. Salbutamol + Beclmethasone Each Metered to contain : 200 doses Salbutamol 100mcg.+ Beclmethasone 50mcg. 293 1042 Adrenaline Inj. Each ml. to contain: acid tartrate eqv. To 1ml amp Adrenaline IP 1 mg. 294 1044 Beclomethasone Rotacaps Each cap to contain : 30 cap Beclomethasone 100mcg. 295 1045 Salmeterol Rotacap Each Rotacap to contain : Salmeterol IP 30 cap 50mcg 296 1046 Bronchodilator Syp. Each 10ml. to Contain : Bromhexine hcl 100ml bottle 8mg. Terbutaline sulphates 4mg., Guaphanesin 200 mg. 297 1047 Paediatric Cough Syp. Each 5ml to contain: Promethazine HCl 60ml bottle 1.5mg, Pholcodine 1.5mg (as citrate) 298 1050 Pediatric Cough Linctus Syp. Each ml to contain: Noscapine 50ml bottle 1.83mg, Citric acid 5.8mg, Sod.Citrate 0.67mg, Amm. Chloride 7mg 299 1052 Tab. Digoxin Each tab. to contain : Digoxin IP 0.25mg 10 tab 300 1055 Tab. Bisoprolol Fumerate- Each tab. to contain: Bisoprolol 10 Tab Fumerate 5mg 301 1057 Tab. Verapamil Each tab. to contain: Verapamil HCl IP 40mg 10 tab. 302 1062 Diltiazem Inj. Each ml. to contain : Diltiazem Hcl IP 5mg. 5ml vial 303 1063 Tab. Trimetazidine- Each tab. to contain: Trimetazidine HCl HCl 10 Tab 20mg 304 1070 Tab. Frusemide + Spironolactone Each tab. to contain : 10 tab Frusemide 20mg, Spironolactone 50mg

37/71

305 1071 Tab. Acetazolamide Each tab. to contain : Acetazolamide IP 10 tab 250mg 306 1072 Tab. Cinnarizine Each tab. to contain : Cinnarizine IP 25mg 10 tab 307 1073 Pentoxyfylline Tab. 10 tab Each tab. to contain: Pentoxyfylline 400 mg. 308 1074 Tab. Isoxsuprine Each tab. to contain : Isoxsuprine HCl IP 10mg 10 Tab 309 1077 Cap. Haemostatic- Each cap. to contain: Citrous Bioflavonoid 10 cap. compound 150mg. Ascorbic Acid 75 mg. Menadione (vit. K) 0.66mg. Ferrous Gluconate 67mg. Tribasic Calcium phosp. 144.43mg. 310 1078 Haemo-coagulant Inj. Each ml. to contain: Aqueous solution of 1ml amp Haemocoagulase (one IU/CU/NIH unit) Isolated from venom of Bothrops, Jararaca or Bothrops Atrox containing Sodium Chloride 0.9% 311 1080 Oint. Heparin Each gm to contain: Heparin Sod. 50IU, Benzyl 15gm tube Nicotinate 2mg/3mg 312 1083 Cap. Each cap. to contain: Tramadol HCL IP 50mg. 10 cap. 313 1084 Buprenorphine Inj., Each ml. To contain: 0.3mg Buprenorphine 2ml 314 1086 Soluble Aspirin tab. Each Tab. to contain : Acetyl salicylic acid 10 tab 350 mg., Cal. Carbonate 105 mg., anhydrous citric acid 35 mg. 315 1092 Susp. Ibuprofen Each 5ml. to contain : Ibuprofen BP 100mg 60 ml bottle 316 1093 Ibuprofen & Paracetamol oral Susp. Each 5ml to contain: 60ml bottle Ibuprofen 100mg + Paracetamol 162.5mg 317 1094 Tab./Cap. Piroxicam Each tab./cap. to contain : Piroxicam IP 10 tab/cap 20mg 318 1096 Inj. Paracetamol Each ml to contain: Paracetamol 150mg 2ml amp 319 1098 Tab. Allopurinol Each tab. to contain : Allopurinol IP 100mg 10 tab 320 1099 Cap. Indomethacin- Each cap. to contain: Indomethacin IP 25mg 10 Cap 321 1100 Cap. Indomethacin SR Each SR cap. to contain: Indomethacin 10 cap. 75mg 322 1105 Tizanidine Tab. Each tab to contain: Tizanidine IP 2mg 10 tab 323 1106 Each ml. to contain: Glycopyrrolate USP 0.2mg. 1ml vial 324 1107 Tab. Serratiopeptidase Each tab. to contain: Serratiopeptidase IP 10 tab 5mg (10000 units of Serratiopeptidase) 325 1108 Each Tab. to contain : Trypsin and chymotrypsin 1lakh units. 10 tab 326 1110 Analgesic Oint- Each tube to contain: Methyl Salicylate 4% w/w, 20 gm Tube Mephensin 5% w/w lodine 0.5% w/w 327 1112 Analgesic Gel- Eac tube to contain : Diclofenac Diethylamine Salt 30gm tube 1.16%, (eqv.to Diclofenac sodium 1%) Linolenic acid 3%, Methyl Salicylate 10%, Menthol 5% 328 1116 Nitrazepam Tab., IP Each Tab. to contain: Nitrazepam IP 5mg 10 tab 329 1117 Tab. Each Tab. to contain Buspirone Hcl IP/USP 5mg 10 tab 330 1124 Tab. Nimodipine- Each tab. to contain: Nimodipine 30mg 10 Tab. 331 1125 Syp. Sodium Valproate Each 5ml. to contain : Sodium Valproate 100ml bot. I.P. 200mg 332 1126 Syp. Carbamazepin Each 5ml. to contain : Carbamazepin IP 100ml bot. 100mg 333 1128 Carbamazepin Tab. Each tab. to contain: Carbamazepin 400 10 tab mg., 334 1130 Inj. Phenytoin - Each tab to contain: Phenytoin Sod50mg. 2ml.amp

38/71

335 1131 Sodium Valproate Each Tab. to contain:Sodium Valproate IP 10 tab 200mg 336 1132 Levodopa & Carbidopa Each tab. to contain: Levodopa 250 mg., 10 tab Carbidopa 25mg., 337 1134 Phenazopyridine Tab. Each tab. to contain: Phenazopyridine 10 tab 200 mg., 338 1135 Tab. Isoxsuprine SR - Each SR tab. to contain: Isoxsuprine Hcl 10 tab 40mg 339 1137 Inj. Carboprost- Each ml to contain: Carboprost 0.25mg 1ml. Amp 340 1138 Dinoprostone Gel. Containing : Dinoprostone 0.5mg 1 PFS

341 1143 Cetrizine Tab. Each tab. to contain: Cetrizine Hydrochloride 10 Tabs 10mg 342 1145 Tab. Fexofenadine- Each tab. to contain: Fexofenadine IP 120mg 10 Tab. 343 1146 Tab. Allylestrenol Each tab. to contain : Allylestrenol IP 5mg 10 tab 344 1149 Tab. Medroxy Progesterone- Each tab. to contain: Medroxy 10 Tab. Progesterone Acetate IP 10mg 345 1150 Ethinyloestradiol tab. Each Tab. to contain: Ethinyloestradiol IP 10 Tab. 0.05mg 346 1156 Tab. Clomiphene Citrate Each tab. to contain: Clomiphene 10 tab Citrate IP 50mg 347 1158 Inj. Menotrophin- Each Inj. to contain: FSH 75 IU & LH-75 IU 1ml. Amp/vial 348 1159 Inj. Betamethasone Each ml. to contain : Betamethasone IP 1ml amp 4mg 349 1160 Tab. Dexamethasone Each tab. to contain: Dexamethasone IP 10 tab 0.5mg 350 1161 Inj. Nandrolone Each ml. to contain : Nandrolone Phenyl 1ml amp Propionate 25mg 351 1162 Nandrolone Decanoate Inj. Containing : Nandrolone Decanoate 1 amp 25 mg 352 1164 Hydrocortisone Sod. Succinate Each vial to contain : 1 vial Hydrocortisone Sod. Succinate eqv. to Hydrocortisone IP 100mg/vial 353 1167 Human Insulin (Soluble)- Each vial to contain: Human Insulin 10 Ml. (Soluble) 40 units/ml, IP -10ml 354 1170 Human Insulin (NPH)- Each vial to contain: Human Insulin 10 Ml. (NPH100%) 40 units/ml-IP 10ml 355 1171 Human Insulin Mixed (25%+75%) Containing : Human Insulin 10 Ml. 25% soluble + 75% NPH 40units/ml, 356 1172 Inj. Human Insulin Mixed (50% + 50%) Human Insulin 50% 10ml soluble + 50% NPH 40 units/ml 357 1173 Inj. Human Insulin Biphasic (30% + 70%) - Each vial to contain: 10ml vial Human Insulin Biphasic 30% Soluble + 70% NPH 40 units/ml 358 1174 Gliclazide Tab. Containing Gliclazide 80mg., IP 10 tab 359 1178 Amoxycillin dry. Syrup, Each 5ml to contain : Amoxycillin 60 ml Bott. Trihydrate eqv to Amoxycillin 125 mg.

360 1181 Inj. Chloramphenicol Each vial to contain : Chloramphenicol 1 vial Sodium Succinate eqv. to Chloramphenicol IP 1gm

39/71

361 1184 Ceftazidime Inj., Each vial to contain : Ceftazidime 250mg 1 Vial 362 1185 Ceftazidime Inj., Each vial to contain : Ceftazidime 1gm. 1 Vial 363 1186 Ceftriaxone Inj., Each vial to contain : Ceftriaxone Sod. Eqv. 1 Vial Anhydrous Ceftriaxone 250mg. 364 1187 Ceftriaxone Sod Inj eqv. to anhydrous Ceftraxone IP 1gm. 1 Vial 365 1189 Amikacin Inj., Each 2ml. to contain : Amikacin 500mg (As 2ml. Vial Amikacin Sulphate) 366 1191 Amoxycillin & Cloxacillin Dry Syrp. Each 5ml. to contain: 30 Ml. bottl. Amoxycillin IP 125mg. Cloxacillin IP 125mg. 367 1193 Cefadroxil Cap/Tab. Each Cap/Tab. to contain , Cefadroxil 10 Tab/Cap 500mg 368 1194 Syp Cefadroxil- Each 5ml to contain: Cefadroxil IP 125mg/5ml 30 Ml. bottl. 369 1197 Rifampicin Syp. Each 5 ml. to contain: Rifampicin IP 100 mg. 100ml bottle 370 1204 Tab. Griseofulvin, Each tab. to contain: Griseofulvin IP 250mg 10 tab 371 1205 Fluconazole Tab./Cap., Each Tab./Cap. to contain : Fluconazole 10 Tab/Cap 150mg 372 1208 Syp Albendazole Each 5ml to contain : Albendazole 200mg., 10ml Bott. 373 1209 Syp Albendazole Each 5ml to contain : Albendazole 400mg., 10 Tab 374 1211 Antibiotic Eye Ointment Each gram to contain: Polymyxin B 5gm tube Sulphate 5000 IU Neomycin sulphate 3400 IU Zinc Bacitracin 400 IU Hydrocortisone 10 mg. in white sterilized petroleum jelly base 375 1212 Flurbiprofen Eye Drops Containing: Flurbiprofen 0.03% w/v IP 5ml vial 376 1213 Atropine Eye Oint.Containing: Atropine sulphate IP 1% 5gm tube 377 1219 Eye drop Containing: Dexamethasone Sod. Phosphate IP 0.1%, 3ml Neomycin Sulphate IP 0.5%, Benzalkonium Chloride IP in Isotonic Soln. 0.02% 378 1223 Cyclopentolate Eye Drops. Containing: Cyclopentolate IP/USP 5ml vial 1% 379 1226 Eye Drops Containing : Hydroxypropyl Methyl Cellulose IP 0.7%, 5ml vial Borax IP 0.19%, Boric Acid IP 0.19%, Sod. Chloride IP 0.45%, Pot. Chloride IP 0.37%, Benzalkonium Chloride IP 0.01% 380 1227 Methyl Cellulose ocular Solu. Contianing: Hydroxy Propyl Methyl 2ml PFS Cellulose IP 2% w/v 381 1228 Acyclovir Eye Ointment Containing: Acyclovir IP 3% 5gm tube 382 1234 Wax Softner Ear Drops Containing: Para Dichlorobenzene 2% 10ml vial w/v, Benzocaine IP 2.7% w/v, Chlorbutol IP 5%, Turpentine Oil 15% w/v 383 1236 Nasal Drop. Xylometazoline Each vial to contain : Xylometazoline 10ml vial IP 0.05% 384 1237 Nasal Drop. Oxymetazoline Containing : Oxymetazoline IP 10ml vial 0.025% w/v- 10ml 385 1238 Beclomethasone Nasal Spray Each actuation to deliver: 200 doses Beclomethasone Dipropionate IP 50 mcg. 386 1239 Nasal Spray. Budesonide Each Actuation to deliver 100mcg 150 doses 387 1240 Gel. Containing : Choline Salicylate 9.0% w/v Benzalkonium 10ml/bottle Chloride 0.02%

388 1241 Ointment Containing: Salicylic Acid IP 6% w/w, Benzoic acid 15gm tube IP/BP 12% w/w, Hydrocortisone Acetate IP 0.5% w/w

40/71

389 1242 Cream Containing: Urea 12% w/w, Lactic acid IP 6% w/w, 50gms Jar Glycine IP 3% w/w, Ammonium Chloride IP 0.5% w/w, Sod. Chloride IP 0.5% w/w, Potassium Chloride IP 0.5% w/w, calcium lactate IP 0.5% w/w, Magnesium Chloride IP 0.3% w/w, Sod. Dihydrogen Phosphate IP 0.5% w/w 390 1243 Ciclopirox Ointment Each gm to contain : Ciclopirox Olamine 15gm tube 10mg 391 1246 Lotion. Gamma Benzene Hexachloride Containing : Gamma 500ml bottle Benzene Hexachloride 1% 392 1248 Povidone Iodine Solution IP 5.00 % w/v 500ml 500ml bottle 393 1249 Cream. Framycetin Sulphate Each tube to contain : Framycetin 100gm tube Sulphate 1% w/w

394 1251 Polymixin Neomycin Eye Oint. Containing per gm. Polymixin B 5gm tube sulphate 5000 IU Neomycin suphate 3400 IU Zinc Bacitracin 400 IU 395 1252 Clobetasol Oint Containing: Clobetasol Propionate IP 0.05% 10gm tube 396 1253 Oint. Betamethasone Each tube to contain: Betamethasone IP ( 20gm tube asValerate) 0.1% 397 1257 Cream Tretinoin- Each tube to contain: Tretinoin (Trans Retionic 20gm tube Acid) 0.05% 398 1271 Glycerine Each Bott. to contain : Glycerine IP- 500gm 500gm bottle 399 1272 IP (Carbolic Acid)- Each Bott. to contain : Phenol 500gm 500mg bottle 400 1277 Inj. Thiopentone Sodium Each vial to contain : Thiopentone 1 vial Sodium IP 0.5gm per vial 401 1286 Pancuronium Inj. Each ml. to contain: Pancuronium 2 mg. 2ml amp 402 1289 Atropine Each ml. to contain: Atropine Sulphate IP 0.6mg. 1ml amp 403 1290 Inj. Fentanyl- Each ml to contain: Fentanyl IP 50mcg. 2ml amp 404 1294 Vitamin B Complex Inj. Each Amp. to contain: Vit. B1 100 mg., 1 amp Vit B2 5 mg., Vit. B6 100 mg., Vitamin B12 1000 mcg. Nicotinamide 100 mg., D-Panthenol 50 mg. 405 1295 Iron Cap. Each Timed release Cap. to contain : Ferrous 10 cap Fumarate 200mg., Cyancobalamin 15mcg., Folic Acid 1.5mg. 406 1297 Tab. Folic Acid Each tab. to contain: Folic Acid IP 5mg 10 tab 407 1299 Chole Calciferol Granules- Each gm to contain: Vit D3 60000 IU 1gm sachet 408 1305 Vit. B complex Tab. Each tab. to contain : NFI- III Prophylactic 10 Tab 409 1307 Cap. Multivitamins + Zinc Each cap to contain : Zinc Sulfate 30 cap Monohydrate 61.8 mg. (eqv. To 22.5 mg. of elemental Zinc.) Vit. B1-10mg., vit. B6-2mg., Vit. B12-5mcg., Ca. Pantothenate 12.5mg., Vit. E Acetate 15mg., Vit. C150mg., Nicotinamide 50mg. And Vit. B2-10mg. 410 1311 Syp. Aminoacid and Iron- Each 10ml. to contain L-Histidine HCl 200ml bottle 4mg., L- HCl 25mg., Thiamine HCl 5mg., Riboflavin 3mg. Nicotinamide 25mg., Pyridoxin HCl 1.5mg., Cyanocobalamin 2.5mcg., Folic Acid 0.5mg., Ascorbic Acid 40.0mg., D-Panthenol 2.5mg. Ferrous Glycinc Sulphate 275mg. 411 1312 Syp. Coloidal Iron + Vitamin Syp. Each ml to contain: Coloidal 200ml bottle Iron eqv to elemental Iron 250mg, Folic Acid 500mcg, Vitamin B12-5mcg

41/71

412 1313 Drop Iron & Folic Acid - Each ml to contain: Colloidal Iron eqv.to 15 ml vial elemental iron 25mg. Lysine Hydrochloride 200mg. Vit. B12- 5mcg. Folic Acid 200mcg. 413 1314 Iron Dextran Inj. Each ml. to contain: Iron Dextran eqv. to 2ml amp Elemental Iron 50 mg. 414 1315 Cap. Amino Acid + Vitamin - Each cap to contain: L- Leucine 10 cap 18.3mg., L- Isoleucine 5.9mg., L-Lysine Hydrochloride 25.0mg., L-Penylalamine 5.0mg., L- Valine 6.7mg. L- Tryptphan 5.0 mg., DL- 18.4mg., 5- Hydroxy Anthranillic Acid Hydrochloride .02mg., Vit. A concentrate 2500 IU, Vit D3 200 IU, Thiamine Mononitrate g., Folic Acid 0.75mg., Calcium Pantothenate IP 5.0mg., Vit. B12 2.5mg., Vit. C 40.0mg., Vit. E acetate 7.5 IU., L- Threonine 4.2mg. 415 1319 DEXTROSE WITH NaCl SOLN IP - Each 100ml to contain: 500ml bottle Dextrose Anhydrous 5gm, Sodium chloride 0.45gm 416 1320 Maintenance solution for paediatric use Each 100ml to contain 500ml bottle (in mmol/L) sodium IP 23.0 Chloride IP 20.0, Potassium IP 20.0 Acetate IP. 23.0, Magnesium IP 1.50 Phosphate IP 1.50 417 1321 Oral Rehydration Salt (WHO Formula) Each sachet to contain : 21gm Sodium Chloride 2.6gm, Potassium Chloride 1.5gm. Sodium Sachet. Citrate 2.9 gm Dextrose (Anhydrous) 13.5gm. 418 1322 Amino Acid (FOR IV INFUSION)- Each ml to contain: L- 200ml glass Arginine Hcl 8.0mg. L-Histidine Hcl. 4.0mg. L- Isoleucine 5.5mg., bottle L-Lysine Hcl. 22.3mg., L-Methionine 7.1mg., L- Theonine 5.4mg., L- Phenylalanine 8.7mg., L-Leucine 12.3mg., L-Valine 6.1mg., Glycine 10.0mg. L- 1.8mg., Sorbitol 50.00mg. 419 1325 Mannitol Injection 20% 100 ml bottle 420 1326 Sodium Bicarbonate Inj. Containing: Sodium Bicarbonate 7.5% 10ml amp 421 1327 Each ml. to contain: Inj Potassium Chloride BP 0.15 gm. 10ml amp 422 1328 Interferon Inj. Each vial to Contain Interferon Alpha 2A : 3Mil. 1 vial I.U. 423 1333 Inj. Methotrexate - Each vial to contain: Methotrexate IP 50mg 1 vial 424 1334 Tab. Tamoxifen - Each tab. to contain: TamoxifenIP 20mg 10 Tab. 425 1336 Syp. Cyclosporin Each ml to contain: Cyclosporin 100mg 50 ML 426 1341 Tetanus Vaccine (ADSORBED) Each 0.5 ml. to contain: Tetanus 0.5ml Amp Toxoid IP 5/LFS 427 1343 Cough Syp. Each 5ml. to contain : Methdilazine 2.5mg,Amm. 115ml bottle Chloride 100mg, sodium citrate 50mg. 428 1344 Syp. ANTACID GEL- Each 5ml to contain: Aluminium Hydroxide 180ml. Bot. 6mg. Hydroxide 80mg. Activated Dimethicone 100mg. Deglycycrrhizimated Liquorice eqv.to Liquoprice 400mg. 429 1345 Laxative Enema- Each bottle to contain: Glycerin I.P. 15%, 30ml bottle Sodium Chloride I.P. 15% 430 1346 Dicyclomine & Mefenamic Each Tab. to contain : Dicyclomine 10 tab 10mg., 250mg. 431 1347 Cap. - Each cap to contain: Thiocolchicoside IP 10 Cap 4mg 432 1348 Tab. Valsartan Each tab. to contain: Valsartan 80mg 10 tab 433 1349 Metolazone Each Tab. to contain : Metolazone 5mg. 10 tab

42/71

434 1352 Meropenam Trihydrate Inj Each vial to contain : Meropenam 1 Vial Trihydrate eqv. to Anhydrous Meropenam 500mg 435 1354 Ampicillin Sod. + Sulbactum Inj. Each vial to contain: Ampicillin 1 vial Sod., IP 1gm, Sulbactum Sod. 0.5gm 436 1355 Azelastine Nasal Spray Containing: Azelastine 0.05% 10ml Pack 437 1356 Inj. Methylprednisolone Sod. Succinate- Each vial to contain: 1 vial Methylprednisolone Sod. 125mg 438 1357 Inj. Methylprednisolone Sod. Succinate- Each vial to contain: 1 vial Methylprednisolone Sod. 500mg 439 1361 Surgical Spirit IP Containing: Surgical Spirit 500ml 440 1364 Salicylic Acid + Beta Ointment Containing Betamethasone IP 20gm tube 0.05%, Salicylic Acid IP 6% 441 1365 Cream. Each tube to contain: Dimethicone 20%, Zinc Oxide 5%, 20gm tube Calamine 1.5%, Cetrimide 1.125%, Cholocresol 442 1366 Lotion. Clobetasol Each to contain: Propionate IP 0.05%- 15ml 443 1370 Tab. Torsemide- Each tab. to contain: Torsemide IP 10mg 10 tab. 444 1371 Tab. Mebeverine- Each tab. to contain: Mebeverine HCl IP135mg 10 Tab 445 1372 Tab. Perindopril + Indapamide- Each tab. to contain: Perindopril 10 tab. Erbumine 4mg + Indapamide 1.25mg 446 1373 Tab. Atenolol + Amlodipine Each tab. to contain: Atenolol 50mg 10 tab. + Amlodipine 5mg 447 1374 Tab. Trimetazidine SR- Each tab. to contain: Trimetazidine SR 10 Tab 60mg 448 1376 Tab. HydroxyChloroquine- Each tab. to contain: 10 Tab HydroxyChloroquine Sulphate IP 200mg 449 1377 Tab. Losartan + Amlodepine- Each tab. to contain: Losartan 10 tab Potassium 50mg, Amlodepine 5mg 450 1378 Syp. Ofloxacin Each 5ml to contain: Ofloxacin IP 50mg 30ml bottle 451 1379 Syp Azithromycin- Each 5ml to contain: Azithromycin IP 15 Ml. bottl. 100mg/5ml-15ml 452 1380 Susp- Colistin Sulphate- Each 5ml to contain: Colistin Sulphate 60ml USP 12.5 mg. 453 1381 Dry Syp. Cefixime- Each 5ml to contain: Cefixime IP 50mg 30 Ml. bottl. 454 1382 ED. Tobramycin - Each vial to contain: Tobramycin USP 0.3%w/v 5ml vial 455 1384 Ciprofloxacine Eye Oint. Containing: Ciprofloxacin Hydrochloride 5gm IP 0.3% w/w 456 1386 Oint. Sodium Fusidate Each 1gm to contain: Sodium Fusidate IP 5gm tube 20mg 457 1387 Gel. Clindamycin Gel- Each tube to contain: Clindamycin IP 1% 20gm tube 458 1388 Cap. Mecobalamin + Lipoic Acid- Each cap. to contain: 10 Cap Mecobalamin 0.5mg, Alpha Lipoic Acid 100mg 459 1389 Infusion. Mannitol + Glycerin Infusion.- Each bottle to contain: 100ml bottle Mannitol I.P. 10%, Glycerin I.P. 10% 460 1390 Clobetasol Gentamysin Miconazole Oint. Each tube to contain: 5gm tube Propionate 0.05% w/w, Gentamycin Sulphate 0.1% w/w, Miconazole Nitrate 2% w/w 461 1391 Cream Acyclovir- Each tube to contain: Acyclovir 5% w/w. 5gm tube 462 1392 Tab. Oxcarbazepine- Each tab. to contain: Oxcarbazepine IP 10 Tab. 150mg

43/71

463 1393 Tab. Mefenamic + Tranexamic acid- Each tab. to contain: 10 tab. Mefenamic Acid 250mg, Tranexamic acid 500mg 464 1394 Lotion. Fluocinolone - Each to contain: Fluocinolone IP 0.01% 15ml w/v 465 1395 Mifepristone tab. Each Tab. to contain: Mifepristone 200 mg. 10 tab. 466 1396 Levonorgestrel Tab. Each Tab. to contain: Levonorgestrel IP 10 tab. 75mg. 467 1397 Gel Clotrimazole- Each tube to contain: Clotrimazole IP 2% 30gm Tube 468 1398 Dry Syp. Cefixime + Lactic Bacillus- Each 5ml to contain: 30ml Cefixime 50mg, Lactic Acid Bacillus 30million Spores 469 1399 Cefixime + Lactic Bacillus Each Tab. to contain: Cefixime IP/USP 6/10 Tab. 200mg. Lactic Acid Bacillus 60 million Spores. 470 1403 Tab. Antioxidant- Each tab./cap to contain: Carotenoids and 10 tab./cap. micronutrients from carrots 100mg. (Eqv.to 100mcg.of carotenoids calculated as beta carotene) Beta Carotene7.5% dispersion 40mg.(Naturalcarotenoids),Vit. C 150mg.vit.E Acetate 25mg. Selenium dioxide75mcg (Eqv.45.9mcg of selenium),Zinc sulphate 70mg. eqv. to 15.9mg zinc). 471 1404 Inj. Docetaxel- Each Inj to contain: Docetaxel 80mg 1 Vial 472 1405 Inj. Peginterferon Alfa-2A Each Inj. to contain: Peginterferon Alfa- 1 vial 2A 180 IU 473 1406 Tab./Cap. Temozolomide Each Tab./Cap. to contain : 5 Tab. Temozolomide I.P. 250mg 474 1413 ANTACID- Each Sachet (0.67g) contains: Water Soluble Sachet Azulene (Sodium Azulenesulfonate) JPC 2.01mg. L-Glutazene JPC 663.3mg. 475 1414 Sachet- Bifilac -Prebiotic and probiotic -Streptococcus faecalis T- Sachet 110 30 million Clostridium butyricum To-A 2 million bacillus mesentericus To A 1 million Lactic Acid bacillus 50 million (Lactobacillus sporogenes) 476 1415 Tab. Ornidazole Each tab to contain : Ornidazole IP 500mg 10 Tab 477 1416 Meclizine HCL + Caffeine Tab. 10 Tab Each tab to contains : Meclizine Hcl 25 mg + Caffeine 20 mg 478 1417 Aceclofenac Inj. Each ml to contain : Aceclofenac 150mg 1ml. Amp/vial 479 1418 Cap.Thiocolchicoside Each tab to contian:Thiocolchicoside IP8mg 10 cap 480 1420 Tab. Telmisartan Each tab to contain : Telmisartan IP 40mg 10 Tab 481 1421 Tab. Perindopril + Amlodipine- Each tab. to contain: Perindopril 10 tab 4mg, Amlodipine 5mg 482 1424 Tamsulosine Tabs./caps Each Tabs./caps to contain: 10 tab/cap Tamsulosine IP 0.4mg 483 1425 Tamsulosin & Dutasteride Tab./Cap. Each tab to contain : 10 Tab./Cap. Tamsulosin 0.4mg. + Dutasteride 0.5g. 484 1427 Loratadine Syp. Each 5ml to contain: Loratadine USP 5mg 30ml bottle 485 1428 Lotion. Clotrimazole + Beclomethasone dipropionate - 15ml bottle Containing: Clotrimazole 1% w/w, Beclomethasone dipropionate 0.025% w/v base- 15ml 486 1432 ED. Olopatadine- Each vial to contain : Olopatadine 1.0mg. 5ml vial 487 1434 Azelastine eye drops Containing: Azelastine 0.05% w/v 5ml vial

44/71

488 1436 Drop. Multivitamin- Each ml to contain: Vitamin A Concentrate 10ml Phial (as palmitate) oily form:3000 Cholecalciferol 400 IU Ascorbic Acid 40mg. Thiamine Mononitrate:2mg. Riboflavin Sodium Phosphate eqv. To Riboflavin:1mg NIcoinamide 10.5mg Pyridoxine Hydrochloride:1mg D- Panthenol 3mg. Tocopheryl Acetate 5.25IU Flavoured Aqueous base (Appropriate overages of vitamins added to compensate for loss on storage) 489 1437 Iron Inj. containing: Iron sorbitol citric acid complex 50mg 1.5ml Amp 490 1438 Inj. Iron- Each ml to contain: Fe Sucrose 20mg 5ml Amp 491 1440 Gel containing: Feracrylum 1% w/w 15gm tube 492 1441 Powder Containing: Zinc Bacitracin 400U, Polymyxin B Sulphate 10gm Phial 5000U, Neomycin Sulphate 3400U 493 1444 Cream Containing: Betamethasone Dipropionate 0.5% w/w, 15gm tube Neomycin Sulphate 0.5% w/w. 494 1445 Cream containing: GBHC IP 1% Benzocaine IP 2% cream base 25gm tube 495 1448 Inj. Nimotuzumab- Each vial to contian: Nimotuzumab 50mg 10ml vial 496 1450 Inj. Anti Hemophillic- Each vial to contain: Anti Hemophillic Factor 1 vial VIII Monoclonal Purified 250 IU 497 1451 Inj. Anti Hemophillic- Each vial to contain: Anti Hemophillic IX 1 vial 600IU 498 1453 Tab. Letrozole - Each tab. to contain: Letrozole 2.5mg 10 tab 499 1456 Low Calcium CAPD- Each to contain: CAPD Bag 7.5% of 2Ltr Bag Icodextrin with asymmetrical Y Connector 500 1458 Tab. Amiodarone- Each tab. to contain: Amiodarone IP 200mg 10 tab 501 1459 Cough Syp. Each 5ml to contain : Ambroxol HCl 30mg, 100ml Bott. Terbutaline 1.25mg,Guaiphenesin 50mg Menthol 0.5mg 502 1461 Tab. HYDROCHLORIDE Each tab. to contain: 10 tab Hydroxyzine HCl IP 25mg 503 1462 Tab. Itraconazole Each tab. to contain: Itraconazole 100mg 4 tab. 504 1463 Polymyxin, Neomycin & HC Ear Drops Ear Drops containing: 5ml vial Polymyxin B sulph. IP/BP/USP 10000 IU, Neomycin sulphate IP 3400 IU & Hydrocortisone IP 10mg w/w 505 1464 Mouth Paint containing: Clotrimazole IP 1% Propylene Glycol IP, 15ml bottle Glycerin IP base 506 1465 Inj. Paclitaxel- Each vial to contain: Paclitaxel IP 300mg 1 vial 507 1466 Inj. PEG Filgrastim- Each PFS to contain: PEG Filgrastim 1ml PFS 508 1468 Medroxy- Progesterone Inj. Containing: Medroxy Progesterone 1ml PFS Acetate IP 150mg 509 1469 Inj. Menotrophin-Each amp/vial to contain:-Recombinant FSH 1 amp/vial 75IU 510 1470 Tab. Ethinylestradiol + Desogestrel- Each tab. to 21 tab contain:Ethinylestradiol 0.02mg + Desogestrel 0.15mg 511 1471 Human Albumin 20% Inj. Containing: Human Albumin 20% 50ml bottle 512 1472 Immunoglobulin Inj. Containing: Immunoglobulin 5% 100ml bottle 513 1475 Tab. Anastrozole Each tab to contain : Anastrozole1mg 10/14 tab. 514 1477 Inj. Pemetrexded Disod.- Containing: Pemetrexded Disod. 1 vial 500mg 515 1478 Low dose Progesterone Oral PillEach Tab. to contain: 28 tab Desogestrel 75mcg. 516 1479 Lornoxicam Inj. Each 2ml to contain : Lornoxicam 8mg 2ml amp/vial

45/71

517 1480 Inj. Clarithromycin- Each vial to contain: Clarithromycin 500mg 1 vial 518 1481 Amoxycillin+Clavulanic Acid Disp Tab. Each Tab. to contain: 10 tab Amoxycillin IP 200mg, Clavulanic acid IP 28.5mg 519 1482 Cefotaxime+Sualbactam Inj. Each vial to contain : Cefotaxime IP 1 vial 500mg + Sulbactam IP/USP 250mg 520 1483 Cefotaxime+Sualbactam Inj. Each vial to contain : Cefotaxime IP 1 vial 500mg + Sulbactam IP/USP 250mg 521 1484 Inj. Imipenem + Cilastatin- Each vial to contain: Imipenem 1 vial 500mg, Cilastatin 500mg 522 1486 Inj. Insulin Glargine Each vial to contain: Insulin Glargine100 3ml vial units/ml 523 1487 Inj. Insulin Aspart Each vial to contain: Insulin Aspart (R-DNA 10ml vial origin) 524 1488 Inj. Biphasic Insulin Aspart - Each penfill to contain: Biphasic 3ml penfill Insulin Aspart (R-DNA origin) 525 1489 Inj. Drotaverine - Each ml to contain: Drotaverine 20mg 2ml amp/vial 526 1490 Tab. Sitagliptin Each tab. to contain : Sitagliptin IP 100mg 7 Tab. 527 1492 Human Epidermal Growth- Each gm to contain: 150µ 7.5mg Recombinant Human Epidermal Growth Factor gel

528 1493 Calcium & Minerals Tabs. Each Tab. to contain Calcium Citrate 10 tab eqv to elemental calcium IP 200mg, Zinc sulphate IP 4mg, Monohydrate, Magnesium Hydroxide IP 50mg, Vit D3 IP 200 I.U Excepients q.s. 529 1494 Lactobacillus Cap. - Each cap to contain: 1 billion C.F.U 10 Cap Lactobacillus Rhamnosus GR-1 Lactocacillus reuteri RC-14 530 1495 ANTACID GEL- Each 5ml to contain: Dried Aluminium Hydroxide 170ml. Bot. Gel 250mg. Activated Simethicone 40mg. 531 1496 Rabeprazole sodium + Citrate Cap., Rabeprazole 10 Cap sodium 20mg Mosapride Citrate 15mg Sustained release 532 1498 Meclizine HCL+Nicotinic acidEach Tab. to contain : Meclizine 10 tab HCL 12.5mg, Nicotinic acid 50mg. 533 1499 Otilonium bromide tab. Each Tab. to contain : Otilonium bromide 10 tab 40mg 534 1501 Ofloxacin+Ornidazole tab. Each Tab. to contain : Ofloxacin 10 tab 200mg, Ornidazole 500mg. 535 1503 Syp. DISORDERS- Each 5ml to contain: Tricholine 200ml bott. Citrate 250mg. Kalmegh IP eq. to andographolides 250mcg. Sorbitrol solution IP (70%) in a flavoured base 536 1504 Syp. LIVER DISORDERS- Each 5ml to contain: Tricholine 200 ml Citrate 0.55mg., Sorbitol 7.15gm 537 1505 Metadoxine Tab Each Tab. contain: Metadoxine 500mg 10 tab 538 1506 Susp. Bacillus clausII spores- Each 5ml to contain: Bacillus 5ml clausii spores 2 Billion spores, susp in 5ml distilled water 539 1507 PRE & PROBIOTIC- Each cap. to contain: Streptocoocus 10 cap Faecalist -110 60 million, clostridium Butyrlcum TO-A4 Million, Bacillus Mesentericus TO-A2 Million, Lactic Acid Bacillus 100 million, (Lactobacillus sporogenes

46/71

540 1511 Euphorbia Prostata- Each tab. to contain: Euphorbia Prostata dry 7 Tab. extract ethanolic 80%(v/v) 100mg. 541 1512 Tab. AMBROXOL HCL+ N- ACETYL -L- - Each tab. 10 tab to contain: Ambroxol Hydrochloride 30mg, N-Acetyl-L- Cysteine 200mg. 542 1513 Tab. Montelukast + Levocetrizine- Each tab. to contain: 10 tab Montelukast 10mg, Levocetrizine 5mg 543 1516 Each 5ml. to contains : (Cough Syp.) Dextromethorphan 50ml bottle hydrobromide 10mg. Phenylephrine hydrochloride 5mg, chlorpheniramine maleate 4mg. Guaiphenesin 100mg. 544 1517 Cough Syp. Each 5ml to contain : Terbutaline sulp. 1.25mg, 100ml bottle ambroxol hyd. 15mg, guaiphensesin 50mg, menthol 1mg 545 1518 Cough Syp.:- Each 10ml to contain: Carbinoxamine Maleate 100ml IP/BP/USP 4 mg, Ammonium Chloride IP 240 mg, Sodium Citrate IP 240 mg, 546 1519 INHALER - Each metered to contain: Budesonide 160mcg, 60 doses Formoterol Fumarate Dihydrate 4.5mcg , Lactose Monohydrate 730mcg. 547 1520 Inhaler Containing : Moulded plastic device containing a foil 30/60 doses strip with 30/60 regularly placed blisters each containing 50 mcg of salmeterol xinafoate and 250 mcg of fluticasone propionate

548 1521 INHALER- Each metered dose to contain: Tiotropium Bromide 120 doses Monohydrate eqv. Tiotropium 9mcg. 549 1522 INHALER- Each metered dose to contain: Ipratropium 20mcg, 200 doses Levosalbutamol 50mcg 550 1524 Budesonide Resp. Each 2ml to contain : Budesonide 1mg steroid 2ml nebulizing fluid 551 1525 Tiortropium Bromide Rotacaps- Each Rotacaps to contain : 30 Cap Transcap - Tiortropium Bromide I.P./BP eqv. To Tiotropium Bromide Monohydrate 18 mcg. 552 1526 Ipratropium + Levosalbutamol- Each 2.5ml. to contain : 2.5ml resp Ipratropium I.P. 500mcg, Levosalbutamol 1.25mg. 553 1528 digoxin Elixir Each ml to contain : Elixir digoxin 0.05mg 30ml 554 1529 Inj. Adenosine Each 2ml. to contain : Adenosine 6mg 2ml 555 1530 Tab. Ivabradine Each tab. to contain: Ivabradine 5mg 10/14tab 556 1531 Tab. Nicorandil Sustained release- Each tab. to contain : 10 tab Sustained release- Tablets of Nicorandil 20mg. 557 1532 Tab. Isosorbide Dinitrate Each tab. to contain Isosorbide Dinitrate 10 tab IP 5mg 558 1536 Fondaparinux sodium Inj.Each PFS: (0.5ml) syringe contains: 0.5ml PFS Fondaparinux sodium 2.5 mg 559 1538 Vitamin K Inj. Each amp to contain: Vitamin K IP 1.0mg 0.5ml Amp 560 1541 Inj. Paracetamol Each ml. to contain : Paracetamol 10mg 100ml 561 1543 Tab./Cap Diacerein Each tab./cap. to contain: Diacerein IP 50mg 10 tab/cap 562 1544 Thiocolchicoside +Diclofenac Sodium Each tab. to contain : 10 Tab Thiocolchicoside Fr. Ph, 4mg. Diclofenac Sodium I.P. 50mg 563 1546 Spray Containing: Diclofenac Diethylmine 1.16%, Methly 100gm Salicylate 10%w/w, Linseed oil ( oleum lini)- 3%w/w, Menthol 5%w/w Excipients & Propellant q.s. 100% w/w

47/71

564 1547 Analgesic Cream- Each tube to contain : Methyl Salicylate 8% 20gm tube w/w, Mephenesin 5%w/w, Methyl Nicotinate 1% w/w, Menthol 2% w/w 565 1548 Strontium Renelate Sachet Each sachet to contain: Strontium Sachet Renelate granules-2gm 566 1549 Inj. Teriparatide Each 2.4ml. PFS/PFP to contain : Teriparatide 1PFS/PFP 600mcg PFS/PFP 567 1550 Tab. Linezolid Each tab. to contain : Linezolid IP 600mg 4 tab 568 1554 Levofloxacin Inj. Each vial to contain: Levofloxacin IP 500mg 1 vial 569 1556 Each vial to contain: Piperacillin Sodium IP/BP/USP 4 gm , 1 vial Tazobactum Sodium 0.5 gm 0.5 gm 570 1559 Linezolid Inj. Each vial to contain: Linezolid IP 600 mg 1 vial 571 1561 Inj. Ertapenem Sodium Each vial to contain : Ertapenem 1gm 1 vial (eqv. To Ertapenem sod.1.046gm.) IV/IM 572 1563 Fluconazole +Azithromycin+ Secnidazole Tabs., IP Each Tab. to 1 kit contain: Fluconazole 150 mg,(1 Tabs.) Azithromycin IP 1 gm(1 Tabs.)Secnidazole IP 1 gm(2 Tabs.) 573 1564 Inj. Artisunate Each vial to contain : Artisunate 60mg per vial 1 vial 574 1565 Primaquin Tab., IP Each Tab. to contain: Primaquine 15mg. 7 Tab. 575 1566 Inj. Acyclovir Each vial to contain : Acyclovir IP 500mg 1 vial 576 1567 Lamivudine, Nevirapine,Stavudine Tabs. Each Tab. to contain: 10 tab Lamivudine IP 150 mg, Nevirapine IP 200 mg, Stavudine IP 30 mg 577 1568 Tab. Lorazepam Each tab. to contain : Lorazepam IP 1mg 10 tab 578 1569 Chlordiazepoxide tab. Each Tab to contain: Chlordiazepoxide IP 10 tab 10 mg, 579 1570 Hydroxyzine Hydrochloride Syp. Each 5ml to contain: 100ml Hydroxyzine Hydrochloride IP/BP/USP 10 mg 580 1571 Syp. Phenobarbitone Each 5ml. to contain : Phenobarbitone 60ml. Bott. 20mg 581 1572 Syp. Triclofos, Each 5ml to contain: Triclofos sodium BP 500mg 30ml bottle 582 1573 Tab. Piracetam Each tab. to contain :Piracetam IP 400mg 10 tab 583 1574 Tab. Piracetam Each 5ml. to contain :Piracetam IP 500mg 100ml bot. 584 1575 Cap./Tab. Pregabalin + Methylcobalamine Each cap./tab. to 10 Cap/ tab contain Pregabalin 75mg, Methylcobalamine 750mcg 585 1576 Cap./Tab. Gabapentine+ Methylcobalamine Each cap./tab. to 10 Cap/ tab contain Gabapentine 300mg, Methylcobalamine 500mcg 586 1577 Tab./Cap. Dutasteride Each tap./cap. to contain : Dutasteride 10 Cap/Tab 0.5mg 587 1578 Alfuzosin tab. Each Tab. to contain: .Alfuzosin IP/Eur.Ph. 10 mg 588 1579 Mix Lactobacill Vaginal Tab - Each vaginal Tab to contain: Mix 4 tab Lactobacill (L. brevis, L. salivarious and L. plantarum) 10E9 589 1580 Sertaconazole Nitrate Vaginal Tab: Each veginal Tab. Contains: 1 vaginal tab Sertaconazole Nitrate B.P.500 mg with applicator 590 1582 Levocetrizine Tabs. Each Tab. to contain: Levocetrizine IP 5mg 10 tab 591 1583 Cetrizine HCL drops Each ml to contain : IP 10mg Cetrizine HCL 10ml Phial 592 1584 Cap. Natural Micronised Progesterone- Each cap to contain: 10 cap Natural Micronised Progesterone 100mg 593 1585 Inj. Noradrenaline Each 2ml to contain : Noradrenaline 4mg. 2ml.amp

48/71

594 1586 Inj. Somatropin (R-DNA)- Each PFS contain: Somatropin (R- 1 PFS DNA) origin Bio synthetic Human Growth Hormone Solution 10mg/1.5ml= 30IU 595 1589 Betamethasone Tab Each Tab to contain:Betamethasone IP 1mg 10 tab 596 1591 Tab. Saxagliptin Each tab. to contain : Saxagliptin 2.5mg 14 tab 597 1592 Inj. Liraglutide - Inj. Human GLP -1 analogue contains : 3ml Liraglutide 6mg/ml- 3ml 598 1593 Inj. Insulin Detemir Each inj. to contain: Insulin Detemir 100 IU/ml 3ml (R-DNA) 599 1594 Gatifloxacin Eye drop containing Gatifloxacin soln. IP 0.3 % w/v 5ml vial 600 1595 ED- Levofloxacin Coontaining: Levofloxacin IP 0.5% 5ml vial 601 1597 ED- Moxifloxacin Containing: Moxifloxacin 0.5%- 5ml 5ml vial 602 1600 Ofloxacin + Prednisolone Eye drop Containing: Ofloxacin IP 0.3% 5ml vial + Prednisolone Acetate IP 1.0% 603 1601 ED. Dorzolamide + Timolol Each vial to contain: Dorzolamide 2% 5ml vial + Timolol 0.5% 604 1602 Travoprost Eye drop Containing: Travoprost 0.004% 5ml vial 605 1604 Natamycin Eye drop Containing: Natamycin IP/BP/USP 0.5% 3ml vial w/v-3ml 606 1607 Latanoprost Eye Drop Containing: Latanoprost 50 mcg 2.5ml vial Benzalkonium Chloride 0.01% w/v Aqueous Buffered Vehicle q.s 607 1612 Cream. Sertaconazole Each tube to contain : Sertaconazole 10gm tube Nitrate 2% 608 1613 Tolnaftate Lotion Each ml to contain: Tolnaftate IP/BP/USP 10mg 10ml 609 1614 Oint. Zinc Oxide Each tube to contain : Zinc Oxide I.P. 20gm tube 610 1616 Mometasone +Salicyclic Acid Oint Containing Mometasone 5gm tube Furoate IP/BP/USP 0.1% + Salicylic Acid 5% IP 611 1617 Clobetasol Salicylic Acid Oint Containing: Clobetasol Propionate 10gm tube BP 0.05% w/w Salicylic Acid IP 6% w/w, 10 gm 612 1619 Hydroquinone + Tretinoin + Mometasone Cream- Each tube to 30gm contain: Hydroquinone IP/BP/USP 4.0%w/w, Tretinoin IP/BP/USP 0.025%w/w, Mometasone Furoate IP/BP/USP 0.1%- 613 1624 Spray. Lidocaine containing : Spray. Lidocaine 1.0%, Cetrimide 100gm Pack 0.1%, Polyvinyl Polymer 2.8% solvent & propellent 614 1628 Hydrogen Peroxide Each bott. to contain : Hydrogen Peroxide IP 400ml bottle - 400ml 615 1629 Liq. Paraffin Cotaining: Liq.Paraffin IP 400ml bottle 616 1632 Vitamin D3 Inj. Each amp. to contain: Inj. Vitamin D3 IPO 3 lac 1 amp IU 617 1633 Inj. Methylocobalamin Each ml. to contain : Methylocobalamin 1ml Amp 500mcg-1ml 618 1634 Each Tab. to contain: (Calcium with Vitamin D NFI) calcium 10 tab Gluconate NFI 0.5gm, Calcium Phosphate NFI 0.15gm Calciferol NFI equ. To 500 units of Vit. D 619 1635 Calcium Syp.- Each 5ml. (Inj. Hepagard-10ml) contain : calcium 120ml bottle Lactodionate 1.50gms (equivalent0.87 g of ), calcium gluconate 0.25g, Cholecalciferol (Vitamim D3) - 200IU, Cyanocobalamin - 2.5mcg, Magnesium Chloride - 21.25mg (equivalent to 2.5mcg of lemental Magnesium), Flavoured base.- q.s.

49/71

620 1636 Ferrous Gluconate Syp. Each 15ml to contain: Syp. Ferrous 200ml Gluconate IP 400 mg 621 1640 Lapatinib Tab. Each tab.to contain: Lapatinib 250 mg 10 tab. 622 1641 Tab./Cap. Aprepitant - Each pack to contain: (125 mg one 3Tab/cap tab/cap and 80mg two tab/cap) pack 623 1642 Leuprolide Inj. Each vial to contain: Leuprolide Acetate 7.5 mg 1 vial 624 1643 Tab. Sevelamer Each tab. to contain : Sevelamer 400mg 10 tab 625 1645 Inj. Paclitaxel Each vial to contain : Inj. Paclitaxel IP 30mg 1 vial 626 1646 ALBUMIN-BOUND PACLITEXEL Each vial to contain: Inj. 20ml vial Nanoptechnology based ALBUMIN-BOUND PACLITEXEL 100MG 627 1647 Inj. Bevacizumab Each vial to contain : Inj. Bevacizumab 100mg 1 Vial 628 1648 Inj. Trastuzumab Each vial to contain : Inj. Trastuzumab 440mg 1 Vial 629 1649 Inj. Human Interferon Beta 1A, Each PFS/vial to contain: 1 PFS/vial Recombinant Human Interferon Beta 1A 44mcg in each PFS/vial 630 1651 Vaccine. Polysaccharide Pneumococcal Each 0.5ml to contain : 1 pfs/vial 0.5ml. Vaccine. Polysaccharide Pneumococcal 0.5ml. 631 1654 Inj. Rabeprazole Each amp/vial to contain : Inj. Rabeprazole 1amp/vial 20mg (amp/vial) 632 1655 Tab. Ilaprazole Each tab. to contain : Ilaprazole 10mg 10 tab 633 1656 LAXATIVE POWDER - Each pouch to contain : Polyethylene 137.15gm/1 Glycol 118gm. Potassium Chloride 1.484gm. Sodium Bicarbonate pouch 3.37gm. Sodium Chloride 2.93gm. Sodium Sulphate 11.36gm. 634 1657 Inj. Hydrochloride Each 1.5ml. to contains : 1.5ml Palonosetron Hydrochloride equivalent to Palonosetron 0.075mg Water for Inj.- q.s. 635 1658 Syp. Zinc Elemental Zinc Each 5ml. to contain : Elemental Zinc 100ml 20mg 636 1662 Ebastine + montelukast Tab. Each Tab. to contains : Ebastine 10 tab 10mg,montelukast 10mg 637 1663 Cough Drop - Each ml. to contain : Phenylephrine HCL IP - 2.5 15ml. mg. Chlorpheniramine Maleate IP 2.0 Mg. Flavoured Base q.s. 638 1664 Cough Syp. - Each 100ml. Solution to contain : Dried IVY leaf 100ml bott. extract 0.7gm 639 1665 INHALER - Each metered dose to contain : Tiotropium 9mcg. 120 MDI Formoterol 6mcg, Ciclesonide 200mcg.(CFC Free) 640 1666 Rotacap Ipratropium bromide Each Rotacap to contain : 30 cap Ipratropium bromide B.P. eqv. to Ipratropoium bromide (anhydrous ) 40mcg 641 1667 Dronedarone hcl Tab. Each Tab. to contain : Dronedarone hcl 10 tab. 400 mg 642 1668 Tab./Cap. Olmesartan Each tab./Cap. to contain : Olmesartan 10 tab. 20mg 643 1670 Haemostatic- Each 5ml to contain: Haemostatic Matrix with 5ml Prefilled Gelatin Granules in Syringes 644 1671 Tab. Acenocoumarol Each tab. to contain : Acenocoumarol 4mg 10 tab 645 1672 Anti Coagulants Two componant fibrin sealant with fast & slow 2ml setting of human thrombin 646 1674 Tab. Each tab. to contain : Sumatriptan 50mg 10 tab

50/71

647 1675 Tab. Lornoxicam SR - Each SR tab. to contain: Lornoxicam 10 tab 16mg 648 1676 Aceclofenac Tab., Each tab. to contain : Aceclofenac 100mg 10 Tabs 649 1677 Etanercept Inj. Each PFP/PFS to contain : Etanercept 50mg - 1 PFP/PFS Etanercept 50mg. 650 1678 ER Tab. Tartrate Each ER tab. to contain : Zolpidem 10 tab Tartrate IP 12.5mg 651 1679 Lorazepam Inj. Each ml to contain: Lorazepam 2 mg 1 amp 652 1681 Tab. Citicoline Each tab. to contain : Citicoline IP 500mg 10 Tab. 653 1682 Divalproex Sod. Tab Each tab to contain: Divalproex Sod.250 mg 10 Tab. 654 1683 Divalproex Sod Tab. Each tab to contain: Divalproex Sod 500 mg 10 Tab. 655 1685 Tab. Dexcholrpheniramine SR- Each SR tab. to conatain: 10 tab Dexcholrpheniramine 6mg 656 1686 Tab. Fexofenadine Each tab. to contain : Fexofenadine IP180mg 6/10 Tab. 657 1687 Tab. Loratidine Each tab. to contain: Loratidine USP 10mg 10 tab 658 1688 Each Tab to contain: Thyroxine sodium IP 25 mcg 100 tab 659 1689 Tab. Saxagliptin Each tab. to contain : Saxagliptin 5mg 14 tab 660 1690 Tab. Vildagliptin Each tab. to contain : Vildagliptin 50mg 14 tab 661 1691 Insuline Inj. - Each Cartridge to contain: 25% Lispro and 75% 3ml Lispro Suspension (100 IU/ml)[Monocomponent Cartridge insulin, recombinant DNA origin] 662 1692 Insuline Inj. - Each Cartridge to contain: 50% Lispro and 50% 3ml Lispro Protamine Suspension (100 IU/ml)[Monocomponent Cartridge insulin, recombinant DNA origin] 663 1693 Tab. Clarithromycin Each tab. to contain Clarithromycin IP 500mg 10 Tab. 664 1694 Inj. Colistimethate Sodium Each vial to contain: Colistimethate 1 vial Sodium BP 1000000 IU 665 1696 Micafungin Sodium Inj. Each vial to contain: Micafungin Sodium 1 vial equivalent to 50 mg Micafungin 666 1697 Inj. Caspofungin Acetate Each vial to contain : Caspofungin 1 Vial Acetate 50mg 667 1698 Tab. Terbinafine hydrochloride Each tab. to contain : Terbinafine 1/7/10 Tab. hydrochloride 250mg 668 1699 Inj. Alpha Beta Arteether Each vial to contain : Alpha Beta 1 vial Arteether (150mg) 669 1700 Tab. Each tab. to Contain: Ivermectin6mg 4/10 Tab. 670 1703 Terbinafine Ointment Containing: Terbinafine Hcl USP1% 10gm tube 671 1704 Antifungal Gel - Each tube to contain : Adapalene 0.1%w/w (as 15gm tube microsheres), Clindamycin Phosphate USP Eqv. to clindamycin 1.0% w/w In an aqueous gel base-q.s. 672 1705 Lotion Containing: Minoxidil 5%, Amenexil 1.5% 60ml 673 1708 Oint. Tacrolimus Each tube to containb : Tacrolimus 0.03% 10 gm. Tube 674 1709 Oint. Tacrolimus Each tube to contain : Tacrolimus 0.01% 10 gm. Tube 675 1711 Lotion. Sertaconazole Nitrate Each phial to contain: 15ml phial Sertaconazole Nitrate 2% w/v Propylene glycol base QS. 676 1712 Gel Benzoyl Peroxide Each to contain Benzoyl Peroxide 2.5% 20gm 677 1714 Cream. Mometasone Each tube to contain : Mometasone 10/15gm Furoate IP 0.1% tube 678 1715 Triamcinolone Acetonide Containing: Triamcinolone Acetonide IP 5gm 0.1%

51/71

679 1716 Cream. Mometasone + Fusidic Each tube to contain : 10gm tube Mometasone 0.1% & Fusidic 2%- 10gm 680 1717 Ointment Containing: Hydrocortisone Acetate 1% 10/20gms 681 1718 Gel Adapelene Each tube to contain Adapelene 0.1% 15mg tube 682 1719 Azelaic acid Cream Containing: Azelaic acid 10% 15gm tube 683 1720 Isotretenoin Cap. Each Caps. to contain: Isotretenoin 20 mg 10 cap 684 1722 Oint. Coal tar + Salicylic acid- Each to contain : Coal tar 6%, 75gm Salicylic acid 3%- 75gm 685 1723 Spray. Each to contain : Isopropyl Alcohol- 55% w/w, Purified 200gm Water- 10%w/w, Propellant Hydrocarbon-35% w/w- 200gm 686 1725 Drop. Each ml. to contain : Peptonised Iron 117.67mg ((eqv. To 15ml bottle 20mg, of elemental iron), Protein (as Peptone) 30mg., Floic Acid IP 200mcg, Vitamin B12-4mcg, Palatable base q.s. 687 1726 Ringer Lactate Inj. Containing: Ringer Lactate 500ml Self 500ml Collapsible IV Fluid PVC Bag having separate administration port with recessed membrane with plastic sterility barrier & self sealing Inj port with silicon septum, no air vent required. 688 1727 DNS Inj., Containing: DNS 500ml Self Collapsible IV Fluid PVC 500ml Bag having separate administration port with recessed membrane with plastic sterility barrier & self sealing Inj port with silicone septum, no air vent required 689 1728 Tab. Gefitinib Each tab. to contain : Gefitinib IP 250mg 30 tab. 690 1729 Inj. Asparaginase Each vial to contain : Asparaginase 10000 unit 1 vial 691 1731 Rasburicase Inj. Each vial to contain: Rasburicase 1.5 mg 1ml vial 692 1732 Inj. Decitabine Each vial to contain: Decitabine 50mg 1 vial 693 1733 Cap. Nilotinib Each cap to contain : Nilotinib 150mg 4 cap 694 1734 Octreotide Inj. Each Pack to contain: Octreotide 10mg (in form of 1vial/pack microspheres)- 1vial, I pre filled syringe of 2.5ml Vehicle for 2.5ml suspension 2 sterile injection needles 695 1735 Cap./Tab. Imatinib Mesylate Each cap./tab. to contain : Imatinib 10/30 Mesylate IP 400mg cap/tab 696 1736 Tab. Each tab. to Contain : 50mg 10 tab 697 1738 Tab. Sevelamer HCl Each tab. to contain: Sevelamer HCl 800mg 10 tab 698 1739 Inj. Each vial to contain: Pralidoxime 1gm 1 vial 699 1740 Antacid Gel. Each 10ml to Contain: Sucralfate 1000mg, 100ml bottel oxetacaine 20mg. 700 1742 PRE & PROBIOTIC AND ORAL REHYDRATION- Sodium Sachet Chloride 0.52gm. Sodium Citrate 0.58gm. Potassium Chloride 0.3gm. Dextrose Anhydrous 2.7gm. Pre & Probiotic Pack 0.5mg. Contains: Streptococcus Faecalis T-110 7.5 million. Clostridium Butyricum TO-A 0.5 Million Bacillus Mesentericus TO A 0.25 Million, Lactobacillus Sporogenes 20.0 Million 701 1745 Tab. Doxofylline Each tab. to contain : Doxofylline IP 400mg 10 tab 702 1746 Inj. Omalizumab Each vial to contain : Omalizumab150mg Vial 703 1748 Cough Syp. Each 5ml to contains : Cetirizine hydrochloride 5mg, 60ml bottle phenylephrine hydrochloride mg, dextromethophan hydrobromide 10mg, menthol 1.5mg. 704 1749 Levosalbutamol (Inhaler) Each metered dose to contain : 200 doses Levosalbutamol tartrate 50mcg.

52/71

705 1750 Nebivolol 2.5mg Tab./Cap. Each Tab./cap. to contain : Nebivolol 10 tab/cap 2.5 mg. 706 1751 Nebivolol 5Tab./Cap. - Each Tab./Cap. to contain : Nebivolol 10 tab/cap 5mg 707 1753 Telmisartan , Amlodipine Tab. - Each tab. to contain : 10 tab Telmisartan 40mg, Amlodipine Besylate equivalent to Amlodipine 5mg 708 1754 Indapamide SR +Amlodipine Tab. - Each tab. to contain : Tab. 10 tab Indapamide SR 1.5mg, Amlodipine Besylate equivalent to Amlodipine Besylate equivalelodipine 5mg 709 1756 Haemmorrhoidal oint. Containing : Lignocaine hydrochloride 2% 20gm tube w/w, hamamelis water 5%,zinc oxide 10% w/w.ointment base q.s. 710 1757 Etoricoxib Tab.-Each tab to contain : Etoricoxib IP 90mg 10 tab 711 1758 Diclofenac colestyramine Cap. Each cap. to contains :Diclofenac 10 cap colestyramine 145.6mg.(Diclofenac resinate). 712 1759 Tabs./cap. Each Tabs./cap. to contain : 10 cap/tab Tolfenamic acid 200 mg. 713 1760 Hylan G-F20 Inj. Each contain : Hylan G-F20 6ml PFS 714 1761 Inj. Tocilizumab 80mg- Each vial to contain Tocilizumab 80mg 4 ml vial 715 1762 Tocilizumab 200mg Each vial to contain : Tocilizumab 200mg. 10ml vial 716 1763 Tocilizumab 400mg Each vial to contain : Tocilizumab 400mg. 20ml vial 717 1764 Zolpidem Tartrate ER 6.25 mg. Each Extended Release Tab. to 10 tab Contain: Zolpidem Tartrate 6.25 mg. 718 1765 Tab. Voglibose Each tab. to contain : Voglibose 0.2mg 10 tab 719 1766 Sitagliptine 50mg+ Metformin 500 mg. Each Tab. to contain: 14 tab Sitagliptine 50mg, Metformin 500 mg. 720 1767 Tab. Sitagliptin 50mg + Metformin 1000mg Each tab. to contain : 14 tab Sitagliptin 50mg + Metformin 721 1768 Vildagliptin 50 mg+ Metformin 500mg. Tab. Each Tab. to contain: 10 tab Vildagliptin 50 mg, Metformin hydrochloride 500 mg 722 1769 Vildagliptin 50 mg+ Metformin 1000mg. Each Tab. to contain: 10 tab Vildagliptin 50 mg, Metformin hydrochloride 1000 mg. 723 1770 Inj. Insulin Lispro Each cartridge contain : Insulin Lispro (100 3ml IU/ml) [Monocomponent Insulin, recombinant DNA origin] 724 1771 Tab./Cap. Clindamycin Each tab./cap. to contain Clindamycin 10 cap/tab 300mg 725 1772 Inj. Clindamycin Each vial to contain : Clindamycin 600mg 1 vial 726 1773 Inj. Tigecycline Each vial to contain : Tigecycline 50mg per vial 1 vial 727 1774 Tobramycin Inj. Each vial to contain: Tobramycin 20mg vial 728 1775 Tobramycin Inj. Each vial to contain: Tobramycin 60mg vial 729 1776 Tobramycin Inj. Each vial to contain: Tobramycin 80mg vial 730 1777 Inj. Amphotericin B Each vial to contain : Amphotericin B 50mg 1 vial 731 1778 Entecavir oral solu. Each ml to contain: Entecavir 0.05 mg. 210ml bottle 732 1779 Inj. Interferon beta 1-a Each PFP to contain : Interferon beta 1-a 0.5ml PFP 30mcg per PFP (6 million IU) 733 1780 Telbivudine Tab. Each Tab. to contain: Telbivudine 600 mg. 15 tab 734 1783 Ranibizumab Inj. Each ml to contains: Ranibizumab 10 mg. 0.23ml 735 1784 Lotion. Desonide Each Bott. to contain : Desonide 0.05% 30ml bottle 736 1785 Mometasone Furoate Solution Containing: Mometasone Furoate 15ml bottle 0.1% w/v.

53/71

737 1786 Oint. Calcitriol Each gm to contain : Calcitriol 3mcg.- 20gm 20gm tube 738 1787 Feracrylum 3% dressing Containing: Feracrylum 3% Gauze Pouch of Dressing Sterile, Cotton dressing impregnated with water soluble 10cmx10cm base. 739 1791 Vitamin & MineralsTabs. Each Tab. to Contain: Thiamine 15 tab Mononitrate 10mg, Riboflavin 10mg,Nicotinic Acid 25mg,Niacinamide 75mg, Pyridoxin Hydrochloride 3mg,Calcium Pantothenate 50mg,Folic Acid 1.5mg,Vitamin B12 15mcg,Vitamin C 150mg,Biotin 260mcg, Light Magnesium Oxide Equivalent to elemental Magnesium 32.4mg. 740 1792 Syp. Haematinic - Each 5ml. to contain : Peptonised Iron 100ml bottle 176.5mg, (Eqv. To 30mg. Of elemental Iron) Protein 100mg, Folic acid 200mcg, Vitamin B12 2.5mcg per 5ml 741 1793 Tab. Calcium- Each tab. to contain : Citrate Malate Equivalent to 10 tab. Elemental Calcium 250mg+ Calcitriol 0.25mcg+Vitamin K2-7 50mcg 742 1794 Calcium & Minerals Tab. Each tab. (Inj. Hepagard-10ml) contain : 15 tab Calcium Carbonate 1000mg, from Organic Heavy Magnesium Oxide 150mg, Zinc Sulphate Monohydrate 13.75mg, L-Lycine HCl 100mg, Pyridoxine HCl 1.5mg, Cholecalciterol 200 IU 743 1795 CALCIUM CAP.- Each cap. to contain: Elemental Calcium 150mg 10 cap (In the form fo Calcuim hydroxide & calcium oxide pretreated with heated algae), zinc sulphate monohydrate equivalent to elemental zinc-7.5mg, calcitriol-0.25mcg 744 1800 Fluids Each 100ml to Contain: Invert Sugar 10 g, Water for 500ml bottle Injection q.s. 745 1801 Fluids Each 100ml to Contain: Invert Sugar 10 g, Sodium 500ml bottle Chloride 0.9 g, water for injection q.s. 746 1802 Tab. Methotrexate Each tab. to contain : Methotrexate 7.5mg 10 tab 747 1803 Tab. Sorafenib - Each tab. to contain: Sorafenib Tosylate 200mg 10 tab 748 1804 Tacrolimus 1mg Tab. Each Tab. to contain: Tacrolimus 1mg. 10 tab 749 1805 Tab. Tacrolimus 2mg Each tab. to contain : Tacrolimus 2mg 10 tab. 750 1807 Tab. Erlotinib Each tab. to contain : HCl Eqv. Erlotinib 100mg 10 tab 751 1808 Inj. Bortezomib Each vial to contain : Bortezomib 1mg 1 vial 752 1809 Inj. Bortezomib Each vial to contain : Bortezomib 3.5mg 1 vial 753 1810 Cap. Nilotinib Each cap. to contain : Nilotinib 200mg 4 cap 754 1811 Cabazitaxel Inj. Each 1.5ml contain: Cabazitaxel 60mg. (Diluent vial 5.7ml of 13% w/wEthanol in water for injection). 755 1812 Inj. Cetuximab 100mg- Each vial to contain: Cetuximab 5mg 20ml vial 756 1813 Inj. Cetuximab 500mg Each ml to contain: Cetuximab 5mg 100ml vial /bottle 757 1815 Inj. Factor Eight Bypassing activity, Containing : Factor Eight Vial Bypassing activity, Anti-Inhibitor-Coagulant Complex 500IU 758 1816 Inj. Recombinant Anti Hemophillic Factor Containing : Pack Recombinant Anti Hemophillic Factor VIII 250 IU 759 1817 Inj. Recombinant Anti Hemophillic Factor Containing : Pack Recombinant Anti Hemophillic Factor VIII 500IU 760 1818 Inj. Recombinant Anti Hemophillic Factor Containing : Pack Recombinant Anti Hemophillic Factor VIII 1000IU

54/71

761 1822 Syp Lactulose Each 15ml. to contain : Lactulose USP 10gm. 200ml Bott. 762 1823 Syp Lactulose Each 15ml. to contain : Lactulose USP 10gm. 450ml Bott. 763 1824 Lactulose Granules Each 15gm of Granules to contain : Pack of 90 (Lactulose BP 10gm, Ispaghula Husk IP 3.50gm in 15gm) gm. 764 1828 Syp. Ondansetron Each 5ml. to contain : Ondansetron IP 2mg. 30ml Bott. 765 1829 Tab Mefenamic Acid Each tab. to contain: Mefenamic Acid IP 10 Tab 500mg 766 1830 Tab. Racecadotril Dispersible Each tab. to contain Racecadotril 10 tab Dispersible10mg 767 1831 Tab. Racecadotril Dispersible Each tab. to contain Racecadotril 10 tab Dispersible30mg 768 1832 Tab/Cap. Racecadotril Each .to contain: Racecadotril 100mg 10 tab./cap 769 1834 Pre & Probiotic Capsule- Each cap. to contain: Lactobacillus 10 cap. Plantarum Lp 299v 10billion CFU 770 1835 Pre & Probiotic Capsule- Each cap. to contain: 2billion spores of 4 cap polyantibiotic resistant Bacillus Claussi 771 1836 HAEMORRHOIDAL CREAM - Each gm to contain : Euphorbia 30 mg tube Prosttrata dr extract etract ethanolic 80% (v/v) ((35-70):1) 10mg ( Containing 0.315-0.825 rhg totel calcluated as -7 glucoside and 1.26-4.40 mg totel phenolics calculated as gallic acid) cream 772 1837 Cap. EPL & Etophylline- Each cap. Each tab. to contain: contain 10 Cap. : Essential phospholipids (EPL substances ) 300mg, Hydroxyethyl Theophyline (Etophylline )BP. 50mg. Excipients QS. Approved colour used in Empty capsule shell. 773 1838 Tab. Garenoxacin - Each film coated tab. to contains : 10 tab Garenoxacin Mesylate equivalent to Garenoxacin 200mg exceipients qs 774 1839 Autohaler- Each delivered of Autohaler to contain : Formoterol 200 MDI Fumarate Dihydrate 6mcg, Budesonide IP 200mcg Suspended in propellant HFA 134a q.s. Also contains Absolute alcohol IP 3.07% v/v (Inh. FORACORT 200 Autohaler) 775 1840 INHALER - Each delivers dose to contain : Salmetrol xinafoate 150 MDI IP Equivalent to salmetrol 25µg Fluticasone Propionate IP 250µg with/without Excipients & Propellant 1, 1, 1, 2 Tetrafluoro Ethane HFA 134a SPACER 776 1841 Inhaler -Each actuation to deliever Formoterol Fumarate 150MDI Dihydrate IP eqv. To Anhydrous Formoterol Fumarate 6mcg, with/without Budesonide IP 400mcg Excipients & Propellant 1,1.1.2 spacer Tetrafluoro Ethane HFA 134a 777 1843 Autohaler- Each delivered Autohaler to contain : Salmeterol (as 200 MDI salmeterol xinafolate )IP 25mcg, Fluticasone Propionate IP 250mcg Suspended in Propellant 134a q.s. (contains Absolute Alcohol IP 5% V/V 778 1844 SPACER DEVICE-Spacer-suitable for MDI inhaler of all brand 1 piece 779 1845 Tab. Metoprolol Succinate SR Each SR to contain : eqv. 10 Tab Metoprolol Succinate 23.75 mg. Metoprolol tartrate 25mg 780 1846 Tab. Each tab. to contain : Propranolol IP10mg 10 Tab 781 1848 Tab. Ranolazine Each tab. to contain: Ranolazine 500mg 10 tab./ cap 782 1849 Inj. Labetalol Each ml. to contain : Labetalol HCL IP 5mg 4ml 783 1850 Tab. Labetalol Each tab. to contain : Labetalol 100mg IP 10 tab

55/71

784 1852 Tab. Cilnidipine Each tab. to contain : Cilnidipine10mg 10 tab 785 1854 Tab. Cilostazol Each tab. to contain: Cilostazol 100mg 10 tab 786 1855 Tab. Tramadol & Acetaminophen Each Film coated tab. to 10 Tab contain L Tramadol HCl IP 18.75 mg Acetaminophen 162.5mg 787 1856 Tab./Cap. Tramadol & Paracetamol Each tab./Cap. to contain : 10 Tab/Cap Tramadol 37.50mg, Paracetamol 325mg 788 1857 Buprenorphine Transdermal Patch - Each Transdermal Patch to 6.25sqcm contain : Buprenorphine 5mcg/hr. Area containing active Path substance 6.25sqcm 789 1858 Buprenorphine Transdermal Patch - Each Transdermal Patch to 12.5sqcm contain : Buprenorphine 10mcg/hr. Area containing active Path substance 12.5sqcm 790 1859 Buprenorphine Transdermal Patch - Each Transdermal Patch to 25sqcm path contain : Buprenorphine 20mcg/hr. Area containing active substance 25sqcm 791 1862 Tab. Febuxostat Each tab. to contain : Febuxostat 40mg 10 Tab 792 1865 Tab. Tolperisone & Diclofenac -Each film to contain: Tolperisone 10 tab Hydrochloride JP 150mg & Diclofenac Sod. IP 50mg 793 1866 Analgesic Cream- Each tube to contain: Methyl salicylate 30% 30gm tube w/w, Menthol 10% w/w, Camphor 4% w/w Excipients q.s 794 1869 Tab. - Each tab. to contain: Amisulpride IP 50mg 10 tab 795 1870 Tab. - Each tab. to contain: Quetiapine 25 IP mg 10 tab 796 1871 Tab. Quetiapine Each tab. to contain: Quetiapine IP 100mg 10 tab 797 1872 Tab. Bupripion- Each tab. to contain: Bupripion ER 150mg 10 tab 798 1873 Tab. Paroxetine- Each tab. to contain: Paroxetine IP 25mg 10 tab/ cap 799 1874 Tab. Duloxipine Each tab./cap. to contain: Duloxipine 30mg 10 tab/cap 800 1879 Tab. Levetiracetam Each tab. to contain: Levetiracetam IP 10 Tab. 500mg

801 1880 Tab. Levetiracetam Each tab. to contain: Levetiracetam IP 10 Tab. 250mg 802 1881 Syp. Phenytoin Sodium Each ml to contain: Phenytoin Sodium IP 100ml bottle 25mg. 803 1882 Tab. Lamotrigine Disperisble Each tab. to contain : Lamotrigine 10 Tab. 25mg 804 1883 Tab. Lamotrigine Disperisble Each tab. to contain : Lamotrigine 10 Tab. 25mg 805 1885 Inj. Levetiracetam Each ml to contain: Levetiracetam100mg. 5ml vial 806 1887 Tab. Sildenafil Each tab. to contain : Sildenafil IP 50mg 4 Tab. 807 1890 Syp. Chlorpheniramine & Phenylephrine : Each 5ml to contain: 60 ml. bott. Chlorpheniramine 1mg, Phenylephrine 2.5mg 808 1891 Tab. Misoprostol Each tab. to contain: Misoprostol 25mcg 4 tab. 809 1893 Levonorgestrel - Each sterlite Intrauterine system to contain: 1 pack Levonorgestrel 52mg (Levonorgestrel 20mcg/24hours intra uterine Delivery System) 810 1894 Tab. Saxagliptin & Metformin (ER) - Each film coated to contain: 7 tab Saxagliptin 5mg + Metformin HCl 500mg (ER) 811 1895 Tab. Saxagliptin 5mg + Metformin HCl 1000mg (ER) 7 tab 812 1896 Tab. Linagliptin- Each film coated tab to contain: Linagliptin 5mg 10 tab

56/71

813 1897 Gliclazide I.P. & Metformin (ER) Tab. - Each uncoated bilayered 14 tab. scored tab. to contain: Gliclazide I.P. (ER) 60mg + Metformin HCl I.P. (ER) 500mg 814 1898 Inj. Insulin Degludec Each1ml of the Solution for subcutaneous 3ml/pfp inj. to contain: Insulin Degludec (R-DNA origin) 100 unit/ml Pre Filled Pen 815 1899 Inj. Insulin Glargine- Each ml to contain: Insulin Glargine 3ml x 100units 5cartridge 816 1900 Inj. Insulin Glulisine Each ml to contain: Insulin Glulisine 100IU, 10ml vial m-cresol 3.15mg- (as preservative excipients) 817 1901 Inj. Insulin Glulisine Each ml to contain: Insulin Glulisine 100IU, 3ml cartridge m-cresol 3.15mg- (as preservative excipients) 818 1902 Cap. Cefixime and Pre&Probiotic- Each cap. to contain: Cefixime 10 cap IP as Trihydrate eqv. to Anhydrous Cefixime 200mg and Each Inner cap. To contain: Sterptococcus Faecalis T-110 JPC 60 Millin clostridium Butyricum TO-A 4 million Bacillus Mesentericus TO-AJDC2 million Lactic Acid Bacillus 100million 819 1903 Tab. Nitrofuradantin SR Each SR Tab. to contain : 10 tab Nitrofuradantin IP100mg 820 1907 Tab. Voriconazole Each tab. to contain : Voriconazole 200 mg 4 tab 821 1909 Anti Malarial Kit- Each Combikit to contain: (A) 2 tab 1 kit. Sulphadoxine 750mg & Pyrimethamine 37.5mg IP (B) 3tab Artisunate 200mg 822 1910 Cap. Clofazimine Each cap. to contain : Clofazimine IP 100mg 10 cap 823 1922 ED. Brimonidine & Timolol- Each vial to contain: Brimonidine 5ml vial 0.15% Timolol 0.5% 824 1923 ED. Carboxy Methyl Cellulose- Each ml to contain: Sodium 10ml vial Carboxy Methyl Cellulose 5mg. 825 1924 ED. Dorzolamide Each vial to contain: Dorzolamide 2% 5ml vial 826 1927 ED. Hydroxypropylmethylcellulose- Each vial to contain: 5ml vial hydroxypropylmethylcellulose 0.3% 827 1935 Nasal Spray. Fluticasone Each Spray delivers Fluticasone 100 MD Propionate 50mcg to contain : Fluticasone Propionate IP 0.05% W/V Benzalkonium Chlocride IP 0.01% w/v (As Preservative) Phenyl Ethyl Alcohl Usp 0.25% (As Preservative) 828 1936 Soln. Chlorhexidine Gluconate Each bottle to contain: 150ml bottle Chlorhexidine Gluconate 0.2% solution IP 829 1937 Potassium Nitrate & Monofluoro Phosphate Paste Each tube to 100gm tube contain: Potassium Nitrate 5% w/w, Sod. Monofluoro Phosphate 0.7% w/w 830 1938 Oral Gel. Metronidazole- Each tube to contain: Metronidazole 20gm tube 1%, Chlorhexidine 0.25% 831 1940 Lotion. Ketoconazole- Each bottle to contain: Ketoconazole 2% 50ml bottle w/v 832 1942 Clotrimazole Dusting Powder- Each to contain: Clotrimazole 75gm Dusting Powder 1% w/w 833 1946 Lotion Minoxidil- Each bott. to contain: Minoxidil 2% 60ml. Bott. 834 1947 Lotion Minoxidil- Each bott. to contain: Minoxidil 5% 60ml. Bott. 835 1956 Paraffin Guaze- Each piece to contain: Paraffin Guaze 10cm x 10 pieces 10cm- 10pcs

57/71

836 1957 Tab. Ferrous Ascorbate Each film coated tab. to contain: Ferrous 10 tab Ascorbate equivalent to elemental Iron 100mg, Folic Acid IP 1.5mg, Cyanocobalamin IP 15mcg, Zinc Sulphate Monohydrate IP equ.to elemental Zinc 22.5mg excepients q.s 837 1958 Cap. Multivitamin - Each hard gelatin cap. to contain: Ferrous 10 tab Fumarate I.P. eqv.to Elemental Iron 30mg. Folic Acid I.P. 250mcg Zinc Sulphate Monohydrate B.P. eqv. To Zinc 20mg, thiamine Mononitrate (Vit.B1)I.P. 1.2mg Riboflavin (Vit. B2) I.P. 1.2, Niacinamide I.P. 10mg, Pyridoxine Hydrochloride (Vit B6) I.P. 1mg, Cyanocobalamin (Vit. B12) I.P. 2.5mcg Ascorbic Acid coated (Vit.C) I.P. 40mcg 838 1959 Cap. Multivitamin with Amino Acid- Each Cap. to contain: L- 10 cap. Arginine Hydrochloride USP 13.28mg. Histidine Hydrochloride H20 BP 3.71mg. L-Isoleucine USP 5.9mg. L-Leucine USP 18.3mg L- Lysine HCL USP 25mg DL- Methionine BP 18.4mg L- Phenylalanine USP 5mg. L-Threonine USP 4.2mg L-Tryptophan USP 5mg. L-USP 6.7mg. 5-Hydroxy Anthranilic Acid HCL 0.2mg. Cholecalciferol IP 200 IU Nicotinamide IP 25mg. Pyridoxine HCL IP 1.5mg. Methylcobalamin 500mcg. Biotin USP 30mcg. Folic Acid IP 0.75mg. Copper Sulphate BP 4mg. Ferrous Sulphate IP 20.5mg Magnesium sulphate IP 7.43mg. Magnesium sulphate BP1.4mg. Potassium lodide IP 0.1mg. Sodium Selenite BP 10.0mcg. Zinc Sulphate IP 15mg. Chromium Polynicotinate 200mcg. 839 1961 Cap. Antioxidant - Each cap to contain: Methylcobalamin 10 Cap 500mcg, Folic Acid IP 1.5mg, Zinc Sulphate IP 25mg, Chromium Polynicotinate 200mc, Selenium 65mcg as Sodium Selenite USP Pyridoxine HCL IP 1.5mg, Inositol 100mg, Alpha Lipoica Acid USP 50mg. Each Inner capsule contains: Streptrococcus Faecalis T-110 JPC 30 million Clostridium Butyricum T-OA 2 million Bacillus Bacillus Mesentericus T-OA JPC 1 million Lactic Acid Bacillus 50 million (Lactobacillus Sporogenes) 840 1962 Tab. Ferrous Ascorbate with Amino Acids & Zinc- Each film 10 tab. coated tab. to contain: Ferrous Ascorbate equivalent to elemental Iron 100mg. Methylcobalamin 1000mcg. Folic Acid 1.5mg. L-Histidine Hcl H2O 4mg. L-Lysine Hcl 25mg. Glycine 10mg. Pyridoxine Hcl 1.5mg. Zinc Sulphate 50mg. 841 1964 TRIPLE CHAMBER BAG- Each to contain: Triple chamber bag 1000ml with Lipid Eulsion (80% Olive Oil &20% Soya Oil ) Amino Acids Glucose and Electrolytes separated by peel seals for Peripheral intravenous 842 1965 TRIPLE CHAMBER BAG- Each to contain: Triple chamber bag 2000ml with Lipid Eulsion (80% Olive Oil &20% Soya Oil ) Amino Acids Glucose and Electrolytes separated by peel seals for Central intravenous 843 1966 Tab. Sirolimus Each tab. to contain: Sirolimus 1mg 10 tab. 844 1968 Tab. Valganociclovir Each tab. to contain: Valganociclovir 450mg 4 Tab. 845 1970 Tab. Mycophenolate- Each tab. to contain: Mycophenolic acid (as 10 tab. Sodium salt ) 360mg 846 1972 Inj. Leuprolide- Each PFS/VIAL to contain: Leuprolide Acetate 1PFS/VIAL Depot 3.75mg 58/71

847 1975 Inj. Botulinum Each vial to contain: Botulinum A Toxin 50 IU 1 vial 848 1976 Inj. Botulinum Each vial to contain: Botulinum A Toxin 100 IU 1 vial 849 1979 Inj. Leucovorin Each vial to conain: Leucovorin 50mg 1 vial 850 1980 Cap. Lenalidomide Each cap. to contain : Lenalidomide 5mg 10 cap 851 1981 Cap. Lenalidomide Each cap. to contain: Lenalidomide 10mg 10 cap. 852 1982 Inj. Oxaliplatin- Each vial to contain: Oxaliplatin 50mg 1 Vial 853 1983 Inj. Oxaliplatin- Each vial to contain: Oxaliplatin 100mg 1 Vial 854 1984 Inj. Paclitaxel- Each vial to contain: Paclitaxel IP 260mg 1 Vial 855 1985 Cap. Temozolomide- Each tab. to contain: Temozolomide 100mg 5 cap. 856 1986 Inj. Zoledronic Acid Each vial to contain: Zoledronic Acid 4mg 1 vial 857 1987 Inj. Octreotide Each vial /pack to contains : Octreotide 30mg 1 vial/pack Long Acting Release 858 1988 Cap./tab. Tacrolimus- Each tab. to contain: Tacrolimus 0.5mg 10 tab./cap 859 1990 Sachet. Sevelamer Each Sachet to contain: Sevelamer 90 Sachet Carbonate 800mg 860 1991 Syp. Liver Disorders- Each 15ml contains: DL Methionine BP 200ml Bott. 100mg. Choline Dihydrogen Citrate NFXII 100 Mg. Leucine USP 19 mg. L-Isoleukcine Usp 10 mg. L-Valine USP 11 mg. Pyridoxine HCL 1.5 mg. Nicotanamide IP 22.5 mg . Biotion Usp 0.1 mg. Folic Acid 0.5 mg. 861 1992 Tab. Liver Disorders- Each tab. to contain: DL Methionine BP 10 Tab 200mg. Choline bitarate USP 200mg. L-Leucine USP 19 mg. L- Isoleucine USP 10 mg. L-Valine USP 11 mg. Pyridoxine HCL 1.5 mg. Nicotanamide IP 22.5 mg . Biotion Usp 0.1 mg. Folic Acid 0.5 mg. Cyanocobalamin IP 3.0mcg, Inositol BP 50mg. 862 1995 Vitamin B Complex, Vitamin C & Zinc Cap/Tab- Each Cap/Tab 10 cap/tab to contain : Zinc Sulphate Monohydrate 61.8 mg. (eqv. to Elemental Zinc 22.5mg.) Ascorbic Acid (as Coated) 150 mg. Nicotinamide 50mg. Thiamine Mononitrate 10 mg. Riboflavine 10 mg. Calcium Pantothenate 10mg. Pyridoxine HCL 3 mg. Folic Acid 1.5 Cyanocobalamin 10mcg. 863 1996 Ciprofloxacin & Tinidazole Ciprofloxacin250+Tinidazole300 Tab 10 Tabs 864 1997 Ciprofloxacin & Tinidazole , Each tab. to contain: 10 Tabs Ciprofloxacin500+Tinidazole600 Tab 865 1999 Aceclofenac & Paracetamol Tab Aceclofenac+Paracetamol Tab 10 Tabs 100+325mg 866 2002 Cetrizine Syp. Each 5ml. to contain : Cetrizine 5 ml. 60 ml. 867 2003 Vitamin A Soln. Each ml. to contain : Vitamin A (As Palmitate) 50ml. 100000 IU in Arachis oil (equivalent to about 1,09,500 IU per gm) 868 2005 Cefoperazone Sodium Inj. Each vial to contain : Cefoperazone 1 Vial Sodium 1gm 869 2006 Cefoperazone & Sulbactum Each vial to contain : Cefoperazone 1 Vial 500+ Sulbactum 500 Inj. 870 2007 Ceftriaxone & Sulbactum Inj. Each vial to contain : Eqv to 1 Vial Anhydrous Ceftriaxone 1gm. + Sulbactum 500mg. 871 2008 Paracetamol & Diclofenac Tab Each tab. to contain : 10 Tabs Paracetamol+Diclofenac Tab 325+50mg 872 2010 Tab/Cap. Pantaprazole 40mg + Domperidone (SR) 30mg- Each 10 Cap/ tab tab./cap. to contain: Pantaprazole 40mg + Domperidone (SR) 30mg

59/71

873 2011 Susp. 1 G Sucralfate- Each 5ml to contain: Sucralfate 1 gm. 100ml bot. 874 2012 PRE & PPOBIOTIC DRY SYRUP - Each 5ml to contains: 50 ml bottle Bifilac- 50ml Bottle - Streptococcus faecalis T-110 30 Clostridium butyricum TO-A 2 million Bacillus mesentericus TO-A1 million Lactic acid bacillus (Lactobacillus sporogenes)50 million Excipients 875 2014 Tab. Montelukast Sodium- Each tab. to contain: Montelukast 10 tab Sodium IP 10mg 876 2016 Budesonide 200mcg + Formoterol Fumarate 6mcg Rotacap - 30 cap Each rotacap to contain : Budesonide 200mcg + Formoterol Fumarate 6mcg 877 2018 Tab. Perindopril erbumine 8mg, Amlodipine besilate equivalent to 10 tab Amlodipine 5mg. Excipients q.s. - Each uncoated tab. to contain : Perindopril erbumine 8mg, Amlodipine besilate equivalent to Amlodipine 5mg. Excipients q.s. 878 2019 Tab. Indapamide (as SR) 1.5mg, Amlodipine besilate equvalent 10 tab to amlodipine 2.5mg excepients q.s. 879 2021 Tab. Perindopril erbumine 8mg, Indapamide 2.5mg excipients 10 tab q.s. scored tab. to contain: Perindopril erbumine 8mg, Indapamide 2.5mg excipients q.s. 880 2022 Tab. Acenocoumarol/Nicoumalone 2MG- Each tab to contain: 10 Tab Acenocoumarol/Nicoumalone IP 2mg 881 2026 Tab. N-Acetyl Cysteine 600mg Each tab. to contain : Acetyl 10 tab Cysteine 600mg 882 2027 Inj. Diclofenac IP 75mg IV Each 1ml. to contain : Diclofenac IP 1 ml Amp 75mg IV 883 2029 Inj. Teriparatide 750mcg- Each 3ml cartridge to contain : 1 Cartridge Teriparatide 750mcg 884 2032 Inj. Follitropin alpha 1050 IU/1.75 ml Each vial to contain : vial Follitropin alpha 1050 IU/1.75 ml 885 2034 Tab. Teneligiptin 20mg Each tab. to contain : Teneligiptin 20mg 10 tab 886 2036 Tab. Artemether 20mg & Lumefantrine 120mg Each tab. to 8 tab contain : Artemether 20mg & Lumefantrine 120mg 887 2040 Inj. Calcium Gluconate Each ml. to contain Calcium Gluconate 10ml IP 100mg amp/vial 888 2041 Tab. Methylcobalamin 500mcg Each tab. to contain : 10 tab Methylcobalamin 500mcg 889 2044 Inj. L-Ornithine L-Aspartate 5.0g- Each inj. to contain : L- 10ml amp Ornithine L-Aspartate 5.0g- 10ml 890 2047 Tab. Calcium Citrate 1000mg, Vit. D3 200 IU, Methylcobalmin 15 tab 500mcg, Folic Acid 5mg, Pyridoxin IP 10mg - Each tab. to contain : Tab. Calcium Citrate 1000mg, Vit. D3 200 IU, Methylcobalmin 500mcg, Folic Acid 5mg, Pyridoxin IP 10mg 891 1005a Tab. Famotidine- Each tab. to contain: Famotidine IP 20mg 892 1005b Tab. Famotidine Each tab. to contain: Famotidine IP 40mg 14 tab. 893 1015a Tab. Maleate Each tab. to contain : 10 tab Prochlorperazine Maleate IP 5mg 894 1034a Terbutaline sulphate Tab., IP Each tab to contain: Terbutaline 10 tab sulphate 2.5 mg 895 1034b Terbutaline Tab Each Tab to contain:Terbutaline sulphate IP 5mg 10 tab

60/71

896 1040b Inh. Beclomethasone Each metered dose to contain : 200 doses Beclomethasone Dipropionate 100mcg 897 1043a Rotacap Salbutamol- Each rotacap to contain : Salbutamol 30 cap 200mcg 898 1043b ROTAHALER DEVICE- Rotahaler 1 piece 899 1056a Tab. Metoprolol Each tab. to contain : Metoprolol Tartrate IP 10 tab 50mg 900 1060a Tab. Iso-sorbide Mononitrate Each tab. to contain : Iso-sorbide 5 10 tab Mononitrate IP20mg 901 1061a Tab. Glyceryl Trinitrate CR Each CR tab. to contain : Glyceryl 25 tab pack Trinitrate 2.6mg 902 1061b Glyceryl trinitrate CR Tab. Each CR Tab. to contain : Glyceryl 25 tab pack trinitrate 6.4 mg. 903 1065a Lisinopril Tab., Each tab. to contain : Lisinopril 2.5 mg. 10tab 904 1065b Lisinopril Tab., Each tab. to contain: Lisinopril 5 mg. 10tab 905 1065c Lisinopril Tab. Each tab. to contain: Lisinopril 10mg. 10tab 906 1066b Tab. Terazocin Each tab. to contain : Terazocin 2mg IP 10 tab 907 1067b Tab. Prazosin SR- Each SR tab. to contain: Prazosin HCl IP 14 Tab 2.5mg 908 1067c Tab. Prazosin SR- Each SR tab. to contain: Prazosin HCl IP 5mg 14 Tab 909 1068b Tab./Cap Ramipril Each Tab./Cap. to contain: Ramipril IP 2.5mg 10 tab/ cap 910 1068c Tab. Ramipril- Each tab. to contain: Ramipril IP 5mg 10 Tab 911 1069b Mephertermine Tab. Each ml. to contain : Mephertermine (as 10ml vial sulphate) IP 30mg 912 1079a Parnaparin Inj Each PFS to contain: Low Molecular weight PFS Heparin Sodium Salt (Parnaparin)-3200 I.U. 913 1082a Inj. Tramadol Each ml. to contain : Tramadol Hydrochloride IP 1ml 50mg 914 1082b Inj. Tramadol -Each ml to contain: Tramadol Hydrochloride IP 2ml 50mg 915 1115b Tab. Phenobarbitone- Each tab. to contain: Phenobarbitone IP 10 Tab 30mg 916 1118a Inj. Midazolam Each amp/vial to contain: Midazolam BP 5mg 1ml amp/vial 917 1118b Inj. Midazolam Each ml. to contain : Midazolam 1mg 5ml Amp/vial 918 1119a Lithium Tabs./ Cap. Each Tab. to contain: Lithium carbonate IP 10 Tab/Cap 150mg 919 1119b Lithium Tabs./ Cap. Each Tab. to contain: Lithium carbonate IP 10 Tab/Cap 300mg 920 1127a Tab. Carbamazepin IP CR- Each CR tab. to contain: 10 tab Carbamazepin 200mg 921 1127b Tab. Carbamazepin CR- Each CR tab. to contain: Carbamazepin 10 Tab. IP 400mg 922 1148b Didrogesttrone Tab., Each Tab. to contain: Didrogestrone IP/USP 10 Tab. 10 mg. 923 1153a Tab. Conjugated Oestrogen Each tab. to contain : Conjugated 28 tab Oestrogen IP 0.625mg 924 1157b Inj. Human Chorionic Gonadotropin Each AMP/Vial to contain : 1ml amp/vial Human Chorionic Gonadotropin 5000 IU 925 1175a Amoxycillin Cap/Tab Each Cap/Tab to contain : Trihydrate eqv to 10 Tab/Cap Amoxycillin Cap/Tab., 250mg

61/71

926 1175b Amoxycillin Cap/Tab Each Cap/Tab to contain : Trihydrate eqv to 10 Tab/Cap Amoxycillin Cap/Tab., 500mg 927 1177a Amoxycillin IP & Clavulanic acid cap/ Tab. Each cap/ Tab. to 6 Tab/Cap contain: Amoxycillin IP 500mg, Clavulanic acid IP 125mg 928 1177b Amoxycillin IP & Clavulanic acid Tab. Each cap/ Tab. to contain: 6 Tab/Cap Amoxycillin IP 250mg, Clavulanic acid IP 125mg 929 117a Tab. Clotrimazole Vaginal Each tab. to contain: Clotrimazole IP 3tab pack 200mg with applicator 930 1184a Ceftazidime Inj. Each vial to contain : Ceftazidime 500mg 1 Vial 931 1185a Ceftriaxone Inj. Each vial to contain : Ceftriaxone Sod. Eqv to 1 Vial Anhydrous Ceftriaxone 500mg 932 1189a Amikacin Inj. Each 2ml to contain : Amikacin 100 mg (As 2ml. Vial Amikacin Sulphate) 933 1189b Amikacin Inj. Each 2ml to contain : Amikacin 250 mg (As 2ml. Vial Amikacin Sulphate) 934 1192a Amox. & Clav. Inj. Each vial to contain : Amoxycillin Sod. + 1 Vial Clavulanate Potassium 1200mg IP 935 1192b Amox. & Clav. Inj. Each vial to contain : Amoxycillin Sod. + 1 Vial Clavulanate Potassium 600mg IP 936 1192c Amoxycillin & Clavulanic Inj. Each vial to contain: Amoxycillin IP 1 Vial 250mg & Clavulanic Acid IP 50 mg. 937 1195a Ofloxacin Tab., Each tab. to contain : IP Ofloxacin 200mg 10 Tabs 938 1195b Ofloxacin Tab., Each tab. to contain : IP Ofloxacin 400mg 10 Tabs 939 1207a Secnidazole Tabs., IP Each Tab. to Contain: Secnidazole IP 4 tab 500mg 940 1207b Secnidazole Tabs., IP Each Tab. to Contain: Secnidazole IP 1gm 2 tab 941 1210b Tab. Levamisole Each tab. to contain : Levamisole IP 150mg 1 tab 942 1214b Homatropine eye drops IP Containing: Homatropine 5ml vial Hydrobromide 2% 943 1218a ED- Timolol Maleate Each ml. to contain : Timolol Maleate IP 5ml vial 3.4mg/ml- 5ml 944 1218b ED- Timolol Maleate Each ml. to contain : Timolol MaleateIP 5ml vial 6.8mg 945 1255a Betamath + Salicylic acid Oint. Each gm. to contain: 10gm tube Betamethasone Dipropionate 0.64 mg. Salicylic Acid 30 mg. 946 1255b Betamath + Salicylic acid Oint Each gm. to contain: 20gm tube Betamethasone Dipropionate 0.64 mg. Salicylic Acid 30 mg. 947 1265a ANTICEPTIC LIQUID- Liq. Each Bott. to contain : Chloroxylenol 500ml Bott. 4.8% w/v Terpineol 9.0% v/v Alcohol absolute (denatured) 13.10% v/v 948 1265b Antiseptic Liquid- Each bottle to contain: Chloroxylenol 4.8%w/v, 5 ltr. Bottle Terpineol 9.0%v/v, Alcohol absolute 13.10%v/v 949 1270a Soln Cetrimide - Each bott. to contain: Cetrimide 3% w/v. 1Ltr. Bottle Chlorhexidine1.5% w/v 950 1270b Soln Cetrimide - Each bott. to contain: Cetrimide 3% w/v. 2Ltr. Bottle Chlorhexidine1.5% w/v 951 1274a Handloom Cotton rolled bandage Handloom Cotton rolled 10 roll pkt bandage (ISI marked) Roll of 6 cm. X 4 m. 952 1274b Handloom Cotton rolled bandage Handloom Cotton rolled 10 roll pkt bandage (ISI marked) Roll of 10 cm. X 4 m.

62/71

953 1276a Plaster of Paris Bandage- Plaster of Paris Bandage Roll BP of 10 roll pkt 10cm x 2.7m 954 1276b Plaster of Paris Bandage- Plaster of Paris Bandage Roll BP of 10 roll pkt 15cm x 2.7m 955 1284a Lignocaine Ointment Containing: Lignocaine 5% 20gm tube 956 1284b Lignocaine Jelly Containing: Lignocaine IP 2% 30gm tube 957 1285b Ketamine Inj., Each ml. to contain: Ketamine Hcl 50 mg. 2ml Vial 958 1285c Ketamine Inj., Each ml. to contain: Ketamine Hcl 50 mg. 2ml Vial 959 1302c Vitamin E cap. Each capsule to contain: Vit. E (alpha Tocopherol 10 cap acetate) 400mg. 960 130a Progesterone Inj., IP Each inj. contain: Hydroxy-progesterone IP 1ml amp 250mg 961 130b Progesterone Inj., IP Each inj. contain: Hydroxy-progesterone IP 2ml amp 500mg 962 1325a Mannitol Inj. Containing : Mannitol 20% IV Infusion IP 350ml. 963 1328a Interferon Inj. Each vial to contain: Interferon Alpha IP 2B: 3Mil 1 vial I.U. 964 1329a Inj. Cisplatinum Each vial to contain: Cisplatinum IP 10mg 1 vial 965 1329b Inj. Cisplatinum Each vial to contain: Cisplatinum IP 50mg 1 vial 966 132a Danazol Tab./Cap.- Each Tab./Cap. to contain: Danazol IP100mg 30 tab/ cap 967 132b Danazol Tab./Cap.- Each Tab./Cap. to contain: Danazol IP 30 tab/ cap 200mg 968 1330b Inj. Cyclophosphamide Each vial to contain : Cyclophosphamide 1 vial IP 200mg 969 1331a Mitomycin Inj., Each vial to contain: Mitomycin 2mg. 1 vial 970 1331b Inj. Mitomycin Each vial to contain : Mitomycin IP 10mg 1 vial 971 1335b Cap. Cyclosporine Each cap. to contain : Cyclosporine IP 25mg 50 cap 972 1338a Non-Ionic Contrast Media Each ml. to contain: Iohexol 518 mg 10ml eqv. to Iodine 240mg.

973 1338b Non-Ionic Contrast Media Each ml. to contain: Iohexol 647 mg 20ml eqv. to Iodine 300mg. 974 1338c Non Ionic Contrast Media- Each ml. to contain : Iohexol 647mg. 40ml Eqv. To IODINE 300mg. 40ml 975 1338d Non-Ionic Contrast Media Each ml. to contain: Iohexol 755 mg 20ml eqv. to Iodine 350mg. 976 1339a Human Tetanus Specific Immunoglobulin Containing: Human 1 vial Tetanus Specific Immunoglobulin 250 units. 977 1339b Human Tetanus Specific Immunoglobulin Containing: Human 1 vial Tetanus Specific Immunoglobulin 500 units. 978 1352b Meropenem Trihydrate Inj., Each vial to contain: Meropenem 1 Vial Trihydrate IP eqv. to Anhydrous Meropenem 1gm 979 1353a Cefaclor Tab/Cap. Each cap/ Tab. to contain: Cefaclor IP 500mg 3 tab/cap 980 1353b Tab./Cap. Cefaclor- Each Tab./Cap. to contain: Cefaclor 250mg 6 tab/cap 981 1370b Tab. Torsemide- Each tab. to contain: Torsemide IP 20mg 10 tab. 982 1375a Tab. Leflunomide- Each tab. to contain: Leflunomide IP 10mg 10 Tab 983 1375b Tab. Leflunomide- Each tab. to contain: Leflunomide IP 20mg 10 Tab 984 1407a Inj. Epirubicin Each Inj. to contain : Epirubicin HCL 10mg 1 vial 985 1407b Inj. Epirubicin- Each inj. to contian: Epirubicin HCl 50mg 1 Vial

63/71

986 1409a Peritoneal Dialysis Fluid- Each 100ml to contain: IP 1.5%- 2Ltr Bag Dextrose Anhydrous 1.5gm. Sodium Lactate 448mg. Na cl 538mg. Ca Cl 25.7mg. Mg Cl 5.08mg 987 1409b Peritoneal Dialysis Fluids IP 1.5%- Each 100ml. to contain : 5Ltr Bag Dextrose anhydrous 1.5mg. Sodium Lactate 448 mg. NaCl 538 mg. CaCl 25.7mg. MgCl 5.08mg. 5Ltr Bag (Dianeal 1.5%- 5 ltr) 988 1410a Peritoneal Dialysis Fluid- Each 100ml to contain: IP 2.5%- 2Ltr Bag Dextrose Anhydrous 2.5gm. Sodium Lactate 448mg. Na cl 538mg. Ca Cl 25.7mg. Mg Cl 5.08mg 989 1410b Peritoneal Dialysis Fluids 2.5%- Each 100ml. to contain : 5Ltr Bag Dextrose anhydrous 2.5mg. Sodium Lactate 448 mg. NaCl 538 mg. CaCl 25.7mg. MgCl 5.08mg. 5Ltr Bag (Dianeal 2.5%- 5 ltr) 990 1411a Peritonial Dialysis Fluid IP 4.25%-Dextro Anhydrous 4.25gm. 2Ltr Bag Sodium Lactate 448mg. Na Cl 538mg. Ca Cl 25.7mg. Mg Cl 5.08mg. 991 1411b Peritoneal Dialysis Fluids 4.25%, Each 100ml to contain: 5Ltr Bag Dextrose Anhydrous 4.25gm. Sodium Lactate 448mg., Na Cl 538mg., Ca Cl 25.7mg. Mg Cl 5.08mg. 992 1423a Reviparin Sod. Inj. Each PFs to contain: Reviparin Sod. 0.6ml PFS 993 1423b Reviparin Sod. Inj. Containing: Reviparin Sod. 0.6ml vial 994 1426a Ebastine Tabs., IP Each Tab. to contain: Ebastine 10mg 10 Tab. 995 1426b Tab. Ebastine- Each tab. to contain: Ebastine IP 20mg 10 Tab. 996 1430a Tab. Each tab. to contain: Mirtazapine IP 7.5mg 10 tab 997 1430b Tab. Mirtazapine Each tab. to contain : Mirtazapine IP 15mg 10 tab 998 1439a Vitamins & Mineral Inj.- Each PFS to contain: Methoxy 1PFS Polyethylene Glycol Epoetin-beta 50mcg 999 1439b Vitamins & Mineral Inj.- Each PFS to contain: Methoxy 1PFS Polyethylene Glycol Epoetin-beta 75mcg 1000 1439c Vitamins & Mineral Inj.- Each PFS to contain: Methoxy 1PFS Polyethylene Glycol Epoetin-beta 100mcg 1001 1447a Tab. Dasatinib- Each tab. to contain: Dasatinib 20mg 60 tab 1002 1447b Tab. Dasatinib- Each tab. to contain: Dasatinib 50mg 60 tab 1003 1447c Tab. Dasatinib- Each tab. to contain: Dasatinib 70mg 60 tab 1004 1449a Inj. Rituximab Each vial to contain : Rituximab 100mg 10ml vial 1005 1449b Inj. Rituximab Each vial to contain : Rituximab 500mg 50ml vial 1006 1454b Tab. Capecitabine- Each tab. to contain: Capecitabine 500mg 10 Tab. 1007 1455a Low Calcium CAPD Containing: CAPD Bags with 1.5% 2ltr. Bag concentration containing 40 mEq/litre of lactate and 2.5 mEq/litre of Ca with asymmetrical Y connector 1008 1455b Low Calcium CAPD Containing: CAPD Bags with 2.5% 2ltr. Bag concentration containing 40 mEq/litre of lactate and 2.5 mEq/litre of Ca with asymmetrical Y connector 1009 1473a Tab./Cap. Sunitinib Malate Each Tab./cap. to contain : Sunitinib 7 tab/cap Malate 12.5mg 1010 1473b tab./cap. Sunitinib Malate Each tab./cap. to contain: 25mg 7 Tab./Cap 1011 1473c Tab./Cap. Sunitinib Malate Each Tab./cap. to contain : Sunitinib 7 tab/cap Malate 50mg 1012 1474a Tab. Everolimus Each tab. to contain : Everolimus 0.25mg 10 tab 1013 1474b Tab. Everolimus Each tab. to contain : Everolimus 0.5mg 10 tab 1014 1474c Tab. Everolimus Each tab. to contain : Everolimus 0.75mg 10 tab

64/71

1015 1476a Tab. Deferasirox- Each tab. to contain: Deferasirox 100mg 6 tab 1016 1476b Tab. Deferasirox- Each tab. to contain: Deferasirox 400mg 6 tab 1017 1485a Tab. Entecavir- Each tab. to contain: Entecavir 0.5mg 10 tab 1018 1485b Tab. Entecavir- Each tab. to contain: Entecavir 1mg 10 tab 1019 1486b Insulin Glargine Inj.- Each vial to contain: Insulin Glargine 100 10 Ml. vial units/ml 1020 1497a Tab/Cap. Esomeprazole Magnesium Each tab./cap. to contain : 10 Cap/ tab Esomeprazole Magnesium IP 20mg 1021 1497b Tab/Cap. Esomeprazole Magnesium Each tab./cap. to contain : 10 Cap/ tab Esomeprazole Magnesium IP 40mg 1022 1533a Tab. Hydrochlorothiazide Each tab. to contain : 10 tab Hydrochlorothiazide IP 12.5mg 1023 1533b Tab. Hydrochlorothiazide Each tab. to contain : 10 tab Hydrochlorothiazide IP 25mg 1024 1534a Inj. Human Recombinant Coagulation Factor VII- Each vial to Vial contain : Human Recombinant Coagulation Factor VII activated 1mg. (r-DNA origin)1mg 1025 1534b Inj. Human Recombinant Coagulation Factor VII- Each vial to Vial contain : Human Recombinant Coagulation Factor VII activated 2mg. (r-DNA origin)1mg 1026 1537a Warfarin sodium Tab Each Tab to contain Warfarin sodium IP 10 tab 2mg 1027 1537b Warfarin sodium Tab. Each Tab. to contain : Warfarin sodium IP 10 tab 5mg. 1028 1539a Tab. Betahistine Dihydrochloride Each tab. to contain : 10 tab Betahistine Dihydrochloride IP 8mg 1029 1539b Tab. Betahistine Dihydrochloride Each tab. to contain : 10 tab Betahistine Dihydrochloride IP 16mg 1030 1540a Tab. Rosuvastatin Each tab. to contain : Rosuvastatin IP 10mg 10 tab 1031 1540b Tab. Rosuvastatin Each tab. to contain : Rosuvastatin IP 20mg 10 tab 1032 1545a Tab. Tolperisone HCl Each tab. to contain : Tolperisone HCl 10 tab 150mg 1033 1545b Tolperisone Hcl Tab. Each Tab. to contain: Tolperisone Hcl JPC. 10 tab 450 mg 1034 1551a Tab. Amoxycillin + Clavulanate + Lactic acid Bacillus- Amoxycillin 10 tab Trihydrate Eqv. to Amoxycillin 500 + Clavulanate Potassium eqv. To Clavulanic Acid 125 + Lactic acid Bacillus 60 million spores 1035 1551b Tab. Amoxycillin + Clavulanate + Lactic acid Bacillus- Amoxycillin 10 tab Trihydrate Eqv. to Amoxycillin 250 + Clavulanate Potassium eqv. To Clavulanic Acid 125 + Lactic acid Bacillus 60 million spores 1036 1552b Cefuroxime Axetil +Clavulanate Potassium Each Tab. to contain: 4/10 tab Cefuroxime Axetil IP 250 mg Clavulanate Potassium IP 62.50 mg 1037 1552c Tab. Cefuroxime + Clavulanic Potassium- Each tab. to contain : 4/10 tab Cefuroxime axetil 500mg, Clavulanic Potassium 125mg 1038 1553a Inj. Doripenem Each vial to contain: Inj. Doripenem 250 mg 1 vial 1039 1553b Inj. Doripenem Each vial to contain: Inj. Doripenem 500 mg 1 vial 1040 1557a Ceftriaxone+Tazobactum Inj. Each vial to contain: Inj.Ceftriaxone 1 vial IP 250 mg , Tazobactum Sodium 31.25 mg 1041 1557b Ceftriaxone+Tazobactum Inj. Each vial to contain: Inj.Ceftriaxone 1 vial IP 500 mg , Tazobactum Sodium 62 mg

65/71

1042 1557c Inj. Ceftriaxone + Tazobactam Sod.- Each vial to contain : 1 vial Ceftriaxone 1gm, Tazobactam Sod. 125mg per vial 1043 1558a Inj. Cefuroxime Each vial to contain : Cefuroxime 750mg IP 1 vial 1044 1558b Inj.Cefuroxime Each vial to contain: Inj.Cefuroxime IP 1.5 gm 1 vial 1045 157b Roxythromycin Tab., Each tab. to contain: Roxythromycin IP 10 Tabs 150mg 1046 1590a Triamcinolone Tab. Each ml to contain: Triamcinolone IP 10 mg 1ml vial 1047 15a Hyoscine Butyl Bromide Tab., Each Tab. to contain: Hyoscine 10 Tabs Butyl Bromide 10mg. 1048 15b Inj. Hyoscine Butyl Bromide Each Disp tab. to contain : 1ml. Amp Hyoscine Butyl Bromide IP 20mg 1049 160a Ampicillin Cap., Each cap. to contain: Ampicillin Trihydrate eqv. 10 Caps to Ampicillin, IP 250mg 1050 160b Ampicillin Cap., Each cap. to contain: Ampicillin Trihydrate eqv. 10 Caps to Ampicillin, IP 500mg 1051 1625b Glutaraldehyde Each 100gm contain: Glutaraldehyde IP 10 gms, 5Ltr. Quaternary Ammonium Compounds 12 gms 1052 1626a Collagen Conatin: Collagen Membrane in Dry Form 5X5CM 1pc. 1053 1626b Collagen Conatin: Collagen Membrane in Dry Form 10x10 CM 1pc. 1054 1626c Collagen Conatin: Collagen Membrane in Dry Form 10x20 CM 1pc. 1055 1626d Collagen Conatin: Collagen Membrane in Dry Form 15x30 CM 1pc. 1056 1627a Collagen Conatin: Collagen Absorbant Dressing 10 X 10CM 1pc. 1057 1627b Collagen Conatin: Collagen Absorbant Dressing 10 X 20CM 1pc. 1058 1627c Collagen Conatin: Collagen Absorbant Dressing 15X30 CM 1pc. 1059 162a Ampicillin Inj., Each vial to contain: Ampicillin Sod. IP 250mg 1 Vial 1060 162b Ampicillin Inj., Each vial to contain: Ampicillin Sod. IP 250mg 1 Vial 1061 1650a Fligrastim Inj. Each PFS/vial to contain: Filgrastim 150 mcg 1 pfs/vial 1062 1650b Inj. Filgrastim Each PFS / vial to contain : Filgrastim 300mcg 1 pfs/vial 1063 1652a Hepatitis B Immunoglobulin Inj. Each 0.5ml to contain: Inj. 0.5ml vial Hepatitis B Immunoglobulin BP 100 IU 1064 169a Cephalexin Cap., Each cap. to contain: Cephalexin Monohydrate 10 Caps eqv. to Cephalexin IP 250mg 1065 169b Cephalexin Cap., Each cap. to contain: Cephalexin Monohydrate 10 Caps eqv. to Cephalexin IP 500mg 1066 170a Gentamycin Inj., Each ml to contain: Gentamycin IP 40mg 2ml Amp 1067 1717b Oint. Hydrocortisone Acetate- Each tube to contain: 20gm tube Hydrocortisone Acetate 1% 1068 171a Erythromycin Tab., Each tab. to contain: Erythromycin Stearate 10 Tabs eq. to Erythromycin IP 500mg 1069 174a Cotrimoxazole Paed. Tab., Each tab. to contain: IP Trimethoprim 10 Tabs 20 mg. Sulphamethoxazole 100 mg. 1070 174b Cotrimoxazole Paed. Tab., Each tab. to contain: IP Trimethoprim 10 Tabs 160 mg. Sulphamethoxazole 800 mg. 1071 175a Tetracycline Cap. Each tab. to contain Tetracycline IP 500mg 10 Caps 1072 177a Ciprofloxacin Tab., Each tab. to contain: Ciprofloxacin 10 Tabs Monohydrate eqv. to Ciprofloxacin 250mg IP 1073 177b Ciprofloxacin Tab., Each tab. to contain: Ciprofloxacin 10 Tabs Monohydrate eqv. to Ciprofloxacin 500mg IP 1074 180a Cefotaxime Inj., Each vial to contain : Cefotaxime Sod. Eqv. to 1 Vial Cefotaxime IP 250mg 66/71

1075 180b Cefotaxime Inj., Each vial to contain : Cefotaxime Sod. Eqv. to 1 Vial Cefotaxime IP 1gm 1076 180c Cefotaxime Inj., Each vial to contain : Cefotaxime Sod. Eqv. to 1 Vial Cefotaxime IP 500mg 1077 184a Tab. Ethambutol Each tab. to contain: Ethambutol IP 200mg 10 Tab. 1078 184b Tab. Ethambutol Each tab. to contain: Ethambutol IP 400mg 10 Tab. 1079 185a Tab. Pyrazinamide Each tab. to contain: Pyrazinamide IP 500mg 10 Tab. 1080 185b Tab. Pyrazinamide Each tab. to contain: Pyrazinamide IP 750mg 10 Tab. 1081 186a Tab. Isoniazide- Each tab. to contain: Isoniazide IP 100mg 10 tab 1082 186b Tab. Isoniazide- Each tab. to contain: Isoniazide IP 300mg 10 tab 1083 187a Cap. Rifampicin Each cap. to contain : RifampicinIP 150mg 10 cap 1084 187b Cap. Rifampicin Each cap. to contain : RifampicinIP 450mg 10 cap 1085 2006a Cefoperazone & Sulbactum, Each vial to contain: Cefoperazone 1 Vial 1gm+Sulbactum 1gm Inj. 1086 203a Tinidazole Tab., Each tab. to contain: Tinidazole 300mg IP 10 Tab 1087 203b Tinidazole Tab., Each tab. to contain: Tinidazole 500mg IP 10 Tab 1088 23a Metronidazole Tab., Each tab. to contain: Metronidazole 200mg 10 Tabs IP 1089 23b Metronidazole Tab., Each tab. to contain: Metronidazole 400mg 10 Tabs IP 1090 245b Inj. Succinyl Choline Each ml. to contain : Succinyl Choline 10ml vial Chloride IP 50mg- 50mg 1091 249a Bupivacaine Inj. IP Containing: Bupivacaine Hcl IP 0.25% 20ml vial 1092 249c Inj. Bupivacaine Heavy containing : Bupivacaine HCl IP 0.5%- 4ml Amp 4ml 1093 278A Dextrose inj.IP (for I.V infusion) Contaning : Dextrose Anhydrous 500ml i.p. 5% w/v 1094 278b Dextrose Inj. IP (for I.V. infusion) Containing: Dextrose 500ml Anhydrous 10% w/v 1095 284a Hepatitis B VACCINE (R-DNA) - Each Vial to contain : 20mcg. 1 vial Of Hepatitis B Surface Antigen 1096 284b Hepatitis B VACCINE (R-DNA) - Each Vial to contain : 10mcg. 1 vial Of Hepatitis B Surface Antigen 1097 284c Hepatitis B VACCINE (R-DNA) - Each Vial to contain : 20mcg. 10ml vial Of Hepatitis B Surface Antigen 1098 302a Levofloxacin Tab., Each tab. to contain: Levofloxacin 250mg IP 10 Tabs 1099 304a Sparfloxacin Tab., Each tab. to contain: Sparfloxacin 100mg 10 X 3 Tab 1100 304b Sparfloxacin Tab., Each tab. to contain: Sparfloxacin 200mg 10 X 3 Tab 1101 30a Tab. Salbutamol Each tab. to contain: Salbutamol IP 2mg 10 Tab 1102 30b Tab. Salbutamol- Each tab. to contain: Salbutamol IP 4mg 10 tab 1103 319a Cap. Ribavirin Each cap. to contain : Ribavirin IP 100mg 4 cap 1104 319b Cap. Ribavirin- Each cap. to contain: Ribavirin IP 200mg 4 cap 1105 324a Tab. Clobazam- Each tab. to contain: Clobazam IP 5mg 10 Tab. 1106 324b Tab. Clobazam- Each tab. to contain: Clobazam I.P. 10mg 10 tab 1107 328b Inj. UrokinaseEach vial to contain : Urokinase 5 lakhs IU 1 vial 1108 329a Glimepiride Tab. Each tab. to contain: Glimepiride 1mg IP 10 Tabs 1109 329b Glimepiride Tab. Each tab. to contain: Glimepiride 2mg IP 10 Tabs 1110 32a SALBUTAMOL RESP. SOLN - Each 2.5ml. to contain : 2.5ml resp Salbutamol sulphate eqv. to Salbutamol 2.5mg in normal saline soln 67/71

1111 32b Resp. Soln. Salbutamol - Each ml to contain:Salbutamol 15ml bottle Sulphate eqv. to sulbutamol 5mg is normal saline soln. 1112 333a Zidovudine cap. Each cap. to contain: Zidovudine IP 100mg. 10 cap 1113 333b Cap./ Tab. Zidovudine Each Cap. /Tab. to contain : Zidovudine 10 tab/cap IP 300mg 1114 335a Tab. Acyclovir Each Tab. to contain : Acyclovir IP 200mg 10 tab 1115 335b Tab. Acyclovir- Each tab. to contain: Acyclovir IP 400mg 5 Tab. 1116 336a Carvedilol tab. Each Tab. to contain : Carvedilol IP 3.125mg. 10 tab 1117 336b Tab. Carvedilol Each tab. to contain : Carvedilol IP 6.25mg 10 tab 1118 336c Carvedilol tab. Each Tab. to contain : Carvedilol IP 12.5mg. 10 tab 1119 341a Tab. Iso-Sorbide Mononitrate SR- Each SR to contain : Iso- 10 tab Sorbide Mononitrate 30mg 1120 341b Tab. Iso-Sorbide Mononitrate SR- Each SR to contain : Iso- 10 tab Sorbide Mononitrate 60mg 1121 346a Cough Expectorant, Each 5ml to contain: HCL 110ml Bott. 14mg., Ammonium chloride 135mg., Sodium citrate 57mg., Menthol 0.9mg. 1122 347a CPM Cough Expectorant, Each 5ml to contain: 110ml Bott. Chlorpheniramine maleate 3.0 mg Ammonium chloride 110 mg, Sodium citrate 46mg. Menthol 0.9 mg. 1123 364a Losartan tab.Each Tab. to contain : Losartan potassium IP 25 7 tab mg. 1124 364b Losartan tab Each Tab. to contain : Losartan potassium IP 50 7 tab mg. 1125 366a Inj. Enoxaprin- Each PFS to contain : Enoxaprin : Sodium IP 1 PFS 20mg/0.2ml 1126 366c Inj. Enoxaprin 60mg/0.6ml- Each PFS to contain : Enoxaprin IP PFS 60mg/0.6ml 1127 368a Atorvastatin tab. Each Tab. to contain : Atorvastatin IP 10mg. 10 tab 1128 368b Atorvastatin tab. Each Tab. to contain : Atorvastatin IP 20mg. 10 tab 1129 372a Tab. Dothiepin Each tab. to contain : Dothiepin HCl 25mg 10 tab 1130 372b Dothiepin Tab. Each Tab. to contain: Dothiepin Hcl IP 75mg 10 tab 1131 373a Cap. Each cap. to contain : Doxepin HCl IP 25mg 10 cap 1132 373b Cap. Doxepin- Each cap. to contain: Doxepin HCl IP 75mg 10 cap 1133 374a Sertraline tab. Each Tab. to contain: Sertraline IP 25 mg 10 cap 1134 374b Tab. Sertraline- Each tab. to contain: Sertraline IP 50mg 10 tab 1135 376a Cefuroxime tab. Each Tab. to contain: Cefuroxime IP 125mg 4 tab 1136 376b Cefuroxome tab. Each Tab. to contain: Cefuroxime IP 250mg 4 tab 1137 376c Cefuroxime tab. Each Tab. to contain: Cefuroxime IP 500mg 4 tab 1138 400a Inj. - Each vial to contain: Propofol IP 1%- 10ml vial 1139 408a Inj. Erythropoietin- Each PFS to contain: Erythropoietin 2000 1 PFS units PFS 1140 408d Inj. Erythropoietin- Each PFS to contain: Recombinant Human 1 PFS Erythropoietin 3000Units 1141 413a Inj. Teicoplanin Each vial to contain : Teicoplanin 200mg per vial 1 vial 1142 413b Inj. Teicoplanin Each vial to contain: Teicoplanin 400mg 1 Vial 1143 420a FLUTICASONE +SALMETEROL INHALER-Each metered dose 120 doses to contain : IP SALMETEROL 25mcg. Fluticasone 50mcg. 1144 420b FLUTICASONE +SALMETEROL INHALER-Each metered dose 120 doses to contain : IP SALMETEROL 25mcg. Fluticasone 250mcg. 68/71

1145 423a Tab. Nicorandil- Each tab. to contain: Nicorandil IP 5mg 20 Tab 1146 423b Tab. Nicorandil- Each tab. to contain: NicorandilIP 10mg 20 Tab 1147 428a Tab. Acetyl Salicylic Acid- Each enteric coated tab. to contain: 14 Tab Acetyl Salicylic Acid IP 75mg 1148 428b Tab. Acetyl Salicylic Acid Each enteric coated tab. to contain : 14 tab Acetyl Salicylic Acid IP 150mg 1149 428c Tab. Acetyl Salicylic Acid I.P. 325mg (Tab. Ecosprin 325mg) 14 tab 1150 433a Tab. Sodium Valproate+Valproic Acid CR Each CR tab. to 10 tab contain : (Sodium Valproate+Valproic Acid) eqv. to Sodium Valproate 200mg 1151 433b Tab. Sodium Valproate + Valproic Acid CR- Each CR tab. to 10 Tab. contain: (Sodium Valproate + Valproic Acid) eqv. To Sodium Valproate 500mg. 1152 434a Tab. Pioglitazone Each tab. to contain : Pioglitazone IP 15mg 10 tab 1153 434b Tab. Pioglitazone Each tab. to contain : Pioglitazone IP 30mg 10 tab 1154 43a Atenolol Tab. Each tab. to contain: IP Atenolol 25mg 10 Tabs 1155 43b Atenolol Tab. Each tab. to contain: IP Atenolol 50mg 10 Tabs 1156 448a Permethrin 1% Lotion Containing: Permethrin 1% 60ml bottle 1157 44b Tab. Propranolol- Each tab. to contain: Propranolol IP 40mg 10 Tab (Tab. PONOL 40) 1158 452a Adhesive Tape, Adhesive Tape BP/ USP 5cmx5m, one spoll Hypoallergenic extra porous 1159 452b Adhesive Tape, Adhesive Tape BP/USP 7.5cmx5m, one spoll Hypolallergenic extra porous 1160 452c Adhesive Tape, Adhesive Tape BP/USP 10cmx5m, one spoll Hypolallergenic extra porous 1161 459a Inj. Gemcitabine- Each vial to contain: Gemcitabine 200mg 1 vial 1162 459b Inj. Gemcitabine- Each tab. to contain: Gemcitabine USP 1gm 1 Vial 1163 463a Zolpidem Tab. Each tab to contain : Zolpidem 5 mg 10 tab 1164 463b Tab. Zolpidem- Each tab. to contain: Zolpidem IP10mg 10 tab 1165 465b Human Anti-D Immunoglobulin Inj. Each inj. Containing : Human 1 pfs/vial Anti-D Immunoglobulin 300 mcg (Ultrafiltered) 1166 466a Methylprednisolone Tab. Each tab. to contain:Methylprednisolone 10 tab 4mg.

1167 466b Methylprednisolone tab.Each Tab. to contain: Methylprednisolone 14 tab IP 16mg 1168 470a Perindopril tab. Each Tab. to contain : Perindopril 2mg. 10 tab 1169 470a Tab. Perindopril- Each tab. to contain: Perindopril 2mg 10 tab 1170 470b Tab. Perindopril- Each tab. to contain: Perindopril 4mg 10 tab 1171 470c Tab. Perindopril- Each tab. to contain: Perindopril Erbumine 8mg 10 tab. 1172 472a Tab. Clonazepam- Each tab. to contain: Clonazepam IP 0.5mg 10 tab 1173 472b Tab. Clonazepam- Each tab. to contain: Clonazepam IP 1mg 10 tab 1174 473a Tab. Resperidone Each tab. to contain : Resperidone USP 1mg 10 tab 1175 473b Tab. Resperidone Each tab. to contain : Resperidone USP 2mg 10 tab 1176 474a Tab. Each tab. to contain : OlanzapineIP 2.5mg 10 tab 1177 474b Tab. Olanzapine- Each tab. to contain: Olanzapine IP 5mg 10 Tab. 1178 475a Haloperidol tab. Each Tab. to contain: Haloperidol IP 1.5mg 10 Tab. 1179 475b Tab. Haloperidol Each Tab. to contain : Haloperidol IP 5mg 10 tab 1180 477a Tab. , Each tab. to contain: IP Amitriptyline 10mg 10 tab 69/71

1181 477b Tab. Amitriptyline Each tab. to contain : Amitriptyline IP 25mg 10 tab 1182 486a Tab. Paroxetine Each tab. to contain : Paroxetine IP 10mg 10 tab 1183 486b Tab. Paroxetine Each tab. to contain : Paroxetine IP 20mg 10 tab 1184 487a Inj. Paclitaxel- Each vial to contain: Paclitaxel IP 100mg 1 Vial 1185 487b Inj. Paclitaxel Each vial to contain: Paclitaxel IP 200mg 1 vial 1186 488a Inj. Carboplatin Each vial to contain: Carboplatin IP 150mg 1 vial 1187 488b Inj. Carboplatin Each vial to contain: Carboplatin IP 450mg 1 vial 1188 49a Tab. Diltiazem Each tab. to contain: Diltiazem IP 30mg 10 tab 1189 49b Tab. Diltiazem Each tab. to contain: Diltiazem IP 60mg 10 tab 1190 4a Ranitidine Tab. IP Each tab. to contain: Ranitidine Hcl eqv. to 10 Tabs Ranitidine 150 mg 1191 4b Ranitidine Tab. IP Each tab. to contain: Ranitidine HCl eqv. to 10 Tabs Ranitidine 300 mg 1192 509a Human Growth Hormone-Each Cartridge containing: Somatropin 1 Cartridge 16 IU (R-DNA origin) 1193 509b Human Growth Hormone-Each Cartridge containing: Somatropin 1 Cartridge 18 IU 1194 509e Human Growth Hormone Cartridge containing: Somatropin 4 IU 1 Vial 1195 509e Human Growth Hormone Containing: Somatropin 4 IU (R-DNA 1 Vial origin) 1196 50a Diltiazem SR tab. Each S.R. Tab. to contain : Diltiazem 90mg 10 Tab 1197 525a Tab. Metoprolol ER 50 - Each ER tab. to contain: Metoprolol 10 Tab Succinate USP 47.5mg. Equivalent to Metoprolol Tartrate 50 mg. 1198 527a Tab. Gabapentin Each tab. to contain : Gabapentin IP 300mg 10 tab 1199 527b Gabapentin tab.Each Tab. to contain: Gabapentin IP/BP/USP 10 tab 400mg. 1200 529a Azithromycin Cap/Tab., IP Each cap./tab. to contain: 10 Cap/Tab Azithromycin 250mg 1201 529b Azithromycin Cap/Tab., IP Each cap./tab. to contain: 10 Cap/Tab Azithromycin 500mg 1202 52b Tab./Cap. Nifedipine SR Each SR Tab./Cap. to contain : 10 tab/cap Nifedipine SR IP 20mg 1203 546a Paper Adhesive Tape - Paper Adhesive Tape Hypoallergehnic 1 roll with Acrylate Adhesive 2.5cm x 9.14m 1204 546b Paper Adhesive Tape - Paper Adhesive Tape Hypoallergehnic 1 roll with Acrylate Adhesive 5cm x 9.14m 1205 547b Fluticasone Rotacap Each Rotacap to contain: Fluticasone IP 30 cap 100mcg 1206 548b Beclomethasone Rotacap- Each Rotacap to contain : 30 cap Beclomethasone 200mg. 1207 554b Tab. Bromocriptin Each tab. to contain: Bromocriptin IP 2.5mg 10 Tab. 1208 555a Tab. Each tab. to contain : Clozapine IP 25mg 10 tab 1209 555b Tab. Clozapine Each tab. to contain : Clozapine IP 100mg 10 tab 1210 556a Tab. Escitalopram Each tab. to contain: Escitalopram IP 10mg 10 Tab. 1211 556b Tab. Escitalopram- Each tab to contain: Escitalopram IP 20mg 10 tab 1212 557a Inj. Dalteparin Sodium Each PFS to contain: Dalteparin Sodium 1 PFS 2500 IU 1213 557b Inj. Dalteparin Sodium 5000 IU 1 PFS 1214 558a Finaestride tab. Each Tab. to contain : Finaestride IP 1mg 10 Tab. 1215 558b Tab. Finasteride Each tab. to contain: Finasteride IP 5mg 10 Tab. 70/71

1216 563a Misoprostol Tab. Each tab. to contain: Misoprostol 100mcg 4 tab. 1217 563b Tab. Misoprostol- Each tab. to contain: Misoprostol 200mcg 4 tab. 1218 567b Tab. Rabeprazole Each tab. to contain : Rabeprazole IP 20mg 10 tab 1219 56a Tab. Enalapril Maleate Each tab. to contain : Enalapril Maleate 10 tab IP 2.5mg 1220 56b Tab. Enalapril Maleate Each tab. to contain : Enalapril Maleate 10 Tab IP 5mg 1221 56c Tab. Enalapril Maleate Each tab. to contain : Enalapril Maleate 10 tab IP 10mg 1222 571b Tab. Simvastatin Each tab. to contain : Simvastatin IP 10mg 10 tab 1223 575b Cefixime Tab., IP Each tab. to contain: Cefixime 100mg 10 Tabs 1224 575c Cefixime Tab., IP Each tab. to contain: Cefixime 200mg 3X10 Tab 1225 576a Tab. Gliclazide MR Each MR tab. to contain : Gliclazide 30mg 10 tab 1226 576b Tab. Gliclazide MR Each MR tab. to contain : Gliclazide 60mg 10 tab 1227 578a Tab. Alendronate Each tab. To contain : Alendronate 35mg 4 tab 1228 578b Tab. Alendronate- Each tab. to contain: Alendronate IP 70mg 4 tab. 1229 585a Cotton Crepe Bandage Cotton Crepe Bandage (Stretched, one roll BPC/ISI marked) Roll of 8 cm. x 4 m. 1230 585b Cotton Crepe Bandage Cotton Crepe Bandage (Stretched, one roll BPC/ISI marked) Roll of 10 cm. x 4 m. 1231 585c Cotton Crepe Bandage Cotton Crepe Bandage (Stretched, one roll BPC/ISI marked) Roll of 15 cm. x 4 m. 1232 587b - Each 250ml. to contain: Sevoflurane USP 250ml 250ml bottle 1233 603a Intravenous Lipid Soln. 10% Each 100ml. to contain: Fat 100ml emulsion containing Fractionated Soyabean Oil 10gm., Fractionated Egg Phospholipids 1.2gm. Glycerol 2.2gm. 1234 603b Intravenous Lipid Solution 20%- Each 100ml. To contain : Fat 250ml emulsion containing fractionated soyabean Oil 20gm, fractionated Egg Phospholipds 1.2 gm glycerol 2.2mg. 1235 61a Tab. Spironolactone Each tab. to contain : Spironolactone IP 10 tab 25mg 1236 61b Spironolactone tab., IP Each tab. to contain: Spironolactone 10 tab 100mg. 1237 68a Ethamsylate tab. Each Tab. to contain Ethamsylate 250mg. 10 tab 1238 68b Tab. Ethamsylate Each tab. to contain : Ethamsylate 500mg 10 tab 1239 72a Tab. Acenocoumarol Each tab. to contain : Acenocoumarol IP 10 Tab 1mg 1240 74a Inj. Streptokinase Each vial to contain : Streptokinase I.P. 7.5 lac 1 vial IU 1241 74b Streptokinase Injection Each Vial to Contain:Streptokinase 15lac 1 vial IU 1242 82a Paracetamol Syp. Each 5ml. to contain: Paracetamol 125 mg. IP 60 ml. 1243 83a Ibuprofen Tab IP Each tab. to contain: Ibuprofen 200mg 10 Tabs 1244 83b Ibuprofen Tab IP Each tab. to contain: Ibuprofen 400mg 10 Tabs 1245 94a Tab. Alprazolam Each tab. to contain : Alprazolam IP 0.25mg 10 tab 1246 94b Tab. Alprazolam Each tab. to contain : Alprazolam IP 0.5mg 10 tab 1247 0 Sterlity Testing for alone -

71/71